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ABSTRACT

I. PEPTIDE ISOSTERIC REPLACMENT PREPARATION USING
ZINC-MEDIATED CHAIN EXTENSION-ALDOL REACTIONS
II. FORMAL SYNTHESIS OF (+)-BREFELDIN A
III. ZINC-MEDIATED CHAIN EXTENSION REACTIONS WITH
SUBSTITUTED CARBENOIDS
By

Weimin Lin
University of New Hampshire, September, 2006

A series of amino acid derived alpha-substituted-gamma-keto amides and esters
have been prepared by zinc-mediated chain extension and tandem chain extension
aldol reactions with various aldehydes and ketones. An efficient diastereoselective
synthetic route has been developed to approach a proposed inhibitor for HCMV
(Human Cytomegalovirus) protease using this zinc-mediated tandem chain
extension-aldol reaction as the key step. An asymmetric formal synthesis of
(+)-Brefeldin A has been developed in which the zinc-mediated ring expansion
/oxidation

/elimination

method

constitutes

a

key

step.

Preparation

xxiv
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of

beta-alkyl-gamma-keto esters through a chain extension reaction using substituted
carbenoids has also been accomplished.

xxv
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CHAPTER I

PEPTIDE ISOSTERIC REPLACEMENT PREPARATION USING
ZINC-MEDIATED CHAIN EXTENSION-ALDOL REACTIONS

1.

Introduction

a)

Introduction to Peptide Isostere
The understanding of enzymatic catalysis is based on the concept that the

enzyme possesses a unique ability to stabilize the transition state.1 The transition state
in a peptide hydrolysis reaction will possess significant tetrahedral character, which
suggests that efficient inhibitors should provide a method to mimic this tetrahedral
character. The nucleophile responsible for the peptide bond 1 cleavage in the active
site of a serine protease is a serine residue. Upon its nucleophilic attack, a tetrahedral
intermediate 2 is formed. Collapse of the tetrahedral intermediate to form the trigonal
product requires the loss of a leaving group. If this leaving group is a portion of the
peptide chain, successful cleavage of the peptide bond has been accomplished. The
serine protease, upon hydrolysis of the serine ester, is available for further catalysis
(Scheme l).2

1
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O
+ Enzyme-OH
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4
Scheme 1: The Hydrolysis of a Peptide Bond with Serine Protease

One

strategy

for

protease

inhibition

involves

the

utilization

of

a

non-hydrolyzable peptide mimic; in other words, a mimic that can be recognized by
the enzyme’s active site, but is unable to be processed (cleaved) by the enzyme. The
ability to adopt a tetrahedral geometry through nucleophilic attack of the serine
residue in a serine protease would be advantageous due to the expected enhanced
binding in the active site; however, if the only possible leaving group of the
collapsing tetrahedral intermediate is the serine residue, the inhibitor is not
hydrolyzed.

The term ‘isostere’ refers to an atom or a group of atoms that are designed to
mimic the steric, and to a lesser extent the electronic properties of another atom or
group. Peptide isosteres are groups of atoms that are designed to mimic the peptide
(amide) bond found in a peptide chain.3 A variety of peptide isosteres have been
developed and studied, including the ketomethylene 5,4 a,a-difluoroketomethylene

2
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6,

c

hydroxyethylene 7,

c

alkene-based systems 8,

7

and others

8

(Figure 1). One

advantage of the ketomethylene system, and that of the a-fluoroketones, is the ability
of the ketone functionality to accept a nucleophile and adopt a tetrahedral geometry,
yet maintain its resistance" to hydrolytic cleavage.

7

8

Figure 1: Isosteric Replacement of Peptide Amino Bond

The ketomethylene isostere has been studied with a variety of enzymatic systems:
e.g. angiotensin-converting enzyme (ACE),9 HIV protease,10 influenza viral
protease,11 transpeptidase enzyme,12 and many aspartyl and serine proteases.13 A
variety of methods have been developed to prepare ketomethylene isosteres, many of
which are described below.

The application of a Grignard reagent to peptide isostere preparation has been
described frequently (Scheme 2).12b For example, an amino aldehyde can be reacted
with a Grignard reagent 9 derived from a three-carbon alkyl halide to generate an

3
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alcohol intermediate. After oxidation of the alcohol, y-keto ether 10 can be prepared.
Through deprotection of the benzyl group and further oxidation, the y-keto carboxylic
acid 11 is generated and is available to couple amino acids to extend the
ketomethylene-containing peptide chain. Racemization of the a-position is often
observed due to the acidic property of the a-amino aldehyde.

CH 3
R'v

BrMg
1)
2) Oxidation

1) H2/Pd

OBn
O

CH 3

10

Further coupling with

R'-

OH

2) PCC

O

CHo

amino acids

11

Peptide isostere

Scheme 2: Peptide Isostere Preparation Using a Grignard Reagent

Another approach to ketomethylene isostere involves using alkylation of a p-keto
ester 13 as a key step to approach the y-keto ester (Scheme 3).14 The P-keto ester 13
can

be

prepared

through

a

modified

Claisen

condensation

using

1,1-carbonyldiimidazole (CDI) as a carboxyl activation agent. A bromoester
derivative was applied to alkylate the P-keto ester 13 using sodium hydride as a base.
Upon treatment with trifluoroacetic acid (TFA), the t-butyl ester is cleaved and
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decarboxylation offers the y-keto ester 14. Ester cleavage with lithium hydroxide and
amide coupling with proline methyl ester provide the peptide chain mimic.

CbzHN

VH

a) CDI
CbzHN

b)

o^<

12

13

1) NaH, BrCH2COOEt

“

2) TFA

9

?

LiOH

C b zH N ^ Y ^ ^ ^ O E t

O
14
o

EDC, HOBT

'Y

CbzHN
N
H

COOMe
N'

OMe
15

Scheme 3: Peptide Isostere Preparation through Alkylation of a P-Keto Ester

The modified Dakin-West reaction constitutes another approach to obtain the
racemic y-keto ester 19 (Scheme 4).15 A reaction between the oxazolone derivative
16 and an acyl chloride using triethylamine as a base provides oxazole derivative 17.
Heating 17 with pyridine offers the migration product 18. Hydrolysis with acetic acid
followed by decarboxylation led to the formation of the dipeptide ketomethylene
mimic 19 with nitrogen atom functionalized with a benzoyl group.

5
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CIOC—\ ^ C 0 2CH3

0 ^ r ^ v^ ' <-'®2CH3
v
,0 ^ /0

^

TEA, THF
16

17

Pyridine, 80 °C

NH

HOAc

OMe

19

Scheme 4: Peptide Isostere Preparation Using Modified Dakin-West Method

In 1995, Rudd’s research group reported the transformation of a P-keto sulfone
intermediate into a ketomethylene isostere (Scheme 5).16 The Boc-protected amino
acid ester derivative 20 is reacted with a methylphenylsulfone dianion to form the
desired P-keto sulfone 21. The sulfone is reacted with the bromoacetamide derived
from an amino acid to provide the P-keto sulfone intermediate 22. A ketomethylene
tripeptide isostere 23 was obtained through the treatment with samarium iodide (Sml2 )
in a mixture of tetrahydrofuran (THF) and methanol.

6

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

O

0
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------------------------
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O
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o

R'
nH

V

JDMe
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ii
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S m l2, THF/MeOH
HN

o
H O
B o c H N ^ U ^ ^ N y L .^

R'

R

OMe

O R '

23
Scheme 5: Peptide Isostere Preparation through a P-Keto Sulfone

For many of the above examples, formation of ketomethylene-containing peptide
chains require the use of not-easily prepared starting materials and lengthy synthetic
routes. Moreover, substituent incorporation, along with the required stereocontrol, is
difficult in most of these synthetic approaches. For example, the requirement of using
amino acid-derived aldehydes as starting material is frequently troublesome, due to
their ease of epimerization. Furthermore, the availability of chiral, enantiomerically
pure a-bromo carboxylic acids is limited. Therefore, most methods cannot provide a
highly efficient diastereoselective route for a-side chain incorporation that would be
useful for peptide isostere preparation. The development of an efficient and simple
method for facilitating the conversion of easily available P-keto esters and amides into
a-substituted-y-keto esters and amides will be extremely useful for peptide isostere
preparation. The development of a method that facilitates the incorporation of a

7
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variety of substituents at the a-position could be beneficial for a host of biological
relevant synthetic targets.

b) Introduction to Chain Extension Chemistry
Ketomethylene isosteres incorporated within a peptide backbone can be viewed
as a y-keto amide that requires the presence of an a-substituent. A number of
strategies has been reported in the literature for the preparation of y-keto ester and
amide groups. One common strategy for the generation of the 1,4-dicarbonyl system
involves utilizing donor-acceptor cyclopropanes as key intermediates. This strategy
has been used to form y-keto esters, amides and phosphonates.17 Many variations
have been used to generate the donor-acceptor cyclopropane. The variations are
reviewed below.

In 1974, BieraugeTs research group reported the first chain extension reaction
that used P-keto esters as starting material, in which the conversion was based on the
fragmentation of a cyclopropane intermediate (Scheme 6).

10

#

An enamine derivative

24 was generated by treatment of an amine with a P-keto ester. After applying the zinc
carbenoid to the enamine derivative, an aqueous workup offered the targeted y-keto
ester 27. However, low yields for the conversion of a series of P-keto esters was
reported, which constituted a serious drawback for this methodology.

8
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EtZnl

R

ch 2i2

OR’
H

24

25
O

+N R , H
OR'

R'

H
OR'

R'

O

O
27

26

Scheme 6: Bieraugel’s Chain Extension Method

Saigo’s research group modified Bieraugel’s method by using TMS enol ether 28
as the starting material. After exposing compound 29 to Simmons-Smith
cyclopropanation conditions, a mixture of carboxylic acid derivatives 30 and 31 was
isolated from saponifination with potassium hydroxide, which indicated that multiple
addition of the carbenoid was taking place. Treatment of compound 28 with ethyl
diazoacetate and copper sulfate (cat) led to the P-carboxy-substituted-y-keto esters 33
(Scheme 7). No simple y-keto esters were isolated under these reaction conditions.19

9
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0

CUS0 4
R'

OEt

O
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v

'OH
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+
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31
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TMSO
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V yor'
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O ^O E?

32

33

Scheme 7: Saigo’s Chain Extension Method

In 1983, Reissig’s research group developed a [2+l]-cycloaddition strategy
(Scheme 8),20 in which a methylcarbonyl-carbenoid was reacted with a silyl enol
ether 34 to generate the intermediate cyclopropane. Fluoride treatment or an aqueous
acidic workup provided the desired y-keto esters 27,. This method differed from those
of Bieraugel and Saigo in that the starting material was derived from a methyl ketone,
as opposed to the P-keto ester starting materials of the Bieraugel and Saigo studies.
O
H
'OR'

tm so ~y
R
34

^

h

V
OR’

TMSO
C u (acac ) 2

R
35

27

A: X = C 0 2 R \ Y=H
B: X=H, Y = C 0 2 R'

Scheme 8: Reissig’s Chain Extension Method
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In 1987, Dowd’s research group developed a different method for the chain
extension reaction of disubstituted P-keto esters 36 (Scheme 9),21 although the
a-substituted-y-keto ester products were generated through a similar donor-acceptor
cyclopropane. The key difference involved the intermediacy of a radical in the ring
expansion or chain extension reaction. This chain extension method cannot be applied
to unsubstituted P-keto esters, which makes the method complementary to that of
Zercher and coworkers.17 Furthermore, no stereoselectivity was demonstrated at the
a-position, which would hinder the application of this method to peptide isostere
formation.
O

O

r'T C d r'
J R"
Br

O

nBu3SnH
R

AIBN

X

36

O

O
OR'

R"
38

37
O

nBu3SnH

O

R”

OR'

OR'

40

39

Scheme 9: Dowd’s Chain Extension Method

In 1997, Zercher’s research group reported a simple, one-pot chain extension
reaction for the formation of y-keto esters from a-unsubstituted-P-keto esters using a
zinc carbenoid for generation of the cyclopropane (Scheme 10).17aThis zinc-mediated
chain extension reaction has been successfully applied to a variety of P-keto esters
and amides. Some difficulty was encountered in performing this reaction on

11
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a-substituted-P-keto

dicarbonyl

substrates,

which

made

generation

of

a-substituted-y-keto esters inefficient. However, tandem reaction sequences have been
developed to target the desired a-substituted-y-keto esters.

The mechanism of this chain extension reaction is believed to involve a
donor-acceptor cyclopropane (Scheme 10).Treatment of a P-keto carbonyl compound
41 with diethyl zinc or a zinc carbenoid produces the enolate, which traps one
equivalent of the carbenoid derived from methylene iodide and diethyl zinc. The
cyclopropane intermediate 44 is accessed through intramolecular cycloaddition. The
three-membered ring’s strain is released by fragmentation, which results in insertion
of a methylene unit in the alkyl chain. The intermediacy of 45 is supported by an
NMR study.22 Quenching the intermediate with a proton source, typically ammonium
chloride, completes the one-pot chain extension process.

Tandem chemistry, used for a-side chain insertion, has been explored in efforts
to broaden the zinc-mediated chain extension method. Reactions between the
zinc-organometallic (enolate-equivalent) 45 and various aldehydes provided the
predominant syn-aldol product 47, with stereoselectivity much greater than the typical
Reformatsky reaction.23 Another modification involves the use of a catalytic amount
of trimethylsilyl chloride, which promotes formation of a zinc homoenolate in the
presence of excess carbenoid. Upon addition of a proton source, a methyl group is

12
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incorporated at the a-position.24 Trapping with other electrophiles, like iodine, 25
ketones,

76

imminium ions,

77

activated imines,

70

is also possible and under further

development.
X

i

I

I

***»

R ^ ^ ^ R '

EtZnCH2l

o'Zno

or EtZnCH2l

R^
41

R.
42

O

X

O

i

O

O
R’

ZnX
43

44

Zn

N H 4C I

R'
45
R"CHO

or' V

46
a) TMS-CI
b) EtZnCH2l
c) E+

OH

R’

O

0

47

48

Scheme 10: Zercher’s Chain Extension Method

Recently, this zinc-mediated chain extension reaction has been applied to peptide
isostere preparation. Two different approaches have been studied. One involves chain
extension of a P-keto ester derived from an TV-protected amino acid (building off the
C-terminus).29 A variety of P-keto esters 50, derived from protected natural amino

13
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acids, was prepared using a modified Claisen condensation reaction developed by
Masamune and Brooks.30 Following treatment with the zinc-mediated carbenoid,
dipeptide mimics 51 were generated in good to excellent yields (Scheme 11). This
method was also proved to be useful for the preparation of tripeptide mimics. Four
common nitrogen-protecting groups (Cbz, Fmoc, Boc, Bz) used for amino acids were
shown to be tolerated in the chain extension reaction. The potential epimerization of
the a-amino acid’s stereocenter during the zinc-mediated chain extension was
excluded based on chiral HPLC studies.

2) MgBu2/THF

=

K

O

4
9
PG

HNk

:

R

OMe

CH2 CI2

O

11OH

9
9

M eO ^ ^

O

JL

^ 0 .Me

51
Scheme 11: Peptide Isostere Preparation Using Zinc-Mediated Chain Extension
Reaction

The other approach to peptide isostere formation involved chain extension of
P-keto amides derived from carboxyl-protected amino acid (chain extension of the
jV-terminus).31 A reaction between the amino acid and diketene under mild conditions
offered the corresponding P-keto amides 53 starting material from protected or

14
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unprotected amino acids. Exposure of P-keto amides to the zinc-carbenoid, in a
similar fashion to that involving the amino acid-derived P-keto esters, resulted in the
formation of dipeptide mimics 54 in satisfactory yields (Scheme 12).

O

Diketene, N aH C 0 3
B en zen e

R
53

52

O

RV

R'

ZnEt2/CH2l2
CH 2 CI2

O

•O.
O

R

R'

0

54

Scheme 12: Synthetic Route to the Peptide Isosteric Replacement via Chain
Extension of the N -7erminus

Since the first aspect of the study, which was to test the efficiency of the chain
extension reaction for the P-keto esters and amides derived from simple protected
amino acids, had been successfully accomplished, the advanced task of identifying
practical methods to incorporate substituents at the a-position was targeted. Both
enantioselective and diastereoselective control at the a-position would be necessary
for the chain extension reaction to be useful for isosteric replacement of the peptide
bond. Based on the regiospecific and highly diastereoselective zinc-mediated tandem

15
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chain extension-aldol reaction, we decided to perform a full study of this potentially
useful tandem reaction on amino acid-derived substrates.

2.

Results and Discussion

a)

Initial Study towards Diastereoselective Zinc-Mediated Chain
Extension-Aldol Reaction of jl-Keto Amides Derived from Amino Acids
Three representative primary and secondaiy amino acids were selected as the

starting materials for the methodological study, proline (Pro), phenylalanine (Phe) and
valine (Val). Since tandem chain extension-aldol reactions are sensitive to the
presence of a proton source, which would quench the enolate prior to the aldol
reaction, appropriate protection of the amino acid is required. Since proline is a
secondary amino acid, no further protection is required for 55, which is derived from
diketene and proline methyl ester.31 The zinc-mediated chain extension reaction was
performed on the substrate (55) using five equivalents carbenoid to test the efficiency
of the chain extension reaction (Scheme 13). The targeted product 56 was prepared in
high yield and was characterized by 3H and 13C NMR spectroscopy.

Et2Zn (5 equiv), CH2 CI2
CH2 I2 (5 equiv)

56

55

Scheme 13: Zinc-Mediated Chain Extension Reaction of 55
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Based on this successful result, the zinc-mediated chain extension-aldol reaction
was performed by adding benzaldehyde to the chain extension intermediate 57.
Surprisingly, the methyl ether 59 derived from the chain extension-aldol product was
detected instead of the anticipated aldol product 58 (Scheme 14). Furthermore, benzyl
alcohol was identified as a byproduct of the reaction. Reduction of benzaldehyde in
the presence of carbenoids is frequently observed, although reduction of other
aldehydes is not observed.

Ph

ZnX

Ph

59
Scheme 14: Attempted Zinc-Mediated Chain Extension-Aldol Reaction Using
Benzaldehyde

The formation of the methyl ether was believed to result from excess carbenoid,
which reacted with the targeted aldol product 58. This assumption was confirmed by
treatment of the aldol product 58, the formation of which is described below, with two
equivalents of carbenoid to generate the identical methoxy-containing product 59
(Scheme 15).
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Scheme 15: Preparation of Compound 59

The solution to the over-alkylation problem was to decrease the carbenoid
equivalents from five to 2.5, which facilitated the chain extension reaction, yet left
little or no carbenoid in the reaction solution at the time of benzaldehyde addition
(Scheme 16). The isolated aldol product 62 was shown to exist as one major
hemi-acetal isomer based on 13C NMR analysis. Greater than 95% diastereoselectivity
in this zinc-mediated chain extension-aldol reaction was achieved, with formation of a
syn-aldol product and the (S)-stereocenter at the a-position assigned on the basis of
X-ray crystallographic

analysis

of compound

62.

The

formation of the

(5)-stereocenter at the a-position meets the stereochemical requirement for the
mimicry of the natural amino acid side chain.
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55

de > 95%, 70% yield

O
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Scheme 16: Preparation of Compound 62

Based on this encouraging result, two modifications of the aldol product 62 were
performed. These modifications were designed to expand the substrate’s utility in
peptide isostere preparation.

One modification involved the treatment of the aldol product 62 with
trifluoroboron etherate and triethylsilane at -78 °C for the formation of a substituted
tetrahydrofuran derivative 63 (Scheme 17),32 which could be viewed a potential
peptide isostere target.33 A mixture of epimers 63A and 63B was generated in a ratio
of 4.4:1 during this reductive chemistry.

O

HQ

O

% -O M e

\-O M e

Et3 SiH, BF3- Et20
CH 2 CI2, -78 °C tort
Ph
62

63A + 63B

Scheme 17: Triethylsilane Reduction on the Compound 62
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The other modification required the identification of a practical deoxygenation
method for the conversion of the aldol product 62 to a mimic of the natural
phenylalanine (Bn) side chain. Two radical-based methods were investigated for this
goal. The use of a hydride-mediated approach was impossible due to the other ester
and amide functionality. Myers’ group has described the conversion of a primary or
secondary alcohol 64 to a monoalkyl diazene through Mitsunobu replacement with
o-nitrobenzenesulfonyl-hydrazine
0 -nitrobenzenesulfinic

(NBSH)

and

in

situ

elimination

of

acid. Loss of nitrogen and trapping of the radical with the

diazene’s hydrogen atom completes the reaction (Scheme 18).34 However, several
attempts to apply this method to compound 62 led to an unidentified mixture of
products, possibly due to the reaction between the ketone and hydrazine functional
groups.

RCH2OH

PPh3, DEAD, NBSH
-------------------------------------►

RCH 2 N(NH 2 ) S 0 2Ar

THF, -30 °C

65

64

r c h 2 n=nh

> 0 °C
-------------

-N ,
RCH,

66

67

Scheme 18: Myers’ Deoxygenation Method

A two-step deoxygenation method developed by Barton’s research group
involves xanthate preparation using carbon disulfide and radical reduction of the
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xanthate functionality (Scheme 19).

Treatment of compound 62 with sodium

hydride, followed by the addition of carbon disulfide and methyl iodide provided
xanthate derivative 68 in a good yield. The AIBN-initiated radical reduction of
compound 68 using tributyltinhydride afforded the final deoxygenated product 69,
which mimicked both the natural phenylalanine side chain and the natural amino acid
stereochemistry.

O

V-OMi

HO

O

a) NaH

.

b) CS2
Ph

c) CH3I

O

"VoM e

Ph

S^SC H 3
62

AIBN, (Bu) 3 SnH,

68

O

V-OMe

Toluene, 8 0 °C

rph
Phenylalanine mimic

69

Scheme 19: Barton’s Deoxygenation Method on Compound 62

Another zinc-mediated chain extension-aldol reaction on the P-keto amide (55)
was explored in which formaldehyde was used as an electrophile. Due to the gaseous
nature of formaldehyde, paraformaldehyde, a polymer of formaldehyde, was used in
the reaction. Surprisingly, no desired aldol product 70 was generated; instead, a dimer
(71) of the zinc-mediated chain extension intermediate 57 was formed (Scheme 20).
The stereochemical assignment was made by X-ray crystallography.
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S c h e m e 20:

Zinc-Mediated Chain Extension-Aldol Reaction Using Formaldehyde

The procedure was modified to transfer formaldehyde gas by cannula, formed by
heating paraformaldehyde, into the solution that contained the chain extension
intermediate

( S c h e m e 2 1 ).

An aldol product (de

>95% ) 70,

exclusively existing in a

ring-opened form, was obtained. The hydroxymethyl side chain mimicked the side
chain of the amino acid serine, although the stereochemistry was unidentified initially.

O

O

° V ° Me
\ /
w

b) CH20 (g)

^

L V
OH
70

5 5

S c h e m e 21 :

j? y-'OMe

a) Et2Zn + CH 2 I2 (2.5 equiv)

Modified Tandem Zinc-Mediated Chain Extension-Aldol Reaction Using
Formaldehyde
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Successful application of Barton’s deoxygenation method to compound 70
provided the a-methylated derivative 73, which can be viewed as a mimic of the
alanine side chain (Scheme 22).

O
a) NaH, b) C S2, c) CH3I

n

M OH
70
O

°V -O M e

AIBN, (Bu)3SnH
N'

I

73

Scheme 22: Barton’s Deoxygenation Method on Compound 70

A

zinc-mediated

chain

extension-methylation

reaction,

in

which

the

zinc-organometallic intermediate is treated with catalytic trimethylsilylchloride and
excess carbenoid, has been developed in our group.24 This method was used by Fan
Su in her B.S thesis research to provide compound 73. Reacting the ketone with
2,4-DNP produced yellow crystals which were determined by X-ray crystallography
to possess the (^-configuration at the stereocenter generated in the tandem chain
extension-methylation reaction (Scheme 23).36 The 'H and 13C NMR spectra of the
deoxygenation product 73 and the chain extension-methylation product 74 were
identical, thereby indicating that proline is an efficient chiral auxiliary for the
diastereoselective zinc-mediated chain extension-aldol reaction.
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Scheme 23: Preparation of Compound 75

Treatment of the aldol product 76 with trifluoroboron etherate and triethylsilane
at -78 °C provided the substituted tetrahydrofuran derivative 77. Once again, a
mixture of isomers 77A and 77B in a ratio of 3.3:1 was generated (Scheme 24).

O

O

"V-OMe

"V oM e

CH2 CI2, -78 °C to rt

77A + 77B

Scheme 24: Triethylsilane Reduction on the Compound 76

The zinc-mediated chain extension-aldol reaction between compound 56 and
acetone was also explored (Scheme 25). Only one predominant aldol product (de
>95%), existing in a ring-opened form with unknown stereocenter at the a-position,
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was produced. Similar reactions to those described above were attempted on
compound 78. Application of Barton’s deoxygenation method was unsuccessful with
this aldol product 78 due to the inability to functionalize the sterically hindered
tertiary alcohol. Efforts to mimic the valine side chain, which would have resulted
from the successful deoxygenation, are underway in the research group using alternate
means.

o

o

CL

V 0Me

a)
Et2Zn + CH 2 I2 (2 .5 equiv)

-------------------------------------b)

A ceton e
OH

56

78

a) NaH,
b) C S 2
c)

q

°V -O M e

CH3I
o c s 2ch

3

79

Scheme 25: Attempted Barton Deoxygenation on Compound 78

Triethylsilane reduction in the presence of trifluoroboron etherate offered the
substituted tetrahydrofuran derivative 80. A mixture of isomers 80A and 80B was
generated in a ratio of 3.5:1, although the stereochemistiy of the two stereocenters is
unknown (Scheme 26).
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Scheme 26: Triethylsilane Reduction on the Compound 78

Lithium aluminum hydride (LAH) reduction of aldol product 80, followed by
esterification with 3,5-dinitrobenzoylchloride, was performed in an effort to gather
information regarding the stereochemistry through crystal formation and X-ray
structural determination (Scheme 27).

However, no crystals were generated, and

the stereochemistry remains unknown.

O

— OH

V-OMi

3,5-DNB
'N '

.

/ -

O'

81

80

NO.

—O

Oily com pound
NO.

82
Scheme 27: Sequential LAH Reduction and 3,5-DNB Esterification on Compound 80

The zinc-mediated chain extension-aldol reaction between compound 56 and
benzophenone was also explored (Scheme 28). Only one predominant aldol product
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(ide >95%) was formed. The compound existed in a ring-opened form with
(^-stereochemistry at the a-position, as assigned on the basis of X-ray structural
analysis. Application of Barton’s deoxygenation method was unsuccessful with this
aldol product 83 due to the inability to functionalize the sterically hindered tertiary
alcohol.

O

O

O

V-OMe

"V -O M e

Ph’"Jh0H

V-OMe

a) NaH

b) CS2
c) CH3I

Ph^TPh

84
Scheme 28: Attempted Barton Deoxygenation on Compound 83

Triethylsilane reduction in the presence of trifluoroboron etherate offered the
unexpected alcohol 85, instead of the substituted tetrahydrofuran derivative (Scheme
29). The stereochemistry generated from the reductive process was identified through
X-ray crystallography.
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■^OMe
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Scheme 29: Triethylsilane Reduction on the Compound 83

As demonstrated by Tryder, P-keto amides derived from unprotected primary
amino acid methyl esters and diketene can undergo the zinc-mediated chain extension
reaction with good to excellent yield. A chiral HPLC study was used to demonstrate
that no epimerization of the a-stereocenter of the amino acids occurred during the
chain extension reaction.31 However, trapping the zinc-mediated chain extension
intermediate 87 with electrophiles required additional protection of the primary amine
due to the existence of an amide proton, which could quench the intermediate 87 as
observed in the previous study (Scheme 30).338
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Scheme 30: Active Proton Transfer during the Zinc-Mediated Chain Extension
Reaction
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The carbobenzyloxy (Cbz) group is a very common protecting group for amino
acids in peptide synthesis and its preparation can be easily performed in aqueous
sodium bicarbonate solution with benzylchloroformate in almost quantitative yield.
After the reaction with diketene, P-keto amides 91 with Cbz protection were prepared
(Scheme 31).

O
RV

^ 0M e

1)

NH2
HCI

N aH C 0 3 (aq)
Benzylchloroformate

2)

diketene
pyridine, heating

90
O

O

/ 11^

R

n xIY
C bz 11

0'

91

Scheme 31: Preparation of 91 Protected by Carbobenzyloxy (Cbz) Group

However, the zinc-mediated chain extension of this compound generated y-keto
amides in low isolated yield, apparently due to hydrolytic instability of the imide
functionality (Scheme 32).31 This result discouraged the use of compound 91 in the
zinc-mediated chain extension-aldol reaction.
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S c h e m e 32:

Attempted Preparation of y-Keto Amides Protected by Carbobenzyloxy
Group through Zinc-Mediated Chain Extension Reaction

Instead of using a carbamate type protecting group, which would incorporate
imide functionality into the substrate, a benzyl (Bn) group was considered as a
suitable replacement for Cbz. The reaction between primary amino acid (Phe, Val)
methyl esters with benzyl bromide and potassium carbonate introduced the benzyl
group on the nitrogen. A reaction with diketene provided .the targeted P-keto amides
93

and 9 4

( S c h e m e 3 3 ) . 31

R V j A OM e

^2

1)K 2 C 0 3 .D M F.
Bn-Br

2

) D iketene
NaHC 0

3

o

, b en zen e

HCI
R=Benzyl, 9 3
R= Isopropyl, 94

90
S ch em e 33:

Preparation of P-Keto Amides Protected by Benzyl (Bn) Group

Before conducting the study of the zinc-mediated chain extension-aldol reaction
on compounds

93

and 9 4 , two investigations were necessary. The efficiency of simple

zinc-mediated chain extension reaction needed to be determined. Furthermore,
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deprotection of the benzyl group from the chain extended material needed to be
investigated. The chain extension reaction, performed on compound 93 and 94 with
five equivalents of diethyl zinc and methylene iodide, proved to be even more
efficient in the formation of y-keto amide 95 and 96 than the reaction of the
unprotected secondary amides (Scheme 34). The absence of proton appeared to aid
the chain extension reaction.

Et2Zn + CH 2 l2 (5 equiv)

9 3 and 9 4

R=Bn, 95
R=/'so-propyl, 96

Scheme 34: Preparation of y-Keto Amides Protected by Benzyl Group through
Zinc-Mediated Chain Extension Reaction

Nevertheless, deprotection of the benzyl group from compound 95 was difficult
even when medium pressure hydrogenolysis conditions were applied (Scheme 35).
The literature confirms that it is quite challenging to cleave an amide’s benzyl group
using hydrogenolysis.39 Other reported methods for the cleavage of Bn group would
not be compatible with the ketone functional group.
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Scheme 35: Attempted Deprotection of Benzyl Group on y-Keto Amide 95 Using
Medium-Pressure Hydrogenolysis

Due to the unsuccessful cleavage attempts of the benzyl protecting group, a
/?-methoxybenzyl (PMB) group was chosen as an alternative protecting group. Instead
of using benzyl bromide, /?-methoxybenzyl chloride was reacted with the amine
nitrogen. After preparation of compounds 98 and 99, the chain extension reaction
proceeded in excellent yield (Scheme 36).

O
1) K2 C 0 3 , DMF

O

R

2) D iketene

OMe
NH2

N aH C 0 3

PMB-CI

PMB O

HCI
R=Benzyl: 98
R=/so-propyl: 99

90
O

Et2Zn + CH 2 I2 (5 equiv)

R

N
PMB O
R=Bn: 100
R=/'so-propyl: 101

Scheme 36: Preparation of y-Keto Amides 100 and 101

Several methods have been reported for the cleavage of PMB groups from an
amide, including refluxing with trifluoroacetic acid,

40

treatment with eerie
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ammonium nitrate (CAN),

and treatment with tert-butyl lithium.

After the

consideration of functional group compatibility under such reaction conditions, eerie
ammonium nitrate (CAN) was selected for the first attempt to remove the amide’s
PMB group. However, the use of water and acetonitrile (1:4 ratio) as the co-solvents
while stirring the reaction overnight did not result in PMB removal from the y-keto
amides 100 and 101. An unidentified mixture of products was generated during the
long reaction time (Scheme 37).

O

R

[]

N

O

PM BO
1 0 0

and

jj

CAN, c h 3 c n , h 2o

».

Unidentified mixture

rt, I 2 h

1 0 1

Scheme 37: Attempted Cleavage of Amide’s PMB Group Using Ceric Ammonium
Nitrate

After shortening the reaction time from 12 h to 30 min and monitoring
consumption of starting material by thin layer chromatography (TLC), a good yield
(> 60%) of the targeted products 97 and 102 was achieved (Scheme 38). The product
had identical 'H and 13C NMR spectra to the compound prepared through
zinc-mediated chain extension reaction of unprotected p-keto secondary amide.
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Scheme 38: Modified Cleavage of Amide’s PMB Group Using Ceric Ammonium
Nitrate

The zinc-mediated chain extension-aldol reaction was performed on the P-keto
amide 98 using formaldehyde as the electrophile. Two inseparable aldol products
103A and 103B (in a ratio of 1:1), existing in ring opened forms, were produced. No
diastereoselectivity was obtained in the aldol reaction (Scheme 39).

O

O

Bn

O

Bn

a) ElgZn + CH2 I2 (2.5 equiv)
PMB O

b) Form aldehyde

98

S hO

^

103A and 103B

Scheme 39: Modified Tandem Zinc-Mediated Chain Extension-Aldol Reaction Using
Formaldehyde as the Electrophile

Direct removal of the PMB group of aldol products 103A and 103B with ceric
ammonium nitrate (CAN) was not successful. An unidentifiable mixture was formed,
which might be attributable to the strong oxidizing ability of CAN (Scheme 40).43
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CAN

*
W

\

PMB0

OH
104A and 104B

103A and 103B

Scheme 40: Attempted Cleavage of Amide’s PMB Group Using Ceric Ammonium
Nitrate

Based on this unexpected result, a tert-butyldimethylsilyl (TBDMS) group,
which is a common protecting group for an alcohol, was used to protect the aldol
products prior to the attempted cleavage of the PMB group.44 However, the CAN
oxidation was still unsuccessful in removing the PMB group and producing the
secondary amide (Scheme 41).

imidazole,
TBDMS-CI, DMF

103A and 103B

105A and 105B

106A + 106B

Scheme 41: Attempted Cleavage of Amide’s PMB Group Using Ceric Ammonium
Nitrate
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Eventually, the protecting group was switched from TBDMS to the TBDPS
(terf-butyldiphenylsilyl) group for the purpose of increasing the silyl ether 107’s
stability. 45 This change allowed for the cleavage of the PMB group. The two
diastereomers 107A and 107B were able to be separated by column chromatography
(Scheme 42); however, stereochemical assignment of the two isomers was not
possible.

O
N
t b d Ps o

PMB O
TBD&0

Two separable diastereom ers
107A and 107B

1

08A and 108B

Scheme 42: Modified Cleavage of Amide’s PMB Group Using Ceric Ammonium
Nitrate

Though deprotection of the TBDPS group was not explored in an effort to
release the hydroxymethyl group (serine mimic), tetrabutylammonium fluoride
(TBAF) treatment is typically used to facilitate the cleavage (Scheme 43) . 44
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o

TBAF
N

THF

O
N

t b d Ps o

109

108A

Scheme 43: Proposed Cleavage of TBDPS Group Using Tetrabutylammonium
Fluoride Treatment

Barton’s deoxygenation method was successfully applied to the aldol products
103A and 103B in order to generate the side chain mimic for alanine. The
intermediate xanthates 110A and 11 OB were separated using column chromatography
(Scheme 44), and the deoxygenation reactions performed on the two isomers 111A
and 11 IB separately.

a) NaH
b) C S 2

HO

PMB O

c)

CH3I

PMB O
SCH

103A and 103B
110A and 110B

AIBN, (Bu)3SnH
PMB O
111A and 111B

Scheme 44: Barton’s Deoxygenation Method on Compounds 103A and 103B
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When the zinc-mediated chain extension-aldol reaction with benzaldehyde was
performed on substrate 98, minimizing the equivalents of carbenoid from 5 to 2.5 was
required to prevent formation of the aldol-methylation by-product. Inseparable aldol
products 112A and 112B (ratiol:l), existing in hemiacetal forms, were formed with
unknown stereochemistry (Scheme 45). It was unclear whether the stereoisomers
were formed due to poor syn/anti aldol selectivity, or due to poor enolate facial
selectivity. Furthermore, the stereochemical analysis was complicated by the
appearance of amide bond rotamers.

112A and 112B

Scheme 45: Modified Tandem Zinc-Mediated Chain Extension-Aldol Reaction

Barton’s deoxygenation method was also successfully applied to the aldol
product 112A and 112B, which provided a side chain mimic of phenylalanine. The
intermediate xanthates 113A and 113B were separated using column chromatography.
Reaction of the purified xanthates provided the a-benzyl amide 114A and 114B
(Scheme 46). The two reduction products were isomeric, indicating that the poor
stereoselectivity in the aldol reaction was due to poor enolate facial selectivity.
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SCH3
112A and 112B

(Two separable diastereomers)
113A and 113B

AIBN, (Bu)3SnH

CAN

Ph
114A and 114B

Ph
114C and 114D

Scheme 46: Barton’s Deoxygenation Method on Compounds 112A and 112B

In summary, the study on the zinc-mediated chain extension-aldol reaction of
p-keto amides derived from amino acids indicated that proline was a good chiral
auxiliary for the chain extension-aldol reaction. High diastereoselectivity, both in
terms of enolate facial selectivity and syn/anti aldol selectivity, was achieved using a
proline-modified substrate. In contrast, neither valine nor phenylalanine provided
good stereocontrol in the chain extension aldol reaction. The challenge in removing
proline, which requires harsh acidic conditions, prevents further derivatization and the
preparation of tripeptide or tetrapeptide mimics. The utilization of another efficient
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and easily removal chiral auxiliary, which provides excellent diastereocontrol and is
easily removed, for the chain extension aldol reaction was necessary.

b)

Study towards Diastereoselective Zinc-Mediated Chain Extension-Aldol
Reaction on P-Keto Imides Derived from Amino Acids
Theberge had used the chain extension reaction approach for the synthesis of

tripeptide 117 and tetrapeptide mimics (Scheme 47) . 46 His approach involved the
conversion of the amino acid’s carboxy terminus into a P-keto ester, which was chain
extended to generate the y-keto ester. With this approach, both the N and C-terminus
are available for further manipulation. However, Theberge did not attempt to
incorporate side chain mimics in the isostere. The development of a diastereoselective
zinc-mediated chain extension-aldol reaction on a substrate with a removable chiral
auxiliary on the carboxylic terminus might allow the incorporation of side chain
mimics with stereocontrol. Furthermore, the ability to derivatize both the N and C
termini of the peptide mimic would greatly aid the utility of the method.
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Scheme 47: Theberge’s Synthesis of Tripeptide Mimic using Zinc-Mediated Chain
Extension Reaction

Proline protected by the tert-butoxycarbonyl (Boc) group (118) was selected as
the starting material for this study, since only one protecting group was needed. No
studies had been performed on the ability of proline, or any other chiral amino acid, to
influence the stereochemistry at the a-position during tandem reaction sequence. The
initial studies were designed to investigate the stereochemical influence of the proline.
Masamune-Brooks reaction with monobenzyl malonate (MBM) offered the targeted
p-keto benzyl ester 119 (Scheme 48). The benzyl ester was selected to facilitate the
subsequent deprotection and amino acid coupling reactions. The removal of the
benzyl ester can be performed using mild hydrogenolysis. In contrast, the cleavage of
a methyl ester, usually performed under strongly basic conditions,47 could cause the
epimerization of the amino acid’s a-proton.
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Scheme 48: Preparation of P-Keto Benzyl Ester 118 Using Masamune-Brooks
Reaction

A tandem zinc-mediated chain extension-aldol reaction was performed on
substrate 119 with formaldehyde in an effort to generate serine mimics (Scheme 49).
Two inseparable diastereomers were formed, which indicated that the remote
stereocenter of proline did not affect the diastereoselectivity of the aldol reaction.

b) CH20 (g a s)
NBoc
119
Two diastereom ers with a ratio of 1:1
120A and 120B

Scheme 49: Zinc-Mediated Chain Extension-Aldol Reaction on Compound 119

In an effort to facilitate product separation and subsequent amino acid coupling
reactions, the TBDMS group was used to protect the primary alcohol generated in the
chain extension-aldol reaction. After the formation of compounds 121A and 121B,
hydrogenolysis of benzyl ester offered the carboxylic acid derivative 122A and 122B.
The

acid

was

coupled

with

(5)-phenylalanine

methyl

ester
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using

1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) and 1-hydroxybenzotriazole
(HOBt) to provide the tripeptide ketomethylene containing mimics 123A and 123B,46
which were separated using column chromatography (Scheme 50).
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Scheme 50: Synthesis of Tripeptide Mimic using Zinc-Mediated Chain
Extension-Aldol Reaction

As discussed previously (Scheme 30), the presence of an active proton source in
the amino acid would quench the chain extension intermediate; therefore a suitable
protecting group for the primary amine was required. The phthalimide protecting
group was selected, since it would avoid the rotamer phenomenon (two identical
functional groups on nitrogen atom) which complicates NMR spectral interpretation.48
A three-step synthetic approach is illustrated below for the preparation of the
phthalyl-protected valine (Scheme 51): ring opening of phthalic anhydride using the
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trifluoroboron ether complex provided
2

the achiral half-ester 125.

Methyl

-((succinimidooxy)carbonyl)benzoate 126 was prepared by reaction o'f compound

125 with ./V-hydroxysuccinimide using dicyclohexylcarbodiimide (DCC) as the
coupling reagent. The compound was allowed to react with the sodium salt of
(S)-valine to offer the product 127.49

BF3-Et2 0

OH
OMe

MeOH

DCC, DME,

OSu
OMe

N -O H

124

Na2 C0 3
HCI
H2N

OH

O O
127

Scheme 51: TV-Phthaloylation of (S)-Valine

A Masamune-Brooks reaction with monobenzyl malonate (MBM) generated the
targeted P-keto benzyl ester 128. When the zinc-mediated chain extension reaction
was performed, the product was the tricyclic compound 130, which was identified by
X-ray crystallography (Scheme 52). The spontaneous attack onto the imide’s
carbonyl group by the enolate-equivalent appears responsible for the formation of
compound 130.
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Scheme 52: Attempted Zinc-Mediated Chain Extension Reaction on P-Keto Benzyl
Ester 128

An identical result was observed when (5)-phenylalanine was used as the starting
material instead of valine. Though the unexpected formation of the bicyclic derivative
excluded the possibility of using the phthalimide protecting group for the
zinc-mediated chain extension-aldol reaction, the formation of this interesting bicyclic
compound was efficient.

The tert-butoxycarbonyl (Boc) and p-methoxybenzyl (PMB) groups were
selected for protection of the amino acids in the ensuing chain extension-aldol
reaction study, since selective removal of these two protective groups appeared
possible. Sodium borohydride reduction of the iminium ion derived from (S)-alanine
and anisaldehyde provided compound 132.50 The incorporation of the Boc group
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using di-/er/-butyl dicarbonate offered compound 133. However, after preparation of
the P-keto benzyl ester 134 using the Masamune-Brooks protocol, the zinc-mediated
chain extension reaction was not successful. Starting material was recovered (Scheme
53).
©
© 3— 4
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Et2 Z n.C H 2 l2
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B oc
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OBn
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PMB
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O
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Scheme 53: Attempted Zinc-Mediated Chain Extension Reaction on P-Keto Benzyl
Ester 134

Switching the protecting group from />-methoxybenzyl (PMB) to benzyl (Bn) did
not

improve

the

efficiency

of chain

extension

reaction.

Therefore,

the

benzyloxycarbonyl (Cbz) group was considered as a replacement for the Boc group.
Compound 137 was prepared followed similar chemistry described above (Scheme
54), although the allyl ester was incorporated as part o f the P-keto ester.
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Scheme 54: Preparation of Compound 137

The zinc-mediated chain extension reaction was successfully performed on
substrate 137 and trapping the chain extension intermediate with formaldehyde
provided two diastereomers 138A and 138B, which is consistent with the poor
stereoselectivity observed in the previous study on the proline derivative (Scheme
55).
PMB 0
Cbz"

Y
ch

0

PMB O

a) Et2 Zn, CH 2 I2
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b) CH20 (g a s)

Cbz
ch

3

3
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137

1 3 8 A and 138A

Scheme 55: The Zinc-Mediated Chain Extension-Aldol Reaction on Substrate 137

tert-Butyldiphenylsilyl (TBDPS) protection of compounds 138A and 138B was
performed in order to simplify NMR spectral interpretation and to facilitate amino
acid

coupling

reactions.

The

allyl

ester

was

cleaved

using
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palladium

tetrakis(triphenylphosphine) and pyrrolidine to produce carboxylic acids 140A and
HOB. 51 The coupling reaction with alanine methyl ester hydrochloride using
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) and 1-hydroxybenzotriazole
(HOBt) provided the tripeptide ketomethylene mimic (141A and 141B) of the
alanine-serine-alanine sequence, albeit as a mixture of diastereomers (Scheme 56).
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Scheme 56: Synthesis of Tripeptide Mimics Using Zinc-Mediated Chain
Extension-Aldol Reaction

Incorporation of an asparagine residue on the TV-terminus would provide a
tetrapeptide mimic of the Human cytomegalovirus (HCMV) protease cleavage site.
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More detailed rationale for targeting this tetrapeptide and for the inclusion of the
A.TV-dimethylasparagine residue will be presented later. The (S)-asparagine derivative
was prepared in a two-step reaction sequence to generate the carboxylic acid 144
needed for the preparation of the tetrapeptide mimic (Scheme 57). The coupling
reaction between the commercially available Boc-protected aspartic acid benzyl ester
142

and

A,jV-dimethylamine

hydrochloride

provided

compound

143.

Palladium-catalyzed hydrogenolysis offered the targeted asparagine derivative 144.
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Scheme 57: Synthesis o f ./V.A-Dimethyl Asparagine Derivative 144

The selective removal of the Cbz group was successfully performed using
hydrogen and catalytic 10% palladium on carbon to produce compounds 145A and
145B. However, the amino acid coupling reaction between compound 145 and 144
proceeded in a low yield, possibly due to the steric hindrance of the tertiary amine 145
(Scheme 58).22 Removal of the PMB group at an earlier stage appeared essential for
the synthesis of the peptide mimic. Since removal of the PMB group would also aid
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NMR interpretation due to the exclusion of rotamer forms, the early removal of the
PMB group was planned in the future synthetic approach.
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S c h e m e 58:

Attempted Synthesis of Tetrapeptide Mimic

A synthetic strategy was designed to address the numerous observations made in
the study. The PMB group would be removed earlier in the reaction sequence, in
order to facilitate the peptide coupling to the A-terminus. Furthermore, a
diastereoselective aldol reaction was necessary to generate a single product isomer,
which would simplify all aspects of analysis. Though proline was shown to be an
excellent chiral auxiliary in previous studies, the harsh condition required to remove
the proline residue and the potential for epimerization of the a-position of amino acids
under the harsh condition required development of another chiral auxiliary for the
zinc-mediated chain extension-aldol reaction.
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Evans’ auxiliaries, derived from chiral amino acids, have been used widely for
asymmetric synthesis.

The incorporation of chiral oxazolidinone onto the amino

acid chain through a Masamune-Brooks reaction would be attractive for formation of
the chiral P-keto imide needed for diastereoselective chain extension-aldol reactions.
The first approach to the carboxylic acid (149) required for a Masamune-Brooks
reaction involved a reaction between (5)-4-benzyloxazolidin-2-one 147 and
trimethylsilylchloride, followed by exposure to Meldrum’s acid (Scheme 59) . 53
However, an unexpected compound was generated instead of the targeted compound
149. The unexpected compound was eventually identified as compound 150 based on
X-ray crystallography.
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Scheme 59: Attempted Synthesis of Compound 149

The preparation of compound 149 was eventually accomplished using an indirect
approach. Monobenzyl malonate 151 was converted into the acyl chloride, which was
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heated with oxazolidinone 147 to produce compound 152.54 The hydrogenolysis
reaction offered the monooxazolidinone malonate 149. However, many attempts at
the attempted preparation of a P-keto imide via a Masamune-Brooks reaction with the
monooxazolidinone malonate 149 were not successful (Scheme 60).

O

O

jf

X

O
1

H O ^^O B n

)O xalyl chloride

--------------------►

°W

0

O
7

-j

ph

^
152

O
UM

Bn

h

H2 -Pd r

NH
V
Bn

O

O

0^ N ^ ^ O B n

2) A
151

O

X

a) M g (B U )2

----------------------------------------b)
^
+ CDI
CbzN

No Reaction

OH
PMB

Scheme 60: Attempted Synthesis of Compound 154

After much effort, a modified Claisen condensation reaction was successful in
generating the targeted P-keto imide 154 (Scheme 61). A chiral HPLC study of the
P-keto imide 154, derived from enantiomerically pure (5)-alanine, indicated that no
epimerization of the alanine a-stereocenter took place during the Claisen
condensation process. Analogous compounds derived from racemic alanine were used
for reference.
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Scheme 61: Synthesis of P-Keto Imide 154 Using Modified Claisen Condensation

The zinc-mediated chain extension-aldol reaction was performed on the P-keto
imide 154 using solid paraformaldehyde as the electrophile. Surprisingly, none of the
desired aldol product was isolated from the reaction mixture. One predominant
cyclopropanol derivative 159 was separated from the crude mixture. The reason for
this unusual reactivity could be attributed to enhanced enolate character associated
with the imide functional group. The mechanism for the formation of compound 159
was proposed to involve spontaneous alkylation of chain extension intermediate 155
with the excess carbenoid, followed by nucleophilic attack of the homoenolate onto
the carbonyl group, which generated the cyclopropanol structure (Scheme 62).55 The
possibility of preventing cyclopropanol formation by controlling reaction time was
excluded due to the coexistence of cyclopropanol derivative 159 and the starting
P-keto imide 154.

53

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Et2 Zn, OH 2 I21
Bn

PMB

NCbz
PMB

154

O
EtZnCH2-l

A

N
Bn

'n -P M B
Cbz

ZnO
n -P M B
Cbz

j
157

Zn

II

OH

N H 4C I

}

Bn
Bn

\

N PMB
Cbz

159

158

Scheme 62: Proposed Mechanism for the Formation of Cyclopropanol Derivative 159

Formation of the cyclopropanol compound was unusual for a number of reasons.
When P-keto esters and amides are used as starting materials for the chain extension,
the zinc-organometallic intermediate (enolate equivalent) is very stable and does not
undergo additional reactions with excess carbenoid. The rapid reaction of the zinc
intermediate of the imide with carbenoid is possibly due to its ability to chelate zinc
between the carbonyls. Furthermore, intramolecular cyclization of the homoenolate to
provide a cyclopropanol has not been observed with ester or amide groups. The imide
functionality is a better electrophile and appears to react more like a ketone than an
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ester. A similar, although not identical, result was observed in the chain extension
reaction performed on substrate 160 (Scheme 63). In this example, the chain
extension intermediate underwent further alkylation to generate the methylation
product 162, in addition to the simple chain extension product 161. However, in this
reaction no cyclopropane product was isolated.
O

161
NCbz

162

Scheme 63: Zinc-Mediated Chain Extension Reaction on P-Keto Imide 160

These unexpected results inspired the study of a chain extension reaction in
which the imide carbonyl takes the place of the ketone. A possible mechanism is
illustrated below (Scheme 64). With this substrate, the cyclopropanol intermediate
163 is part of a donor-acceptor system, as opposed to 155 or 156. Donor-acceptor
cyclopropane 163 will fragment to complete the chain extension. A tandem chain
extension-aldol reaction provided 166 as a single unidentified diastereomer. This
method might be useful for the preparation of substituted y-lactones, like the
paraconic acids.56
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Scheme 64: Preparation of Lactone 166 Using Zinc-Mediated Chain Extension-Aldol
Reaction on Compound 152

Fortunately, a solution to the overalkylation/cyclopropanol formation problem
was identified. After formation of the carbenoid, excess paraformaldehyde (10 equiv
to the starting P-keto imide 154) was added prior to the addition of P-keto imide 154.
The reaction of the enolate with the aldehyde was preferred to homoenolate formation.
The successful zinc-mediated chain extension-aldol reaction provided a single aldol
product 167, which existed mostly in the ring-opened form, although the
stereochemistry at the a-position was unknown (Scheme 65). The 'H and 13C NMR
spectra were difficult to interpret due to the presence of two rotamers and the
equilibrium between ring-opened and hemiacetal forms. Electrospray ionization (ESI)
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MS, however, supported the structural assignment of compound 167 due to the
presence of an ion peak with mlz = 611 (M+Na+).

NCbz
PMB

Scheme 65: Modified Zinc-Mediated Chain Extension-Aldol Reaction

Cleavage of the PMB protecting group was expected to facilitate NMR spectral
interpretation through biasing the rotamer populations. Amino acid coupling was also
expected to be simplified without the PMB group on the amide. Therefore, cleavage
of the amide’s PMB group using eerie ammonium nitrate (CAN) was undertaken.
However, the removal of the imide’s PMB group with CAN did not provide the target
compound 168. A lactone product 169 was generated under these reaction conditions.
The structural assignment of compound 167 was confirmed by removal of the Evans
chiral auxiliary from 169 through treatment with lithium hydroxide and hydrogen
peroxide52b to offer compound 170, tetrahydro-5-oxofuran-3-carboxylic acid, which is
known in the literature (Scheme 66).56 Evidence of the a-stereocenter generated from
the zinc-mediated chain extension-aldol reaction was obtained by measurement of the
optical rotation ([a]25o = + 40.0 (c = 0.001 g/mL, MeOH)). The literature report for
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(i?)-170 has a rotation of ([a]25D = + 47.1 (c = 0.14 mmol/mL, MeOH)), which
allowed assignment of the stereochemistry of the a-position of compound 170 as (R).
This stereochemical result is consistent with the reported aldol reaction using the
Evans auxiliary in the literature.52®Therefore, in order to mimic natural amino acid
stereochemistry, which is (S), the Evans auxiliary derived from the (7?)-amino acids
must be used.

CAN (4 equiv)
PMB" N 'C bz

CH3 CN, h 2o

LiOH, H2 0 2

170
Scheme 66: Cleavage of Imide’s PMB Group Using CAN

Similar chemistry was performed on a variety of substrates with different
functional groups in order to obtain more detailed information about this unusual
CAN-mediated chemistry. Reaction between aldol-product 172 and CAN provided
the identical lactone 169, which means the existence of the PMB group is not
necessary for lactone formation (Scheme 67).
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Scheme 67: Preparation of Compound 169

Triethylsilane reduction of the aldol product 172 with known stereochemistry
provided the substituted tetrahydrofuran derivative 173A and 174B in a 1:1 mixture of
isomers (Scheme

6 8 ).

The proline stereocenter does not appear to control the

reduction of the hemiacetal.
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Scheme

68

: Formation of Substituted Tetrahydrofuran Derivativel74A and 174B
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However, when the triethylsilane reduction was performed on the aldol product
derived from («S)-alanine, an unidentified product was generated instead of the
targeted substituted tetrahydrofuran derivative 185 (Scheme 69). Analysis by ESI MS
(m/z=595, (M+Na+)) and 13C NMR spectra (no ketone resonance) indicated a possible
intramolecular Friedel-Crafts reaction, which means a different protecting group
would be needed in place of the PMB group for the formation of the tetrahydrofuran
derivative. The assigned structure of 186 is speculated. Additional evidence would be
necessary to confirm compound 186.
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CbzN

186

Scheme 69: Attempted Formation of Substituted Tetrahydrofuran Derivative 185

The P-keto benzyl ester 175 and methyl ester 178 were prepared from
PMB-protected-Cbz-(5)-alanine. Compounds 176 were obtained as a mixture of
diastereomers (approx 1:1) after the tandem-chain extension aldol reaction. Treatment
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of these aldol products (176A and 176B) with CAN provided the racemic lactone,
which indicated that the Evans auxiliary is not required for CAN-mediated
lactonization (Scheme 70).
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Scheme 70: Preparation of Compound 177

Oxidative cyclization of compound 178, derived from the methyl ester, was
successful in providing lactone 179; however, its high volatility resulted in low mass
recovery (Scheme 71)

P

PMB

i

C bz^ N \ ^ \ ^ X
CH 3

^ 0M e

CAN (4 equiv)

O

CH 3 CN:H20 = 4:1, rt

178

0

V ^x^O M e
0

179

1 :1 ratio of d iastereom ers

High volatility

Scheme 71: Attempted Cleavage of Imide’s PMB Group Using CAN
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Two simple aldol products 180 and 181 were prepared to determine whether the
heteroatom (nitrogen) a to the ketone played a role in this reaction. No lactone was
generated when the aldol products were subjected to the reaction conditions used for
oxidative cyclization (Scheme 72). Therefore, it was confirmed that a heteroatom at
the a-position to the ketone is necessary for lactone formation. Subsequent work by
Walls and Jacobine has provided preliminary evidence that oxygen functionality a-to
the ketone can also facilitate the oxidative cyclization.57
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Scheme 72: Attempted Lactone Formation Using CAN

For the purpose of mimicing the natural stereochemistry of a peptide backbone,
an Evans chiral auxiliary derived from (i?)-phenylalanine was necessary to induce
formation of the aldol product with an (<S)-stereocenter. This chiral auxiliary was
generated via standard literature methods. 58 A modified Claisen-condensation
reaction provided the P-keto imide and zinc-mediated chain extension reaction
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produced only one predominant aldol-product. A diastereomeric ratio of greater than
95:5 was estimated from the

13

C NMR spectrum of the crude reaction material.

Compound 183 was generated through treatment with CAN and the chiral auxiliary
was cleaved to provide compound 184 (Scheme 73). The optical rotation of 184 was
-35.0 (c = 1.2 mg/mL, MeOH)), which allowed assignment of the desired
(^-configuration at the aldol stereocenter.

O
184

Scheme 73: Preparation of (S)-Paroconic Acid

Similar chemistry was performed on the aldol-product 188, produced from
paraformaldehyde and the (5)-proline derived P-keto imide (Scheme 74). The usage
of the auxiliary generated from (R)-phenylalanine provided the identical lactone 183.
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Scheme 74: Preparation of Compound 183

With the successful development of diastereoselective zinc-mediated chain
extension-aldol reactions using an Evans chiral auxiliary, a specific compound was
targeted in an effort to test the methodology and overall strategy.

c)

Synthesis of a Proposed Inhibitor of Human Cytomegalovirus (HCMV)
Protease Using Diastereoselvetive Zinc-Mediated Chain Extension-Aldol
Reaction
Human cytomegalovirus (HCMV) is a pathogen which is a member of the

P-herpes subfamily of the herpes virus family (Herpesviridae) . 59 HCMV can be
spread by human-to-human contact and it has been estimated that, within the United
States, greater than 50% of the adult population and about 20% of the pre-pubescent
population is infected. Serious health risks (retinitis, pneumonia, and death) can be
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caused by HCMV, especially in the immunocompromised and immunologically
immature

patients,

like

transplant

recipients,

newborn

infants,

and

AIDS/HIV-infected patients. The generation and reproduction of HCMV relies upon a
unique 28-kDa serine protease.60 An amino acid sequence of Val-Asp-Ala-Ser is
necessary for this serine protease’s site-specific recognition, resulting in cleavage of
the Ala-Ser bond (Figure 2).

HCMV Serine Protease Cleavage Site

O
189

Figure 2: Preferred Site of HCMV Protease Cleavage

The development of a successful strategy for this protease’s inhibition will
constitute an attractive method for disrupting the HCMV life cycle. A study has
suggested that peptide isosteres could be effective inhibitors of HCMV protease;
however, no ketomethylene isosteric group was used in that study. 61 Since the
ketomethylene isostere has been successful in protease inhibition, a tetrapeptide
mimic 190 of the Asp(A,Ar-dimethyl)-Ala-Ser-Ala sequence was proposed as a
potential inhibitor of HCMV protease (Figure 3). The use of AJV-dimethyl asparagine
instead of asparagine was targeted due to the report of enhanced inhibition in the
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study.61 Furthermore, replacement of the asparagine’s two amide protons with a
methyl group should obviate the need to protect the asparagine’s amide side chain.

Isosteric Amide bond Replacement

CH

CH

BocHN

OMe
HO'

O
190

Figure 3: The Proposed Inhibitor of Protease of HCMV

The successful diastereoselective preparation of a dipeptide mimic of
alanine-serine, as described above (Scheme 65), offered the possibility for the
preparation of the proposed HCMV protease inhibitor by coupling an alanine residue
to the C-terminus and W -dim ethyl asparagine to the N-terminus. The protection of
the aldol product 182 with the TBDPS group was needed for the successful removal
of the imide’s PMB protecting group, while avoiding CAN-mediated oxidative
lactone formation. Compound 192 was successfully prepared in good yield by the
reaction with tert-butyldiphenylsilyl chloride followed by CAN oxidative cleavage
(Scheme 75).
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Scheme 75: The Imide’s PMB group removal using CAN

The typical removal of the Evans auxiliary with lithium peroxide to generate the
carboxylic acid 197 was not successful. A Bayer-Villiger reaction was proposed based
on the isolation of products 196,62 147 and 195 from the mixture (Scheme 76).
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Scheme 76: Attempted Cleavage of Evans Chiral Auxiliary Using Lithium Peroxide

The use of lithium hydroxide instead of lithium peroxide for the removal of the
Evans auxiliary was considered. Treatment with excess

(6

equiv) lithium hydroxide

resulted in epimerization of a stereocenter, most likely that of the (5)-alanine’s
a-position. By reducing the equivalents of lithium hydroxide from six to one and by
careful control of the addition time and reaction temperature, the Evans auxiliary was
successfully cleaved with no epimerization. The coupling reaction between carboxylic
acid 197 and alanine methyl ester hydrochloride provided the tripeptide mimic 198 as
a single diastereomer (Scheme 77).
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Scheme 77: Synthesis of Tripeptide Mimic 198

The removal of the TBDPS group was tested on this compound and shown to be
successful (Scheme 78). The product possesses three of the four amino acids
proposed for HCMV protease recognition and will be submitted for testing against
HCMV protease.

TBAF, THF
NHCbz

198

199A

Scheme 78: Deprotection of TBDPS Group for Tripeptide Mimic

Removal of the Cbz group by hydrogenolysis was performed in methanol.
Anhydrous /Moluenesul fonic acid was used to trap the newly generated amine and
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avoid formation of a dimeric product derived from the free amine and ketone
functional groups. However, an unidentified mixture of products was formed possibly
due to the instability of the TBDPS group in the acidic methanolic environment
(Scheme 79) . 45
.O T B D P S
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H
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Scheme 79: Attempted Removal of Cbz Group Using Hydrogenolysis in Methanol

By switching the hydrogenolysis solvent from methanol to 2-propanol, the
reaction provided 199. Amino acid coupling between 199 and the asparagine
derivative 144 provided the TBDPS-protected tetrapeptide mimic 200 (Scheme 80).
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Scheme 80: Synthesis of Tetrapeptide Mimic 200
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ch

O
3

Treatment of compound 200 with excess sodium methoxide provided two
diastereomers (Scheme 81). The comparison of 'H and ,3C NMR spectra between
compound

200

and the mixture of diastereomers indicated that the synthetic route

developed for the synthesis of the tetrapeptide mimic proceeded with greater than
95% diastereoselectivity.

O

CH 3

B o c H N ^ ^ N A v^

(H aC feN y?

H

O

O
^

A

ch

3

NJ v \o M e

V OTBDpsO

NaOMe, THF

1

"

O
200
o

ch

o

3

ch

3

BocHN^ANA ^ ^ A NA^OMe
(h3c )2n ^
°

h

o

k Q "B Dpi>

201

Two d iastereom ers b ased on 13C NMR spectra

Scheme 81: Racemic Study on Compound 200

The removal of the TBDPS group from compound 200 was successfully
performed to offer the proposed inhibitor, existing in hemiacetal form, of HCMV
protease (Scheme 82). The high polarity of the final compound resulted in low mass
recovery when the compound was purified by column chromatography. Efforts to
improve mass recovery and improve the isolated yield are still underway.
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Scheme 82: Synthesis of Tetrapeptide Mimic 202

In summary, the diastereoselective zinc-mediated chain extension-aldol reaction
using proline or an Evans chiral auxiliary has been demonstrated to be of practical
synthetic utility in the construction of highly functionalized ketomethylene-containing
dipeptide mimics. The incorporation of ketomethylene isosteric amide bond
replacement into tripeptide and tetrapeptide analogues was easily accomplished when
using this strategy. A facile synthetic route has been developed for a proposed
inhibitor for Human Cytomegalovirus (HCMV) protease.
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CHAPTER II

FORMAL SYNTHESIS OF (+)-BREFELDIN A

1.

Introduction

a)

Introduction to (+)-Brefeldin A
(+)-Brefeldin A (Figure 4), a bicyclic compound with a 13-membered

macrocyclic structure, is a fungal metabolite. The isolation of (+)-Brefeldin A from
the fungi (such as Penicillium decumbens, P. brefeldianum, and Phyllosticta
medicaginis) was first reported in 1958,63 and the structure and stereochemistry of
(+)-Brefeldin A were clarified by X-ray crystallography in 1971.64

H O "’

(+)-Brefeldin A

203
Figure 4: Structure of (+)-Brefeldin A

A wide range of intriguing biological properties of this interesting molecule has
been reported, such as antiviral, cytostatic, antitumor, and antibiotic effects. 65
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Furthermore, a recent study has demonstrated that (+)-Brefeldin A can drive Golgi
complex disassembly and redistribution to the endoplasmic reticulum, and can inhibit
protein transport to post-Golgi compartments in the cell.66 (+)-Brefeldin A has also
been investigated as an anticancer agent.

i)

fH

Previous Representative Synthetic Approaches to (+)-Brefeldin A
(+)-Brefeldin A has two trans double bonds, five sp3 stereogenic centers, and a

13-membered macrocyclic lactone. As a result of this challenging structure and broad
biological activity, many research groups have developed synthetic approaches to
(+)-Brefeldin A, 68 including the first reported total synthesis of (±)-Brefeldin A by
Cory’s research group in 1976.68a Corey’s synthetic approach used a known bicyclic
ester 204 as the starting material (Scheme 83). After hydroboration with borane and
oxidation with chromic acid, treatment with triethylamine provided the enone 205.
Reaction between the Gilman cuprate and the sodiomalonate derivative of enone
produced the desired conjugate addition product 206. After lithium borohydride
reduction, the alcohol was protected as a methoxyethoxymethyl ether 207. Following
saponification with sodium hydroxide, treatment with n-butyllithium, oxygenation in
the presence of trimethyl phosphite and oxidative decarboxylation, the methyl ester
derivative 208 was prepared using diazomethane.
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Scheme 83: The First Total Synthesis of (±)-Brefeldin A (Part I)

Diisobutylaluminum hydride (DIBAL-H) reduction of the ester and oxidation
using the Collins reagent provided the aldehyde 210. Addition into the carbonyl by
the lithiated alkene (prepared by treatment of an organotin compound with
n-butyllithium) and hydroxyl group protection with methoxyethoxymethyl chloride
generated the compound 211. Removal of methylthiomethylene protecting group was
successfully accomplished using mercuric chloride and calcium carbonate to offer
compound 212. After oxidation with Collins reagent and deprotection of the silyl
ether with a fluoride source, compound 213 was prepared using the successful
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Yamaguchi macrolactonization for the conversion from A-brefeldinoic acid to
(±)-Brefeldin A.68f Deprotection of the MEM group with titanium chloride and
selective oxidation of the allylic alcohol with manganese (IV) oxide preceded the
sodium borohydride’s stereoselective reduction to form the required 4a-alcohol.
(±)-Brefeldin A was prepared through removal of the MEM group (Scheme 84). The
efficient conversion of compound 214 to (±)-Brefeldin A has inspired efforts of other
research groups to complete the formal synthesis o f Brefeldin A through targeting 214
as a key synthetic intermediate.
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Scheme 84: The First Total Synthesis of (±)-Brefeldin A (Part II)

Subsequent to Corey’s report on the synthesis of the racemic material, many
synthetic approaches have been developed for the stereoselective synthesis of
enantiomerically pure (+)-Brefeldin A.68b’68c’68d For example, the synthetic approach
with the fewest steps was reported by Trost’s research group in 2002 (Scheme 85 and
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8 6 ).68e The

synthesis of 4-napthyloxybutenolide 218 was accomplished through a

palladium-catalyzed asymmetric allylic alkylation in the presence of chiral ligand 217.
A

palladium-catalyzed

trimethylenemethane

cycloaddition

offered

the

cis-cyclopentane 219. Oxidative cleavage and DIBAL reduction provided the alcohol
derivative 220 with good diastereoselectivity. After the protection with a TBDMS
group, a Weinreb amide was generated from the lactone precursor. Treatment with
DBU caused the epimerization of the aldehyde and provided the trans-cyclopentane
stereochemistry required for compound 221. A lithium anion, derived from ethyl
propriolate, was added to the aldehyde to produce the propargyl alcohol

222

.

Ruthenium-catalyzed hydrosilylation and cesium fluoride desilylation provided the
compound 223 in one pot. After protection with TBDMS group, a transformation
from Weinreb amide to aldehyde was successfully performed with DIBAL-H to offer
aldehyde 224.
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2.5% Rd2 dba 3 -CHCI3,
CH 2 CI2, 30% Bu 4 NCI, 0 ° C
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C 0 2Et

o
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224

a) 2.5% Pd(OAc)2, 20% P(OiPr)3, toluene, b) N a l0 4, 5% 0 s 0 4. c) DiBAL, BHT, tolene.
d) TBSOTf, pyridine, e ) iPr2 MgCI, MeO(Me)NH 2 CI, THF. f) DBU. g) Li0CCO 2 Et,
THF/HMPA. h) (EtO)3 SiH, 1% Cp*Ru(CH 3 CN) 3 PF6, CH 2 CI2, C sF (96%). i) TBSOTf,
pyridine,
j) DIBAL, THF

Scheme 85: Trost’s Total Synthesis of (+)-Brefeldin A (Part I)

The other portion (lower side chain) of this convergent synthesis to (+)-Brefeldin
A was also initiated via asymmetric allylic alkylation. The reaction between crotyl
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carbonate

225

and

/?-methoxyphenol

provided

allylic

ether

226.

Hydroboration-oxidation, oxidation to the aldehyde, and in situ treatment with the
Wittig reagent offered the a,p-unsaturated ethyl ester derivative 227. Treatment with
sodium borohydride in the presence of catalytic nickel dichloride resulted in
1,4-reduction of compound 227. DIBAL-H reduction of the ester generated the
primary

alcohol

228.

Mitsunobu

coupling

between

compound

228

and

l-phenyl-5-thiotetrazole, followed by oxone oxidation, offered the sulfone derivative
229. Modified Julia coupling of compound 229 and 224 proceeded successfully to
give predominantly the trans-olefin product 230 (E/Z > 12/1). Cleavage of the PMP
group by treatment with eerie ammonium nitrate (CAN) and ester hydrolysis with
sodium

hydroxide

solution

generated

the

precursor

231

for

Yamaguchi

macrolactonization. Finally, silyl deprotection with tetrabutylammonium fluoride
(TBAF) produced the targeted compound: (+)-Brefeldin A (Scheme

86

).
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2 03
a) p-M ethoxyphenol, 0.25% Pd 2 dba 3 -CHCl3 , 0.75% 2 17, toluene, b) 9-BBN, THF, then
H2 0 2, aq NaOH. c) PCC, then E t0 2 CC(H)PPh3. d) NaBH4, MeOH, 5% NiCI2.
e) DIBAL-H, THF. f) DIAD, PPh 3 , 1-phenyl-5-thioltetrazole. g) O xone, MeOH
h) KHMDS, DME, then 224. i) C.A.N.. j) 1N NaOH. k) MsCI, Et3 N, 2 ,4 ,6 trichlorobenzoyl chloride, 4-DMAP. I) TBAF, THF.

Scheme 8 6 : Trost’s Total Synthesis of (+)-Brefeldin A (Part II)

b)

Introduction to Formation of a,p-Unsaturated-1,4-Dicarbonyl Compounds
A

variety

of

natural

a,p-unsaturated-y-hydroxy-macrolide

or

products
the

containing

the

a,P-unsaturated-y-keto-macrolide

functional group has been reported in the literature (Figure 5), like (+)-Brefeldin A
20363 (+)-Patulolide A 232,69 (-)-Patulolide B 233,70 (-)-Pyrenophorin 23471 and
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(-)-A26771B 235.72 All of these macrolides would require suitable method for the
formation of a, P-unsaturated-y-keto system within macrocyclic systems. Although
few

methods

have

been

reported

for

the

specific

generation

of

a,p-unsaturated-y-keto-lactones, many approaches have been developed for the
formation of a,P-unsaturated-y-keto esters. Some of the more general methods are
described below.

HO"

(+)-Brefeldin A

(+)-Patulolide A

203

(-)-Patulolide B

233

232

(-)-Pyrenophorin

(-)-A 26771B

234

235

Figure 5: Natural Products Containing a,P-Unsaturated-y-Hydroxy or Carbonyl
Functional Groups

One method for the formation of a, P-unsaturated-y-keto esters involved the
treatment of y-keto esters 27 with bromine under photochemical conditions, which
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provided the P-bromo-y-keto esters 236.73 After elimination with triethylamine, the
targeted esters 237 were prepared with only trans-double bond formation (Scheme
87). However, the unavailability of diverse 1,4-dicarbonyl compounds and poor
regio/chemo-selectivity in the bromination reaction limits application of this method.

O
237
Scheme 87: Generation of a, P-Unsaturated-y-Keto Esters Using Photochemical
Bromination and Elimination

A modification of this method was reported by Reissig, whose reaction was
designed to overcome the shortcoming of unavailable 1,4-dicarbonyl compounds
(Scheme

8 8 ) . 74

Easily-prepared trimethyl(vinyloxy)silane derivatives 238 were used

to generate the various siloxy-substituted methyl cyclopropanecarboxylate 239.
Treatment with bromine resulted in oxidative ring opening and elimination with
triethylamine provided the compound 240. Once again the E-alkene was the major
reaction product of this method.
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r

0
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88

: Reissig’s Method for the Preparation o f a,P-Unsaturated-y-Keto Esters

1994,

Hoffman’s

research

group

developed

the

first

chain

extension/elimination reaction in which 1,3-dicarbonyl compounds were used to
generate 1,4-dicarbonyl compounds (Scheme 89).75 An unsubstituted P-keto ester
241 was alkylated with a-bromoacetate to offer compound 242. After reacting with
(p-nitrophenyl) sulfonyl peroxide (p-NBSP), which resulted in the insertion of the
nosyloxy group, trifluoroacetic acid was used to deprotect the f-butyl ester.
Decarboxylation provided the 3-(nosyloxy)-4-keto ester 243. Elimination of nosyloxy
group with a base provided the a,P-unsaturated-y-keto esters with selective formation
of the E-olefin 244.
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o

OR

O
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Scheme 89: Hoffman’s Method for the Preparation of a, P-Unsaturated-y-Keto Esters

In 2006, Blechert’s research group illustrated another method to prepare
a,P-unsaturated-y-ketone macrolides in the total synthesis of antibiotic (-)-A26771B
(Scheme 90).76 The P-keto lactone 245 was generated via a lengthy synthetic
sequence. After sodium borohydride reduction and mesylation, elimination with DBU
offered compound 246. Deprotection with trifluoroacetic acid and oxidation with
TEMPO/pTSOH produced the hydroxyketone 247. Finally, successful esterification
of compound 247 with succinic anhydride offered the final (-)-A26771B 248.
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1)N aB H 4, MeOH

1) TFA, MeCN/H20

2) MeCI, pyridine
3) DBU, CH2CI2

2) TEMPO, pTsOH

245

246

C 0 2H
,OH
Succinic anhydride
DMAP

247

248

Scheme 90: Blechert’s Method for the Preparation of a,P-Unsaturated-y-Keto
Macrolide

Although methods for the preparation of a, P-unsaturated-1,4-dicarbonyl
compounds that would be applicable to macrolide system are available, the
development of a general and highly-efficient method to facilitate formation of
compounds

possessing

a,P-unsaturated-y-hydroxy

or

a,P-unsaturated-y-ketone

functionality is still needed.

Zercher’s research group has successfully developed a convenient, one-pot
zinc-mediated chain extension reaction for the preparation of y-keto carbonyl
compounds. 17 Recently, a modification on this reaction was developed to approach
a,P-unsaturated-1,4-dicarbonyl compounds.25 According to the mechanism of the
chain extension reaction described earlier (Scheme 10), the zinc organometallic
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intermediate 45 is postulated. Oxidation of the intermediate with iodine and treatment
with DBU facilitate the formation of a,P-unsaturated-y-keto carbonyl systems. A
series of starting materials with various functional groups was investigated by
Ronsheim (Scheme 91). P-Keto esters and P-keto amides were good substrates for
this tandem reaction sequence. Even alkene functionality was tolerated well in the
reaction with no observed cyclopropanation, as long as carbenoid equivalents and the
time of the reaction were controlled. Amino acid derived y-keto esters and amides
were prepared through this zinc-mediated chain extension-oxidation-elimination
reaction, which offers an alternative synthetic approach to peptide isostere
preparation.
0

O

1

1

rA

A

Et,Zn
1-----------or EtZnCH2l

r.

O

R'

41

45

I

0

X
Zn

DBU
R'

249
1)

31
n^N B z

251

250

O

CO0CH3

4)

21

O

O

Bn
CbzN

O
OChU

Bn
252
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Scheme 91: Zercher’s Method for the Preparation of a,P-Unsaturated-y-Keto

Carbonyl Compounds
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Moreover, this methodology has been extended to a variety of P-keto macrolides
with different ring size and the formal synthesis of (-)-Pyrenophorin. 25 The total
synthesis of (-)-Patulolide A and (±)-Patulolide B was also accomplished.77 The
general strategy for macrolide formation is described below (Scheme 92). Diketene
254 was reacted with various unsaturated alcohols to produce P-keto esters 255. The
bis-olefin 256 can be formed by alkylation of the dianion. Ring closing metathesis
with Grubbs’ first generation catalyst offered the unsaturated P-keto macrolides 257.
Hydrogenation under palladium catalysis reduced the double bonds and generated the
precursor (258) for the chain extension-oxidation-elimination reaction. The final
products 259A and 259B were formed with variations in the ZJE ratio that depended
on

the

macrolide

ring

size.

When

extension-oxidation-elimination reaction of

Ronsheim

1 2 -membered

studied

the

chain

ring, the 13-membered ring

product was formed with excellent E selectivity. Formation of a 13-membered ring
with selective formation of an is-alkene is needed for the synthesis of (+)-Brefeldin A.
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Scheme 92: Zercher’s Method for the Preparation of a,P-Unsaturated-y-Keto
Macrolides

Since the conversion from 260 to 203 has been successfully reported (Scheme
93) 78 and an efficient method of the formation of a,P-unsaturated-y-keto macrolides
has been developed in the Zercher research group, we decided to undertake a formal
synthesis of (+)-Brefeldin A through formation of 260.

HO"

J. Org. Chem. 2002,
6 7 ,7 6 4 -7 7 1 .

260

203
(+)-Brefeldin A

Scheme 93: Conversions from 260 to 203
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2.

Results and Discussion

a)

Initial Model Study towards the Formal Synthesis of (+)-Brefeldin A Using
Zinc-Mediated Chain Extension-Oxidation-Elimination Reaction
Since the zinc-mediated chain extension-oxidation-elimination has not been

performed on a bicyclic compound with a thirteen-membered ring, a simplified model
261 was designed to investigate the key chain extension-oxidation-elimination before
investing a great deal of effort in the total synthesis (Figure 6 ). We felt that removal
of the methyl group from the thirteen-membered ring and the alcohol on the
five-membered ring would provide an appropriate model for testing the key steps in
the synthetic approach.

MOMO"

260

261

Figure 6 : Proposed Model for the Study

Retrosynthetic analysis suggested a P-keto macrolide 262 with the E-double
bond configuration would be needed for performing the zinc-mediated chain
extension-oxidation-elimination reaction. This macrocyclic olefin 262 could be
generated from ring-closing metathesis, which would require the P-keto ester 263
starting

material.

A

modified

Claisen

condensation

reaction
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using

the

/ram-homoallylic carboxylic acid 264 as the starting material was proposed for the
preparation o f compound 263 (Scheme 94).

262A

261

c
263

"

6
264

Scheme 94: Retro-synthetic Analysis of the Proposed Model Study towards the
Formal Synthesis of (+)-Brefeldin A

Carboxylic acid 264 with desired stereochemistry was unknown in the literature,
which indicated that a simple approach to its preparation was needed. Since the
trans-homoallylic alcohol 265 was reported in the literature,

7Q

a suitable oxidation

reaction of compound 265 should provide the targeted key intermediate 264 (Scheme
95).
r A

.

Oxidation

f

\

P
OH

264

265

Scheme 95: Attempted Oxidative Preparation of Homoallylic Carboxylic Acid 264
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A regioselective cyclization reaction with epoxide opening was applied initially
(Scheme 96).79a The reaction between the lithium salt of compound 267 and the
epoxide derivative 268 provided compound 269. After a radical-mediated reaction
initiated by AIBN, the epoxy-allylic stannane was obtained in good yield. The
cyclization was accomplished by treatment with n-butyllithium at -78 °C to provide
the homoallylic alcohol 265.

MCPBA

a) BuLi-HMPA/THF

(Bu)3 SnH, AIBN/toluene

T oIS 0 2

BuLi/THF
-78 °C
265

Scheme 96: Preparation of Compound 265 Using Epoxy-Allylic Stannane Cyclization

A mild, two-step oxidation for the conversion from alcohol 265 to carboxylic
acid

264

was

used

A-methylmorpholine

(Scheme
TV-oxide

97).

Treatment

(NMO)

with

a

of compound

265

catalytic

amount

92

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

with
of

tetra-M-propylammonium perruthenate (TPAP) produced the precursor aldehyde
271,

on

which was oxidized with sodium chlorite in good yield.

NMO

C ^ o

TPAP

ot

Nac'g*— Qh°h

265
Scheme 97: Oxidative Preparation of Compound 264

Though this synthetic approach to compound 272 was performed successfully,
the toxicity of the organostannane compound, modest diastereoselectivity and the use
of non-economic reagents like TPAP encouraged the use of another approach, in
which the homoallylic ethyl ester 272 was used as the precursor for hydrolysis to
prepare compound 264 (Scheme 98).

Hydrolysis

264

272

Scheme 98: Attempted Approach to Compound 264 Using Saponification

A synthetic route was selected, in which conjugate addition of /j-tolyl
a-lithio-P-(trimethylsilyl) ether sulfoxide and subsequent electrophilic trapping of the
resulting enolate reaction product were used to prepare compound 264. 82 Upon
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preparation of (Z,)-menthyl-tolylsulfmate 274,

o-,

>

a Grignard reagent prepared from

methyl iodide was added to offer the optically pure methyl tolylsulfoxide 275. After
treatment with n-butyllithium, the a-sulfinyl carbanion was generated and reacted
with iodomethyl-trimethylsilane to form compound 276 with excellent yield (Scheme
99) . 84

P
= /

ONa

a) SOCI2
,s ~0-(/_)-M en th ol

b) (L)-menthol, pyridine
c) HCI

274

2 73

9

CH3Mgl

a) LDA
,(CH 2 )2 -S iM e 3

b)
Me3Si
2 75

I
276

Scheme 99: Preparation of/?-Tolyl-P-(Trimethylsilyl)ether Sulfoxide 276

The electrophile 279 was prepared in a three-step reaction sequence, previously
reported in the literature (Scheme 100) . 85 A ring-opening reaction between
tetrahydrofuran and hydrobromic acid offered the l-bromo-4-butanol 277. After PCC
oxidation, Homer-Emmons reaction provided the targeted electrophile 279 in near
quantitative yield.

94

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

277

278

NaH, THF

OEt

Br

O
279

Scheme 100: Preparation of (£)-Ethyl 6-Bromohex-2-Enoate

Conjugate addition of the a-sulfmyl carbanion, generated with lithium
diisopropylamide (LDA), to the a,P-unsaturated system generated an enolate, which
cyclized to form the five-membered ring in which the two substituents were trans.
Compound 280 was unstable at room temperature or in an acidic environment. A
by-product was formed when the material was left to sit over time. This by-product
was determined to be 281, which was formed by elimination of the sulfonyl group
(Scheme 101).
O
O

a ) LDA (2.2 equiv), THF, -78 °C

''(CH2 )2 SiMe3

OEt

b) £tQ
> Y ^ ( CH2)3

SOTol

O
276

SiM e 3

de>99%

O
2 80

SiM e 3
281

Scheme 101: Formation and Decomposition of Compound 280
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Therefore, immediate treatment of 280 with tetrabutylammonium fluoride
(TBAF) was necessary to minimize the formation of 281 and provide the homoallylic
ethyl ester 272. Saponification of the ester with 3M lithium hydroxide for

8

h

produced the targeted homoallylic carboxylic acid 264 in 80% yield (Scheme 102).
No a-proton epimerization was observed by NMR analysis.

/^ r ^ O E t

TBAF

rSO
To

ft

ft

LiOH

CC°B — ' CC0H

SiM e 3

280

272

264

Scheme 102: Successful Preparation of Compound 264 Using Saponification

A Masamune-Brooks reaction was attempted for the preparation of the P-keto
ester 263 using 2-((hex-5-enyloxy)carbonyl)acetic acid (Scheme 103). However, this
reaction provided very little o f the desired P-keto ester. A by-product (282) was
formed through self-condensation. Inefficient formation of the sterically hindered acyl
imizadole appears to be responsible for this poor reactivity. After extending the
reaction time between compound 264 and CDI from 10 min to 1 h, the P-keto ester
282 was prepared in a modest yield.
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OH

a) CDI, THF (10 min)

263

264
HO
(Inverse addition)

282

Scheme 103: Attempted Preparation of Compound 263 Using Masamune-Brooks
Reaction

Since an efficient modified Claisen condensation reaction was developed by our
group for the preparation of series of P-keto imides, similar chemistiy was also
utilized to prepare compound 263 using hex-5-enyl acetate 283 as the enolate source
(Scheme 104). After careful control of enolate formation to avoid self-condensation,
the acyl imidazole solution was transferred to the enolate solution by cannula to
provide compound 263 in a yield greater than 80% without detectable epimerization.

O

A
283

a) LDA, THF, -78 °C

OH + CDI, THF, 1h

263

Scheme 104: Preparation of Compound 263 Using Modified Claisen Condensation
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With the successful formation of unsaturated P-keto ester 263, ring closing
metathesis (RCM) using Grubbs’ first generation catalyst in the dichloromethane was
performed to prepare the unsaturated P-keto macrolide 262 (Scheme 105).

or

A

second portion of catalyst was necessary for complete conversion of the reaction that
ran overnight at reflux. Two separable macrolides 262A and 262B were detected with
E\Z = 3.5:1 ratio based on 'H NMR and ID NOE spectra of the crude reaction
material.

Grubbs' 1st generation
catalyst ( 2 portions), 1 0 %
CH 2 Cl2 , reflux
£: 262A
26 3
Z: 2 6 2 B
E:Z = 3.5:1

Scheme 105: Ring Closing Metathesis (RCM) for the Preparation of Unsaturated
P-Keto Macrolide 262

Attempted iodine-catalyzed double bond isomerization86 over the course o f seven
days was unsuccessful for the conversion of compound 262B to compound 262A.
However, isomerization of the Z double bond to the E double bond was successfully
achieved by using thiophenol in the presence of the radical initiator AIBN (Scheme
106).87
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PhSH, AIBN, Toluene

262A

262B

Scheme 106: Isomerization of Unsaturated Macrolide Double Bond

A zinc-mediated chain extension-oxidation-elimination reaction was performed
on compound 262A to give the a, P-unsaturated-y-keto macrolide 261 (Scheme 107).
Though the targeted compound was unable to be purified from the crude reaction
mixture due to the small scale of the reaction (0 . 1 mmol), coupling constant analysis
(J = 16.0 Hz) of the 'H NMR spectrum of the crude reaction material indicated an
^-configuration for newly formed double bond. This result suggested that the formal
synthesis

of

(+)-Brefeldin

A

using

this

zinc-mediated

chain

extension-oxidation-elimination method would be possible.

a ) Et2 Zn+CH 2 l2 (7.5 equiv)

(E)

O

b) l2 ( 8 equiv)
c) Na 2 S 2 0 3
d) DBU
262A

Scheme 107: Zinc-Mediated Chain Extension-Oxidation-Elimination Reaction on
Macrolide 261
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b)

Formal Synthesis of (+)-Brefeldin A Using Zinc-Mediated Chain
Extension-Oxidation-Elimination Reaction
Using the successful model study as a guide, retrosynthetic analysis for the

formal synthesis of (+)-Brefeldin A was conducted (Scheme 108). An unsaturated
P-keto macrolide 284A with ^-double bond configuration was needed for performing
the zinc-mediated chain extension-oxidation-elimination reaction. Ring-closing
metathesis using Grubbs’ first generation catalyst would offer the macrocyclic system
284A, which required access to the P-keto ester 285. A Claisen condensation reaction
to generate 285 requires access to the trans-homoallylic carboxylic acid 286, which
could be viewed as the key intermediate. A challenging aspect of this approach is the
diastereoselective

incorporation

of a

secondary

alcohol

protected

by

the

methoxymethyl (MOM) group.

O
MOMO"

O

MOMO"

260

O

284A

O

MOMO

OH

MOMO"

2 85

286

Scheme 108: Retrosynthetic Analysis for the Formal Synthesis of (+)-Brefeldin A
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One method known in the literature to approach the key intermediate 286
involves a highly diastereoselective palladium-catalyzed cyclization as the key step
(Scheme 109).88 A reaction between epoxide 287 and alkyne anion, generated by
treatment with w-butyllithium was reported to provide compound 288. After reduction
with palladium/barium sulfate to provide the Z-alkene, the epoxide 289 was opened
using

ethyl

2-(phenylsulfonyl)acetate

anion.

The

deprotection

of

the

tetrahydropyranyl group with methanol and p-toluenesulfonic acid resulted in the
spontaneous lactonization and formation of compound 290. After carbonate formation
with ethyl chloroformate, palladium-catalyzed cyclization in dichloromethane offered
the highly diastereomerically-enriched product 292. Removal of the sulfonyl group
offered the trans-1,2-substituted hydroxycyclopentane 293. For the purpose of a
synthetic approach to (+)-Brefeldin A, MOM-protection and saponification with
lithium hydroxide should provide the targeted compound 286.
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.OTHP

P d /B a S 0 4

THPO
q

n-BuLi, -78 °C

287

Quinoline, MeOH

288

1) E t0 2 CCH 2 S 0 2 Ph,

2) TsOH,

EtONa, EtOH, reflux

MeOH

2 89
P h 0 2S
OCO;>Et
OH

0^ 0
291

290
6

% Na/Hg

OEt

N a 2 H P 0 4, EtOH
HO''2 92
MOM-CI

293

LiOH
OH

MOMO''
286

Scheme 109: A Highly Diastereoselective Palladium-Catalyzed Cyclization

In spite of the availability of this literature procedure, the lengthy synthetic route
and the toxicity of some reagents inspired the development of an alternate synthetic
approach. In the model study described earlier (Scheme 101), the conjugate addition
of p-tolyl a-lithio-p-(trimethylsilyl) ether sulfoxide and subsequent electrophilic
trapping reaction were successful in generating compound 280 in high yield and high
stereoselectivity. Performance of a similar reaction on a substrate in which the
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MOM-protected secondary alcohol was introduced (Figure 7) could provide the
solution to the preparation of the key intermediate 294.

L Br

o
294

Figure 7: (25,5£)-Ethyl-6-Bromo-5-(Methoxymethoxy)hex-2-Enoate

A synthetic route using (5)-malic acid 295 as the starting material was designed
to approach compound 294 (Scheme 110). Though the enantiomerically pure
1,2,4-butanetriol 296 is commercial available, convenient reduction of (5)-malic acid
with borane provided a large supply, which was adequate for the entire study.

OQ

Acetal 297 was prepared using / 7-toluenesulfonic acid as a catalyst. Swem oxidation
was adopted instead of PCC oxidation and provided the aldehyde 298 in a high yield.
After Homer-Emmons reaction and hydrolysis of the acetal with 1M hydrochloric
acid, the unsaturated 1,2-diol was prepared in overall 80% yield in 3 steps. 90
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OH
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OH
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PCC or Swern Oxidation

.0

Q

OX

X X / 0

Hom er-Em m ons
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297
EtO
O

OH
300

299

Scheme 110: Preparation of (5S,2£)-Ethyl-5,6-Dihydroxyhex-2-Enoate

Two different approaches were attempted for the preparation of compound 294.
The indirect route used tosylchloride to react with the primary alcohol of the 1,2-diol
300 are provided compound 301.91 MOM protection of the secondary alcohol87 was
followed by replacement of the tosylate with bromide, which provided the
(5S,2£)-ethyl 6-bromo-5-(methoxymethoxy)hex-2-enoate 294. (Scheme 111).
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MOM-CI
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O
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302
..vOMOM
O

Br

294
Scheme 111: The Indirect Preparation of 294

A direct approach to compound 294 was developed in which the primary alcohol
was selectively brominated using triphenylphosphine and carbon tetrabromide
(Scheme 112) . 92 Syringe pump addition of triphenylphosphine was necessary to
optimize selective bromination of the primary alcohol. Reaction between compound
303 and methoxymethyl chloride using diisopropylethylamine as the base provided
the targeted electrophile 294.

cB r4, PPh 3
°

OH

CH 2 CI2

°

300

Br
303

MOM-CI

E tO ^ -^ s /x -O M O M

diisopropylethyl am ine

®

Br

294
Scheme 112: The Direct Preparation of 294
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The stereoselective conjugate addition of the a-sulfinyl carbanion, derived from
(Z)-menthyl-tolylsulfinate and LDA, to compound 294 was studied (Scheme 113).
Very encouragingly, only one predominant diastereomer 304 (de >95%) was detected
by the 13C NMR analysis of the crude reaction mixture, although the stereochemistry
could not be assigned.

a) LDA (2.2 equiv)

OEt

MOMO"-

SOTol
EtO.
276
304

Scheme 113: Formation of Compound 304

The configuration of the newly generated stereocenters was clarified after
tetrabutylammonium fluoride (TBAF) induced elimination and lithium aluminum
hydride (LAH) reduction of the ester 305 (Scheme 114). After comparing the
spectroscopic data to those reported for compound 310,

78

•

•

the homoallylic primary

alcohol 306 was determined to possess the incorrect stereochemistry.

106

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

O
MOMO'"

‘OEt

TBAF

SOTol

MOMO'"

Si(M e ) 3

LAH, THF

305

304

MOMO'"

OEt

OH

306
Scheme 114: TBAF Elimination and LAH Reduction on Compound 304

Since the stereochemistry of the MOM-protected alcohol was determined by the
(<S)-malic acid and the formation of the tra/is-substituted cyclopentane was favored in
the model study, we felt that inversion of both of the two tertiary sp3-centers was
necessary for formation of the desired compound. The method to invert the absolute
configuration at the other two sp3-centers would require use of the alternate
menthol-derived sulfoxide. Stereoselective cyclization through the conjugate addition
of the a-sulfinyl carbanion derived from (D)-menthyl-tolylsulfinate to compound 294
was investigated (Scheme 115). Not surprisingly, only one predominant diastereomer
308 (de >95%) was detected by analysis of the 13C NMR spectrum, although the
stereochemistiy could not be assigned. The newly generated stereocenters were
clarified through a procedure similar to that described in Scheme 114. After
comparing the spectroscopic data to the known compound 310, homoallylic primary
alcohol was shown to be the desired compound.
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a) LDA (2.2 equiv)

p -T oK > (CH 2 )2 -S i(M e ) 3 --------------------------------------------b)

EtOv

(2

TBAF

----------

o-

3 0 7

M O M O -^ J T
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THF -
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H

^
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(desired isom er)

Scheme 115: TBAF Elimination and LAH Reduction on Compound 308

Saponification with 3M lithium hydroxide for eight hours produced the targeted
homoallylic carboxylic acid 286 in an excellent yield with no epimerization (Scheme
116). Lithium hydroxide was found to be more suitable than sodium hydroxide for
this ester cleavage.

/ ^
MOMO"

A

J ^

QEt

3M LiOH
MOMO" < ^ J

309

^

286

Scheme 116: The Other Approach to Compound 286

With the successful formation of the key intermediate 286, a simple two-step
reaction sequence was performed to prepare compound 313, the precursor for the
modified Claisen condensation (Scheme 117).86 Generation of the cuprate from
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l-bromo-4-butene and addition to (S)-propylene oxide provided an enantiomerically
pure alcohol 312, which could be acetylated in almost quantitative yield. After
treatment of compound 313 with LDA, a solution of acyl imidazole was transferred to
the enolate solution by cannula. Compound 285 was generated in greater than 80%
yield without the detectable epimerization.

CH3

a) Mg. THF, l2 (Trace)
b) Cul +

o

l> —

311

Acetyl chloride

312

, Diethylether

N
CH3 O

a)

LDA, THF, -78 °C

b)

uo

313
MOMO'

a

OH + CDI, THF, 1 h

2 85

Scheme 117: Preparation of Compound 285 Using Modified Claisen Condensation

After obtaining the unsaturated P-keto ester 285, Grubbs’ first generation catalyst
was used to conduct a ring closing metathesis (RCM) and prepare the unsaturated
P-keto macrolide 284 (Scheme 118). Dichloromethane proved to be a better solvent
than toluene for full conversion of the starting material to the targeted compound 284,
although addition of a second portion of catalyst was still necessary during overnight

109

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

reflux. Two macrolides 284A and 284B, separated by column chromatography were
formed with E:Z = 3.5:1 ratio, as assigned by 'H NMR and ID NOE analysis of the
crude reaction mixture. This result was consistent with the model study described
above.
Grubbs' 1st generation
catalyst ( 2 portions), 1 0 %
CH2 CI2 , reflux
28 5

O

O

E\ 284A
Z: 284B

MOMO"

E:Z = 3.5:1

Scheme 118: Ring Closing Metathesis (RCM) for the Preparation of Compound 284

In a similar fashion to that observed in the model study, iodine-catalyzed double
bond isomerization in the macrocyclic compound was unsuccessful for converting
compound 284B to compound 284A. However, isomerization of the Z to the E double
bond was accomplished by treatment with thiophenol in the presence of AIBN at 80
°C (Scheme 119).

MOMO'

PhSH, AIBN, Toluene

Scheme 119: Isomerization of Macrolide Double Bond
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Before

a

full

investigation

of

the

zinc-mediated

chain

extension-oxidation-elimination reaction for the preparation of compound 260 was
performed, the efficiency of the simple chain extension reaction was studied.
Following generation of the zinc-carbenoid (7.5 equiv), the macrolide 284A was
added to the solution and allowed to react for 30 min. Although no cyclopropane
formation was observed with this excess amount of carbenoid, the zinc-mediated
chain extension reaction did not go completion. The reaction time was extended from
30 min to 2 h, but starting material was still observed in the product mixture. The
reason for the presence of unreacted starting material is unknown, although the
combination of the slow chain extension reaction of P-keto macrocyclic compounds
and competitive decomposition of the carbenoid may be responsible. Increasing the
equivalents of carbenoid from 7.5 to 10 did result in more efficient chain extension,
although an unexpected cyclopropane derivative 315 was detected by analysis of the
'H NMR spectrum (Scheme 120). The stereochemistry of the cyclopropane was not
assigned.
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Scheme 120: Attempted Zinc-Mediated Chain Extension Reaction on Macrolide
284A

A modification of the reaction was performed, in which carbenoid (overall 7.5
equiv) was added in two portions (Scheme 121). After treatment of the P-keto
macrolide 284A for 30 min with 5 equivalents of carbenoid prepared in advance, a
second portion of diethyl zinc and 1,1-diiodomethane (2.5 equiv) was added
sequentially. After an additional thirty minutes of reaction time, complete conversion
of the chain extended product 314 was accomplished.

O

O

a) Et2Zn + CH 2 l2 (5 equiv)
b) Et2Zn (2.5 equiv)
c) CH 2 I2 (2 .5 equiv)

MOMO"*

284A
MOMO"

314
Scheme 121 : Modified Zinc-Mediated Chain Extension Reaction on Macrolide 284A
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These conditions were repeated and iodine

(8

equiv) was added to the solution to

trap the chain extension intermediate (Scheme 122). However, after elimination of
iodide

by

treatment

with

DBU,

only

a

trace

of

the

targeted

a,P-unsaturated-y-keto-macrolide was produced. The major product was the simple
chain extension product 314.

a) I2

(8

equiv, 1 min)

MOMO
b) N3 2 S 2 O 3
C) DBU

MOMO"

316
31 4 , major product

Scheme 122: Attempted Oxidation-Elimination Reaction of Compound 316

Extending the reaction time between the iodine and the zinc-organometallic from
1 min to 30 min did not increase the ratio of the targeted compound 260. However, an
increase in the amount of cyclopropane product was observed (Scheme 113).

O

Zn;
a) I2

MOMO"

(8

equiv, 3 0 min)

b) N32S203
c) DBU
316
MOMO"-

3 15, major product

Scheme 123: Attempted Oxidation-Elimination Reaction of Compound 316
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Eventually, increasing the equivalents of iodine from eight to fourteen and
shortening the reaction time (to avoid the cyclopropane by-product formation)
provided the targeted compound 260 (Scheme 124). The newly formed double bond,
generated from the zinc-mediated chain extension-oxidation-elimination reaction, was
assigned the ^-configuration based on ’H-'H coupling constant (J= 15.0 Hz), as well
as through comparison to the known literature data.87 The spectroscopic data of the
material in the chain extension-oxidation-elimination sequence was identical to that
report in the literature. Therefore, the successful preparation of 260 completed the
formal synthesis of (+)-Brefeldin A.

0

0

MOMO'

284A

a) Et2Zn +CH 2 l2 (5 equiv)
b) Et2Zn (2 .5 equiv),
c) CH2 I2 (2 .5 equiv)
d) l2 (1 4 equiv, 10 min)
e) Na 2 S 2 0 3
f) DBU
MOMO'"

260

Scheme 124: Successful Zinc-Mediated Chain Extension-Oxidation-Elimination
Reaction on Macrolide 284A

Overall, the successful formal synthesis of (+)-Brefeldin A using zinc-mediated
chain extension-oxidation-elimination reaction as a key step represents the shortest
synthetic route to (+)-Brefeldin A reported to date. This accomplishment illustrates
the power and utility of the zinc-mediated chain extension reaction.
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CHAPTER III

ZINC-MEDIATED CHAIN EXTENSION REACTIONS W ITH SUBSTITUTED
CARBENOIDS

1.

Introduction to P-Substituted-y-Keto Carbonyl Compounds
As discussed in Chapter 1, variations in the tandem zinc-mediated chain

extension reaction developed by Zercher’s research group have successfully
facilitated the regio- and stereoselective insertion of a-substituents into 1,4-dicarbonyl
compounds. 17 In order to extend the scope o f this practical method, a new variant of
the zinc-mediated chain extension was proposed which would allow the generation of
P-substituted-y-keto carbonyl compounds using substituted carbenoids.

Literature reports have described efforts to selectively alkylate 1,4-dicarbonyl
systems. 93 However, unsatisfactory regioselectivity and multiple-alkylations are
frequently observed. A hypothetical example is illustrated below (Scheme 125).
Treatment of a 1,4-dicarbonyl compound 317 with base to generate an enolate and the
reaction of this enolate with alkyl halide could generate a number of potential
monoalkylation products, like 318, 319, 320, due to small pKa difference of various
a-protons. Regioselective control is further complicated by the potential for multiple
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alkylation. Furthermore, aryl incorporation at an a-position is quite challenging using
these classical reaction conditions. The difficulty in performing these reactions
suggests that a method which facilitates the regiospecific incorporation of a
(3-substituent into 1,4-dicarbonyl compounds would be useful. A number of
approaches have been developed for this purpose. Some of these methods are
described below.
O
,R
R'
°
,
R'

a
R
p

R

||
O

Base

R'

O

R"

318

------------------------------- -

Electrophiles, eg:
Alky halides: R"-X

O

313
Q

R"
R

317
R'

O

o

R„

+

/R
R'

320

R"

O

321

Scheme 125: Alkylation of 1,4-Dicarbonyl Compounds

In 1991, Kulkami’s research group used the well-known sequentially Claisen
rearrangement and Wacker oxidation to generate the P-methyl-y-keto esters (Scheme
126).94 Heating but-3-en-2-ol 322 and triethylorthoacetate to 140 °C produced the
y,8 -unsaturated ester 323 through a Claisen rearrangement. Wacker oxidation of 323
in aqueous dimethoxyethane at 80 °C provides the P-methyl-y-keto ester 324.
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'crv_
OH

140 °C

Wacker oxidation

I

o
323

322

0

^

324
Scheme 126: Kulkami’s Method for the Preparation of P-Methyl-y-Keto Esters

In 1993, Kohno’s research group developed a radical-initiated reaction for the
formation of (3-alkyl-y-keto amides (Scheme 127).95 After the oxidation of
a-tributylstannyl amide 325 with tetrabutylammonium hexanitratocerium (IV), the
a-radical intermediate 326 reacts with a silyl enol ether to provide the
p-alkyl-y-radical intermediate 327. One electron oxidation of 327 from additional Ce
(IV) and loss of the silyl group produces the targeted P-alkyl-y-keto amides 328. One
drawback for this methodology is that the oxidation reaction requires the presence of
a benzylalkoxy radical, which limits the application of this method to specific
substrates.
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Scheme 127: Kohno’s Method for the Preparation of P-Alkyl-y-Keto Amides

In 2000, Satoh’s research group reported another method for P-alkyl-y-keto
amide preparation (Scheme 128).96 Reacting 3-iodobutyramide 329 with activated
zinc provided zinc-homoenolate 330. Acylation with benzoyl chloride derivatives in
the presence of palladium (0) produced the desired P-methyl-y-keto amides 331 in
good to excellent yields.

O

I

O — -Zn
Zn
N
Pd

329

330

R=H, -Cl, -OCH 3

331

Scheme 128: Satoh’s Method for the Preparation of P-Methyl-y-Keto Amides
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Recently, Kashima’s research group published a variation on a traditional
alkylation approach to P-substituted-y-keto esters

(S ch em e

1 2 9 ) . 97

The reaction

between the lithium enolate of an acylated-3,5-dimethylpyrazole

332

and

a-bromoacetate esters generated a 3-substituted-4-(3,5-dimethylpyrazol-l-yl)-4-oxobutanoic esters

333.

Subsequent reaction o f 3 3 3 with a Grignard reagent affords

the P-substituted-y-keto esters 3 3 4 .

O

Me

vVrs

R'O.

O

BrCH2 COOR'

R

R"MgX

N =/

Me

Me
332

333

O
R, R’, R"= various alkyl group
O

R
3 34

S c h e m e 129:

Kashima’s Method for the Preparation of P-Alkyl-y-Keto Esters

Moreover, 3-phenyl-/-menthopyrazole was shown to be a good chiral auxiliary
for the enantioselective synthesis of p-substituted-y-keto esters following the identical
synthetic route described above. The chiral auxiliary can be almost fully recovered
without detectable racemization

(S c h e m e

1 3 0 ).

The ratio of enantiomers was

quantified by a HPLC study and the absolute configuration of targeted products was
characterized by optical rotation. However, the efficiency of the replacement of the
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chiral auxiliary with the Grignard reagent was diminished with the increasing steric
bulk of the auxiliary.

LDA

R"MgX

R'O

BrCH2 COOR'

F

336

335

O
^^

R
O

"

^"= var'o u s a 'kyl group

R

337
S c h e m e 130:

Kashima’s Method for the Stereoselective Preparation of
p-Alkyl-y-Keto Esters

Though some facile methods have been developed to generate P-alkyl-y-keto
carbonyl compounds, most methods possess limitations, such as high reaction
temperature, specific functional group requirements, and inefficient reactions due to
steric effects. The availability of a simple, high-yielding method to generate the
desired P-substituted-y-keto esters from easily accessible starting materials would be
desirable.
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2.

Results and Discussion

a)

Initial Study towards Preparation of p-Substituted-y-Keto Esters
A facile zinc carbenoid-mediated chain extension method for conversion of

P-keto carbonyl compounds to y-keto carbonyl compounds has been developed, in
which the carbenoid is generated from diethyl zinc and diiodomethane. The proposed
mechanism is illustrated below, which suggests that substituted carbenoid derivatives
should serve to incorporate substituted methylene units during the conversion of
P-keto carbonyl compounds to y-keto carbonyl compounds (Scheme 131). Treatment
of P-keto carbonyl compounds 41 with diethyl zinc produces an enolate that could
trap a carbenoid derived from diethyl zinc and a diiodoalkane. The substituted
cyclopropane intermediate 339 could be formed through intramolecular cyclization.
Release of the three-membered ring’s strain would result in formation of
«

P-substituted-y-keto carbonyl systems. Furthermore, trapping this P-substituted
zinc-mediated chain extension reaction intermediate 340 with various electrophiles
would generate more complex derivatives. While the stereochemistry at the a-position
is established during the reaction between the zinc enolate and the electrophile, the
stereochemistry of the P-substituent would be formed in the cyclopropanation process.
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Scheme 131: Proposed. Mechanism for the Zinc-Mediated Chain Extension Reaction
with Substituted Carbenoid

The preparation of P-substituted-y-keto esters through the chain extension of
P-keto esters requires a substituted carbenoid, which can be prepared through the
reaction of a 1,1-diiodoalkane with diethylzinc. The most common zinc-carbenoid,
besides 1 , 1 -diiodomethane, is derived from 1 , 1 -diiodoethane, which has been used
♦

successfully in carbenoid-mediated cyclopropanation reactions.

98

Several methods are reported in the literature for the preparation of
1,1-diiodoethane.99’ 101 One common method, reported by Kammeyer and coworkers,
involves reacting iodoethane with

1 , 1 -dichloroethane

in the presence of catalytic
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anhydrous aluminum chloride (Scheme 132)."a A modest yield of 1,1-diiodoethane is
formed using this method. Purification involves vacuum distillation, in which the
volatile byproducts are easily separated from the high boiling diiodoethane. The
targeted compound 344 must be stored in the dark using copper wire as a stabilizer.

,CI

^

A IC I3

(cat.)

/I

'Cl

'I

342

343

Cl

344

345

Scheme 132: Aluminum Chloride Catalyzed Preparation of 1,1-Diiodoethane

With the precursor 1,1-diiodoethane 344 prepared, the zinc-mediated chain
extension reaction was performed on a series of the P-keto esters, which were either
commercially available or easily prepared from a reaction between an alcohol and
diketene. However, the chain extension reaction was not successful when the
carbenoid was generated prior to addition of the P-keto esters (Scheme 133). Using
these standard conditions, the P-keto ester starting materials were recovered. The
reason for the lack of reactivity was attributed to the absence o f enolate formation.

O
C H 3 C H I2

+

Et2Zn

^

O

------------------

,

- k —

i

§

346
Scheme 133: Attempted Preparation of P-Methyl-y-Keto Esters
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However, after treatment of the P-keto esters with five equivalents of diethyl zinc
for ten minutes at 0 °C to facilitate the enolate formation (Scheme 134), addition of
five equivalents of 1 , 1 -diiodoethane provided the targeted P-methyl-y-keto esters in
good to excellent yield in thirty minutes at room temperature (Table 1 ).

0

0

^

p
'
'
^
—
V
K
u

a) Et2Zn (5 equiv), CH 2 CI2

j

ft

^
V
(1
u

b) CH 3 CHI2 (5 equiv)

O

347

346

Scheme 134: Successful Preparation of P-Methyl-y-Keto Esters

Entry

R

R’

Yield

A

Me

Me

76%

B

r-Butyl

Me

82%

C

Ph

Et

84%

D

Me

Bn

80%

E

Me

f-Butyl

8 8

%

Table 1: Conversion of P-Keto Esters to P-Methyl-y-Keto Esters

A by-product, 2-iodobutane, was always observed in this zinc-mediated chain
extension reaction process. This by-product has been reported in the earlier study of
cyclopropanation

reaction

involving

the

zinc-carbenoid

generated

from

1,1-diiodoethane. 100 It was not clear whether 2-iodobutane is formed as a result of
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carbenoid decomposition or whether it is a by-product of the reaction between
1 , 1 -diiodoethane

and diethylzinc.

The same reaction conditions were also used to chain-extend compound 348,
which was derived from allyl alcohol and diketene. Although no cyclopropane
formation was observed when using an excess amount of carbenoid, the
zinc-mediated chain extension reaction did not go to completion within 30 min
(Scheme 135). The ratio of starting material (348): to product (349) was 3:1.
Extending the reaction time from 30 min to 2 h and increasing the equivalents of
carbenoid from 5.0 to 7.5 did not improve the ratio of starting material to product.

O
a) Et2Zn (5 equiv), CH 2 CI2

348

+

O

O

348

Scheme 135: Attempted Preparation of P-Methyl-y-Keto Allyl Ester 349

The carbenoid addition (overall 7.5 equiv) protocol was modified, based on the
assumption that the carbenoid was undergoing decomposition. The detailed procedure
was as follows (Scheme 136). The P-keto allyl ester 348 was treated with five equiv
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of diethyl zinc for ten minutes at 0 °C to facilitate enolate formation, at which point
five equiv of 1,1-diiodoethane were added. After the reaction was allowed to proceed
at room temperature for 30 min, a second portion of diethyl zinc and 1,1-diiodoethane
(2.5 equiv each) was added sequentially. After an additional 30 min, no starting
material was present and the targeted p-methyl-y-keto allyl ester was isolated in 74%
yield.

0

0

a ) Et2Zn (5 equiv), CH2 CI2
b) CH 3 CHI2 (5 equiv)

c) Et2Zn (2 .5 equiv)

Q

b) CH3 CHI2 (2.5 equiv)

348

349

Scheme 136: Successful Preparation of P-Methyl-y-Keto Allyl Ester 349 with
Modified Procedure

Another member of the research group, Rob McGinness, studied the
zinc-mediated chain extension reaction with the carbenoid derived from diethyl zinc
and 1,1-diiodoethane on a series of P-keto tertiary amides (Scheme 137). Modest
yields and the continued presence of starting material were often observed (Table 2).
The modified procedure involving two additions of carbenoid did not improve the
conversion significantly. 101
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9 9

a) Et2Zn (5 equiv), CH CI
b) CH CHI (5 equiv)
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Scheme 137: Preparation of p-Methyl-y-Keto Amides

Entry

R

R’

R”

Yield

A

Me

Me

Me

67%

B

Me

(CH2) 4

74%

C

/-Butyl

Me

Inseparable

Me

with SM
D

/-Propyl

Me

Me

Inseparable
with SM

Table 2: Conversion of P-Keto Esters to P-Methyl-y-Keto Amides

A more disappointing result was observed when a secondary P-keto amide was
used as the starting material. An unidentified mixture of products was detected after
the zinc-mediated chain extension reaction was performed with carbenoid derived
from 1,1-diiodoethane and diethyl zinc (Scheme 138). The reason for this complexity
might be due to the secondary amide’s acidic proton.
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9 9
i
Bn

a ) Et2Zn (5 equiv), CH 2 CI2
------------------------------------------b) CH 3 CHI2 (5 equiv)

Unidentified mixture

352

Scheme 138: Attempted Preparation of p-Methyl-y-Keto Secondary Amide

Since the insertion of a P-methyl group during the chain extension process was
successful on the P-keto esters and tertiaiy amides, another variation was also
explored in which 1,1-diiodotoluene 355 was used as the carbenoid source. The
aluminum chloride-catalyzed method used for the preparation of 1 , 1 -diiodoethane
cannot be applied to the preparation of compound 355 because of the possible
Friedel-Crafts reaction. 1,1-Diiodotoluene can be prepared by the reaction of
hydrazones with iodine; 102

however, the more convenient and high yielding

preparation involving a reaction between trimethylsilyliodide and benzaldehyde was
chosen (Scheme 139).103 1,1-Diiodotoluene and hexamethyldisiloxane 356 are the
products of this reaction. The targeted solid 355 was isolated in greater than 50%
yield by vacuum sublimation.
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Scheme 139: Preparation of 1,1-Diiodotoluene Using Benzaldehyde and
Trimethylsilyl Iodide

With 1,1-diiodotoluene prepared, the zinc-mediated chain extension reaction was
performed on three P-keto esters using the identical procedure described for
1,1-diiodoethane (Scheme 140). The results listed in Table 3 suggest that with
increasing steric size of the R and R’ groups, a decreased yield of the chain extension
product was observed. When the starting material was the sterically hindered
4,4-dimethyl-3-oxopentanoate, no chain extension product was detected.
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0
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a) Et2Zn (5 equiv), CH2 CI2

R ^ A ) 'R

b)

R

I
(5 equiv)

3 4 7

357

Scheme 140: Preparation of P-Phenyl-y-Keto Esters

E ntry

R

R’

Yield

A

Me

Me

74 %

B

Me

/-Butyl

44 %

C

/-Butyl

/-Butyl

Unpurified mixture

Table 3: Conversion of P-Keto Esters to P-Phenyl-y-Keto Esters

b)

Initial Study towards Enantioselective Preparation of
P-Substituted-1,4-dicarbonyl Compounds
An enantioselective P-methyl insertion during the zinc-mediated chain extension

reaction with carbenoid was also attempted. Since the stereochemistry of the
P-substituent is determined in the formation of donor-acceptor cyclopropane, the
exploration of enantioselective cyclopropanation methods appeared attractive.
Denmark’s research group reported the catalytic, enantioselective cyclopropanation of
allylic alcohols using the 7V,7V-bis(methanesulfonyl) derivative of (R,R)-1,2-diamino-cyclohexane (Scheme 141).104
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Et2 Zn, CH 2 I2, CH2 CI2
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R"

R
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— OH
358

R

Me
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R"

V

N— (OH

359
(0 . 1 equiv)

■NH

Jo rMe
°
360
Scheme 141: Enantioselective Cyclopropanation of Allylic Alcohols Using
N, A-B is(methanesulfonyl) Derivative

(./?,/?)-1,2-Diaminocyclohexane was accessed via resolution of the racemates
(Scheme 142).105 After racemic diaminocyclohexane reacted with (Z,)-tartaric acid,
one diastereomer 362 precipitated selectively. Neutralization of the precipitate with
sodium hydroxide provided the enantiomerically pure 361A. Compound 364 was
prepared through acylation of compound 361A with butanesulfonyl chloride using
triethylamine as a base. Butanesulfonyl chloride was used instead of methanesulfonyl
chloride due to the improved solubility of the chiral ligand in the enantioselective
cyclopropanation reaction. 106
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a

Et3N,

i'NH2
*NH2

B u S 0 2CI

(enantiomerally pure)
36 4

361A

Scheme 142: Preparation of iV,iV-Bis(butanesulfonyl) Derivative 364

The zinc-mediated chain extension reaction with carbenoid derived from
diethylzinc and

1 , 1 -diiodoethane

was performed using a catalytic amount of the

bis-sulfonamide derivative 364 for the enantioselective P-methyl insertion. The
A(7V-bis(butanesulfonyl) derivative 364 was added after deprotonation of the P-keto
ester 347A with diethylzinc. The addition of 1,1-diiodoethane then followed. The
chain extension reaction proceeded successfully with full conversion of starting
material to the targeted compound 346A. However, the optical rotation measurement
of product 346A was zero, which indicated no preference for the synthesis of one
enantiomer over the other (Scheme 143). The identification of other suitable chiral
ligands for zinc might provide a solution for the enantioselective synthesis of
P-methyl-y-keto esters in the future.
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a) Et2Zn (5 equiv), CH2CI2
Bu

i

o=s=o
I
(O.leqiuv)
NH

\

O

b)
/

(5 equiv)

347A

346A

Scheme 143: Attempted Enantioselective Synthesis of (3-Methyl-y-Keto Esters

An Evans chiral auxiliary has been used to control the stereochemistry in the
zinc-mediated chain extension-aldol reaction when carbenoid derived from
diethylzinc and methylene iodide was used. In that case, no stereocenter is generated
at the P-carbon; however, we felt the potential for controlling stereochemistry at the
P-carbon through an Evans auxiliary needed to be investigated. The chain extension
reaction involving the chiral P-keto imide and carbenoid derived from diethylzinc and
1,1-diiodoethane were investigated (Scheme 144). Two diastereomers in a 1:1 ratio
(based on the ]H NMR spectrum of the crude reaction mixture) were obtained, which
excluded the possibility of diastereoselective p-methyl insertion using an Evans chiral
auxiliary.
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a) Et2Zn (5 equiv), CH2CI2

P

*?

b) CH 3 CHI2 (5 equiv)

o

D*
Bn

Bn''
366A and 366B

3 0 5

Two diastereom ers with a ratio of 1:1
S c h e m e 144:

Attempted Diastereoselective Synthesis of p-Methyl-y-Keto Imides

In summary, the zinc-mediated chain extension reaction using carbenoids
derived from

1 , 1 -diiodoethane

and

1 , 1 -diiodotoluene

were successfully developed.

This modification facilitates the incorporation of (3-substituents and thereby
complements the tandem reaction strategy which facilitates a-substitution. Controlling
the stereochemistry at the (3-position and the development of tandem reaction
strategies in which both a and P-substituents are incorporated are under development.
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CHAPTER IV

EXPERIMENTAL SECTION

1.

General Experimental

Unless otherwise noted, all reactions were run in oven-dried glassware and stirred
with teflon-coated magnetic stir-bars. The terms concentrated in vacuo or under
reduced pressure refer to the use of a rotaiy-evaporator or vacuum pump.

a)

Solvents

Methylene chloride (CH2 CI2 ), tetrahydrofuran (THF), acetonitrile (CH3 CN), toluene,
diethylether (Et2 0 ), AUV-dimethylformamide (DMF) and methanol were dried by
passing through a column using an Inovative Technology Inc. solvent delivery system.
Methylene iodide was purchased and copper was added as a stabilizer. Ethyl acetate
(EtOAc) was purchased from Pharmco and distilled prior to use. Hexanes were
purchased from Pharmco and distilled prior to use. Benzene was distilled from
calcium hydride prior to use.

b)

Chromatography

Chiral HPLC analysis was performed with a Daicel Chiralpak® AD-RH reverse
phase column. Thin Layer Chromatography (TLC) was carried out on EM Science
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F254 glass plates and visualized by UV and anisaldehyde or KMnC>4 stains. Column
chromatography was performed with Sorbent Technologies flash silica gel (32-63pm).
Mobile phases were used as noted.

c)

Spectroscopy

Melting points were determined using a Thomas Hoover melting point apparatus and
are uncorrected. High Resolution Mass Spectroscopy was performed at Merck
Pharmaceutical Co. Optical rotations were conducted using a Rudolf Research
Autopol III automatic polarimeter in specified solution and concentrations are given
in g/mL. Infrared spectroscopy was performed on a Nicolet 205 Fourier Transform
spectrometer. Nuclear Magnetic Resonance (NMR) spectroscopy was performed on
Varian Mercury operating at 399.768 MHz for 'H nuclei and 100.522 MHz for 13C
nuclei, and Varian Inova operating at 499.766 MHz for 'H nuclei and 125.679 MHz
for 13C nuclei. All 13C are 'H-decoupled. Unless otherwise noted, all NMR
experiments were carried out in deuterochloroform (CDCI3) solvent purchased from
Cambridge Isotope Laboratory and stored over 4 A sieves. All chemical shifts are
reported in parts per million (ppm) downfield of tetramethylsilane (TMS) internal
standard.
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d)

Reagents

Diethylzinc was purchased both as a solution (1.0 M in hexanes) and neat
Methylene iodide (CH2 I2) was purchased from Lancaster chemical companies.
Non-oxidized copper wire was added as a stabilizer. Iodine was sublimed prior to use.
Palladium 10% on carbon was purchased from Aldrich Chemical Co. and used
without

purification.

Bis(tricyclohexylphosphine)benzylidine

ruthenium

(IV)

dichloride (Grubbs’ 1st catalyst) was purchased from Strem Chemical Co. and used
without further purification.

2.

Preparation of Peptide Isostere

a)

Preparation of Peptide Isostere through N-Terminus

(5)-Methyl l-(3-oxobutanoyl)pyrro!idine-2-carboxylate 55
A 250-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with proline methyl ester
hydrochloride salt (10 g, 60 mmol), benzene (100 mL), sodium bicarbonate (16.8 g,
200 mmol) and diketene (8.4 mL, 100 mmol) in the indicated order. The suspension
was stirred overnight at room temperature. The resulting liquid was filtered through
filter paper and ethyl acetate (100 mL) was added to the filtrate. The organic solution
was washed with 1 M HC1 (50 mL), brine (50 mL), saturated sodium bicarbonate
solution (50 mL), and brine (50 mL). The solution was concentrated under reduced
pressure. The product was purified by flash chromatography on silica (hexanes:ethyl
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acetate = 3:1, R/ = 0.10) to offer 10.1 g (79%) of 55 as a yellow oily mixture of two
rotamers in a 6:1 ratio, with some minor enol forms present. Major rotamer: 'H NMR
(400 MHz, CDCI3) 5 4.40 (dd, 1H, J = 3.9, 6.1 Hz), 3.62 (s, 3H), 3.54-3.27 (m, 4H),
2.19 (s, 3H), 2.18-1.81 (m, 4H); 13C (125 MHz, CDCI3) 5 201.8, 172.1, 165.1, 88.4,
58.5, 51.9, 50.9, 47.4, 29.0, 24.5. Resonances observed for the minor rotamer: *H
NMR (400 MHz, CDC13)

8

4.34 (dd, 1H, J = 2.5, 8.4 Hz), 3.40 (s, 3H), 2.17 (s, 3H);

13C NMR (125 MHz, CDCI3) 8 201.8, 174.8, 170.2, 58.3, 51.6, 46.8, 30.3, 24.7, 22.8.
Resonances observed for the enol forms: *H NMR (400 MHz, CDCI3)

8

4.94 (s, 1H),

1.84 (s, 3H). IR (neat, cm'1): 2900-2700,1750-1700, 1650, 1230-1140.

(A)-Methyl l-(4-oxopentanoyl)pyrrolidine-2-carboxylate 56
A 100-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with 40 mL of methylene
chloride and diethyl zinc (1.0 M in hexanes, 15.0 mL, 15.0 mmol). The solution was
cooled to 0 °C and methylene iodide (1.2 mL, 15.0 mmol) was added slowly by
syringe. After stirring for 10 minutes, compound 55 (0.64 g, 3.0 mmol, in 3 mL of
methylene chloride) was added by syringe to the resulting white suspension. The
mixture was stirred for 30 minutes. After TLC analysis (hexanes:ethyl acetate = 3:1;
R/ = 0.10) indicated that the starting material was consumed, the solution was
quenched by cautious addition of saturated aqueous ammonium chloride (25 mL). The
mixture was extracted with diethyl ether (2 x 30 mL), washed with brine (25 mL), and
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dried over anhydrous sodium sulfate. The resulting liquid was filtered and
concentrated under reduced pressure. The residue was chromatographed on silica
(hexanes:ethyl acetate = 1.5:1, R/ = 0.20) to yield 0.52 g (76%) of 56 as a colorless
oily mixture of two rotamers in a 4:1 ratio, [a] d = -39.1 (c = 0.033 g/mL, CHCI3).
Major rotamer: ’H NMR (400 MHz, CDCI3) 5 4.35 (dd, 1H, J = 3.9,

8 .6

Hz), 3.62 (s,

3H), 3.59-3.45 (m, 2H), 2.87-2.37 (m, 4H), 2.10 (s, 3H), 2.20-1.78 (m, 4H); 13C (100
MHz, CDCI3 ) 8 : 207.4, 172.6, 170.2, 58.4, 51.9, 46.6, 37.4, 29.8, 29.0, 27.9, 24.5.
Resonances observed for the minor rotamer: 'H NMR (400 MHz, CDCI3)
1H, J = 2.6,

8 .6

8

4.45 (dd,

Hz), 3.67 (s, 3H); 13C NMR (100 MHz, CDC13) 8 172.4, 170.5, 59.1,

52.3, 46.2, 37.8, 31.1, 22.3. IR (neat, cm’1): 3350-3250, 2900-2700, 1750-1700, 1650,
1230-1140.

(S)-Methyl
l-((5)-2-((5)-methoxy(phenyl)methyl)-4-oxopentanoyl)pyrrolidine-2-carboxylate
59
A 25-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with 10 mL o f methylene
chloride and diethyl zinc (1.0 M in hexanes, 2 mL, 2.0 mmol). The solution was
cooled to 0 °C and methylene iodide (0.16 mL, 2.0 mmol) was added slowly by
syringe. After stirring for 10 minutes, compound 58 (0.33 g, 1.0 mmol, in 1 mL of
methylene chloride) was added by syringe to the resulting white suspension. The
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mixture was stirred for 30 minutes. After TLC analysis (hexanes:ethyl acetate =1:1,
Rf = 0.25) indicated that the starting material was consumed, the solution was
quenched by cautious addition of saturated aqueous ammonium chloride (5 mL). The
mixture was extracted with diethyl ether (2 x 10 mL), washed with brine (15 mL), and
dried over anhydrous sodium sulfate. The resulting liquid was filtered and
concentrated under reduced pressure. The residue was chromatographed on silica
(hexanes:ethyl acetate = 1:1, R/ = 0.30) to yield 0.17 g (50%) of 59 as a yellow oily
mixture of two rotamers in a 4:1 ratio. (NMR spectrum available in the CD)

(*S)-Methyl
l-((2.S',3.S',55)-5-hydroxy-5-inethyl-2-phenyltetrahydrofuran-3-carbonyl)pyrrolidi
ne-2 -carboxylate 62
A 25-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with 10 mL of methylene
chloride and diethyl zinc (1.0 M in hexanes, 2.5 mL, 2.5 mmol). The solution was
cooled to 0 °C and methylene iodide (0.20 mL, 2.5 mmol) was added slowly by
syringe. After stirring for 10 minutes, compound 55 (0.22 g, 1.0 mmol, in 2 mL of
methylene chloride) was added by syringe to the resulting white suspension. The
mixture was stirred for 30 minutes, at which time freshly distilled benzaldehyde (0.13
g, 1.2 mmol) was added into the reaction mixture by syringe. After TLC analysis
(hexanes:ethyl acetate = 1.5:1, R/ = 0.20) indicated the chain extension intermediate
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was consumed, the solution was quenched by cautious addition of saturated aqueous
ammonium chloride (10 mL). The mixture was extracted with diethyl ether (2 x 15
mL). The combined organic extracts were washed with brine (10 mL) and dried over
anhydrous sodium sulfate. The organic solution was filtered and concentrated under
reduced pressure. The residue was chromatographed on silica (hexanes:ethyl acetate =
1:1, Rf = 0.25) to yield 0.23 g (70%) of 62 as white crystals (mp: 113-115 °C) in
which one major hemiacetal form is present. [a]25o = -11.6 (c = 0.011 g/mL, CHCI3).
'H NMR (500 MHz, CDCI3 )
Hz), 4.56 (dd, 1H, J= 3.5,

8 .6

8

7.41-7.26 (m, 5H), 6.65 (s, 1H,), 5.18 (d, 1H, J = 5.0

Hz), 3.80 (s, 3H), 3.38-3.23 (m, 3H), 2.31-1.84 (m, 6 H),

1.69 (s, 3H); 13C NMR (125 MHz, CDC13)

8

174.8, 171.9, 142.0, 128.5, 127.8, 125.4,

105.3, 83.2, 58.8, 52.2, 51.0, 47.6, 41.6, 28.9, 24.9, 24.3. The presence of the open
chain form as a minor constituent is confirmed by the 13C resonance of 207.7. IR (neat,
cm'1): 3400 (b, OH), 2956, 1744,1640, 1448.

(25)-Methyl
l-((25',35j-5-methyl-2-phenyltetrahydrofuran-3-carbonyl)pyrrolidine-2-carboxyl
ate 63A and 63B
A 25-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with dichloromethane (10 mL),
compound 62 (0.43 g, 1.3 mmol). After the solution was cooled to the -78 °C,
triethylsilane (0.86 mL, 5.2 mmol) and boron trifluoride diethyl etherate (0.52 mL, 5.2
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mmol) were added dropwise in the indicated order. The reaction solution was left
stirring for forty minutes at -78 °C and twenty-one horns at room temperature. The
solution was quenched with saturated sodium bicarbonate solution (10 mL), extracted
with diethyl ether ( 3 x 1 5 mL). The combined organic layers were washed with brine
(15 mL) and dried over anhydrous sodium sulfate and concentrated in vacuo. The
product was purified by flash chromatography on silica (hexanes:ethyl acetate = 2 : 1 ,
R/ = 0.20) to offer 0.29 g (70%) of 63A and 63B as a yellow oily mixture of two
isomers in a 4.4:1 ratio. Resonance observed for the major isomer 63A: *H NMR (500
MHz, CDC13) 8 7.48-7.25 (m, 5H), 4.97 (d, 1H, J = 7.9 Hz), 4.45 (dd, 1H, J = 4.2,

8 .6

Hz), 4.32 (m, 1H), 3.75 (s, 3H), 3.22 (m, 1H), 3.04 (m, 1H), 2.88 (m, 1H), 2.48 (m,
1H), 2.10 (m, 1H), 1.96-1.71 (m, 3H), 1.38 (d, 1H, J = 6.2 Hz), 1.24 (d, 3H, J = 6.1
Hz), 1.18 (m, 1H); 13C (100 MHz, CDCI3)

8

170.0, 169.4, 138.8, 125.9, 125.3, 123.5,

82.2, 73.3, 56.4, 49.7, 49.4, 44.4, 36.0, 26.6, 22.2, 18.6. Resonances observed for the
minor isomer 63B: 'H NMR (500 MHz, CDC13) 8 4.97 (d, 1 H , J = 8.5 Hz), 4.46 (dd,
1H, J = 3.7, 8.1 Hz), 3.69 (s, 3H), 1.36 (d, 3H, J = 6.1 Hz); 13C NMR (100 MHz,
CDCI3)

8

170.0, 169.2, 138.3, 126.1, 124.4, 123.1, 82.6, 73.2, 56.4, 50.1, 49.4, 44.0,

36.0, 28.5, 20.0, 18.9.
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(5)-Methyl
l-((»S)-2-((5)-(methylthiocarbonothioyloxy)(phenyl)methyl)-4-oxopentanoyl)pyrr
olidine-2 -carboxylate

68

A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with sodium hydride (24 mg, 0.6
mmol, 60% in the mineral oil). Hexanes (2 mL) was added to the flask to wash the
sodium hydride. The hexane was removed by syringe, and then tetrahydrofuran (4 mL)
was added by syringe. The solution was cooled to 0 °C and carbon disulfide (76 mg,
1.0 mmol) was added by syringe. After stirring for 5 minutes, compound 62 (0.10 g,
0.3 mmol, in 1 mL of tetrahydrofuran) was added by syringe, followed by methyl
iodide (0.14 mg, 1.0 mmol). After TLC analysis (hexanes:ethyl acetate = 1:1, R/ =
0.25) indicated 62 was consumed, the solution was quenched with saturated aqueous
ammonium chloride (3 mL). The solution was extracted with diethyl ether ( 2 x 5 mL).
The combined organic layers were washed with brine (5 mL) and dried over
anhydrous sodium sulfate. The resulting liquid was filtered and concentrated under
reduced pressure. The residue was chromatographed on silica (hexanes:ethyl acetate =
1.5:1, R/ = 0.20) to yield 96 mg (74%) of 6 8 as a yellow oily mixture of two rotamers
in a 3.3:1 ratio. [a]25o = +15 (c = 0.004 g/mL, CHCI3). Major rotamer: *H NMR (500
MHz, CDCI3) 5 7.37-7.27 (m, 5H), 6.59 (d, 1H, J = 9.0 Hz), 4.31 (dd, 1H, J = 4.4, 8.4
Hz), 3.77-3.64 (m, 2H), 3.64 (s, 3H), 3.22 (dd, 1H, J = 10.3, 18.3 Hz), 2.92 (m, 1H),
2.79 (dd, 1H, J = 2.9, 18.3 Hz), 2.55 (s, 3H), 2.14 (s, 3H), 2.06 (m, 1H), 1.88-1.73 (m,
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3H); 13C (125 MHz, CDC13)

8

214.1, 207.2, 172.2, 169.8, 137.0, 128.5, 128.4, 127.4,

84.1, 59.2, 51.9, 47.0, 45.4, 43.6, 30.1, 29.2, 24.8, 19.2. Resonances observed for the
minor rotamer: 'H NMR (500 MHz, CDCI3)
J=

8 .6

8

6.51 (d, 1 H , J = 10.0 Hz), 3.84 (d, 1H,

Hz), 3.77 (s, 3H), 2.53 (s, 3H); 13C NMR (125 MHz, CDCI3)

8

214.4, 205.7,

172.3, 169.7, 137.4, 128.5, 126.8, 85.0, 59.1, 52.3, 46.1, 45.8, 43.5, 30.6, 30.2, 22.1,
19.2. IR (neat, cm’1): 2954-2852, 1740, 1715, 1640,1436,1202.

(5)-Methyl l-((/?)-2-benzyl-4-oxopentanoyl)pyrrolidine-2-carboxylate 69
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with toluene (4 mL). Compound
68

(0.16 mg, 0.4 mmol), tributyl tinhydride (0.16 mL, 0.6 mmol) and AIBN (10 mg,

0.06 mmol) were added sequentially to the flask. The solution was heated to 80 °C for
eight hours. The mixture was concentrated in vacuo, and the resulting residue was
purified by column chromatography on silica gel (hexanes:ethyl acetate = 1:1, R/ =
0.11) to give

88

mg (69%) of 69. [a]25D = +3.8 (c = 0.002 g/mL, CHC13). ’H NMR

(500 MHz, CDCI3) 8 7.32-7.18 (m, 5H), 4.46 (dd, 1H, J = 4.7, 8.9 Hz), 3.81 (m, 1H),
3.73 (s, 3H), 3.40 (m, 1H), 3.20 (m, 1H), 3.12-3.00 (m, 2H), 2.59 (dd, 1H, J = 8 .8 ,
13.7 Hz), 2.38 (dd, 1H, J = 3.2, 18.0 Hz), 2.18 (m, 1H), 2.06 (s, 3H), 2.06-1.92 (m,
3H); ,3C NMR (125 MHz, CDC13)

8

207.8, 173.4, 172.7, 138.7, 129.1, 128.4, 126.4,

58.7, 52.0, 46.8, 45.1, 40.6, 37.7, 29.9, 29.1, 24.8. IR (neat, cm’1): 2923-2851, 1744,
1713, 1634,1436, 1365.
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(iS)-Methy!

l-((5)-2-(hydroxymethyl)-4-oxopentanoyl)pyrrolidine-2-carboxylate

70
A 100-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with 35 mL of methylene
chloride and diethyl zinc (1.0 M in hexanes, 15.0 mL, 15.0 mmol). The solution was
cooled to 0 °C and methylene iodide (1.20 mL, 15.0 mmol) was added slowly by
syringe. After stirring for 10 minutes, compound 55 (0.64 g, 3.0 mmol, in 3 mL of
methylene chloride) was added by syringe to the resulting white suspension. The
mixture was stirred for 30 minutes. Paraformaldehyde (0.5 g) was placed in a dry
one-necked round-bottomed flask, which was capped with a rubber septum. One end
of a cannula was inserted through the septum in the flask that contained
paraformaldehyde, and the other end of the cannula was inserted through the septum
in the flask that contained the zinc reagent. The paraformaldehyde flask was heated
with a heat gun to induce formation of formaldehyde, which was bubbled into the
zinc-carbenoid solution for 10 minutes. After TLC analysis (hexanesrethyl acetate =
1.5:1, R/ = 0.20) indicated the chain extension intermediate was consumed, the
solution was quenched by cautious addition of saturated aqueous ammonium chloride
(15 mL). The solution was extracted with ethyl acetate (3 x 20 mL). The combined
organic layers were washed with brine (20 mL), and dried over anhydrous sodium
sulfate. The resulting liquid was filtered and concentrated under reduced pressure.
The residue was chromatographed on silica (hexanesrethyl acetate = 1:1, R/ = 0.20) to
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yield 0.57 g (74%) of 70 as a yellow oil with some minor hemiacetal forms present.
[a]25D = -25.3 (c = 0.003 g/mL, CHC13). ’H NMR (500 MHz, CDC13) 5 4.52 (dd, 1H,
J = 4.8, 8.9 Hz), 3.88-3.84 (m, 2H), 3.72 (s, 3H), 3.68-3.66 (m, 2H), 3.28 (m, 1H),
3.22-3.19 (t, 1H, J = 7.0 Hz), 3.01 (dd, 1H, J = 10.0, 18.4 Hz), 2.48 (dd, 1H, J = 3.7,
18.4 Hz), 2.24 (m, 1H), 2.12 (s, 3H), 2.02-1.93 (m, 3H); 13C NMR (125 MHz, CDCI3)
8

207.0, 173.6, 173.3, 64.5, 58.8, 52.5, 47.3, 42.1, 41.2, 29.8, 29.0, 24.8. Resonance

observed for minor hemiacetal forms: 13C NMR (125 MHz, CDCI3 )

8

175.3, 172.6,

172.0, 105.0, 104.9, 69.5, 69.4, 25.1, 24.6. IR (neat, cm'1): 3435 (b, OH), 2956-2852,
1743,1714, 1624, 1447.

(S)-Methyl
l-((5)-2-((methylthiocarbonothioyloxy)methyl)-4-oxopentanoyl)pyrrolidine-2-car
boxylate 72
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with sodium hydride (48 mg, 1.2
mmol, 60% in the mineral oil). Hexanes (2 mL) was added to the flask to wash the
sodium hydride. The hexane was removed by syringe, and then tetrahydrofuran (4 mL)
was added by syringe. The solution was cooled to 0 °C and carbon disulfide (0.15 g,
2.0 mmol) was added by syringe. After stirring for 5 minutes, compound 70 (0.26 g,
1.0 mmol, in 1 mL of tetrahydrofuran) was added by syringe, followed by methyl
iodide (0.21 g, 1.5 mmol). After TLC analysis (hexanes:ethyl acetate = 1:1, R/ = 0.20)
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indicated compound 70 was consumed, the solution was quenched with saturated
aqueous ammonium chloride (3 mL). The solution was extracted with diethyl ether (2
x 5 mL). The combined organic layers were washed with brine (5 mL), and dried over
anhydrous sodium sulfate. The resulting liquid was filtered and concentrated under
reduced pressure. The residue was chromatographed on silica (hexanes:ethyl acetate =
1.5:1, R/ = 0.2) to yield 0.24 g (6 8 %) of 72 as a yellow oil. [a]25o = -2.0 (c = 0.007
g/mL, CHCI3). 'H NMR (400 MHz, CDCI3)

8

4.78 (dd, 1H, J = 7.3, 10.7 Hz), 4.58

(dd, 1H, J = 7.3, 10.7 Hz), 4.46 (dd, 1H, J = 4.6,

8 .6

Hz), 3.90 (m, 1H), 3.79 (m, 1H),

3.70 (s, 3H), 3.58 (m, 1H), 3.14 (dd, 1H, J = 10.4, 18.2 Hz), 2.60 (dd, 1H, J = 3.3,
18.2 Hz), 2.58 (s, 3H), 2.22 (m, 1H), 2.15 (s, 3H), 2.10-1.96 (m, 3H); ,3C NMR (125
MHz, CDCI3 )

8

215.5, 206.5, 172.4, 170.5, 72.9, 59.0, 52.2, 47.3, 42.8, 38.1, 29.9,

29.2, 24.9, 19.0. IR (neat, cm'1): 2955-2850, 1743-1640, 1640, 1214, 1068.

(■S)-Methyl l-((/?)-2-methyl-4-oxopentanoyl)pyrroIidine-2-carboxylate 73
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with toluene (4 mL). compound
72 (35 mg, 0.1 mmol), tributyltin hydride (0.05 mL, 0.2 mmol) and AIBN (5 mg, 0.03
mmol) were added to the flask in the indicated order. Then the solution was heated to
80 °C for eight hours. The mixture was concentrated in vacuo, and the resulting
residue was purified by column chromatography on silica gel (hexanes:ethyl acetate =
3:1, R /= 0.15) to give 17 mg (70%) of 73 as a yellow oil. *H NMR (400 MHz, CDCI3)
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8

4.46 (dd, 1H, J = 4.6, 8.7 Hz), 3.83-3.64 (m, 2H), 3.70 (s, 3H), 3.12-2.94 (m, 2H),

2.36 (dd, 1H, J = 3.2, 17.3 Hz), 2.12 (s, 3H), 2.25-1.93 (m, 4H), 1.15 (d, 3H, J = 6.9
Hz); 13C NMR (125 MHz, CDCI3)

8

207.9, 174.5, 172.9, 58.5, 52.1, 47.2, 46.8, 33.1,

30.1, 29.1, 24.9, 16.7. IR (neat, cm'1): 2957, 1746, 1645, 1434.

(25)-MethyI
l-((35)-5-methyltetrahydrofuran-3-carbonyl)pyrrolidine-2-carboxyIate 77A and
77B
A 25-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with dichloromethane

(6

mL),

compound 76 ((130 mg, 0.5 mmol). After the solution was cooled to the -78 °C,
triethylsilane (0.4 mL, 2.0 mmol) and boron trifluoride diethyl etherate (0.2 mL, 2.0
mmol) were added dropwise in the indicated order. The reaction solution was left
stirring for forty minutes at -78 °C and twenty-one hours at room temperature. The
solution was quenched with saturated sodium bicarbonate solution (5 mL), extracted
with diethyl ether ( 3 x 1 0 mL). The combined organic layers were washed with brine
(10 mL) and dried over anhydrous sodium sulfate and concentrated in vacuo. The
product was purified by flash chromatography on silica (hexanes:ethyl acetate = 2 : 1 ,
R/ = 0.20) to offer 83 mg (69%) of 77A and 77B as a yellow oily mixture of two
isomers in a 3.3:1 ratio. Major isomer 77A: 'H NMR (500 MHz, CDCI3 )

8

4.50 (dd,

1H, J = 4.4, 8.7 Hz), 4.22 (dd, 1H, J = 8.4, 8.4 Hz), 4.13-3.97 (m, 2H), 3.72 (s, 3H),
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3.67-3.56 (m, 2H), 3.26 (m, 1H), 2.32 (m, 1H), 2.19 (m, 1H), 2.12-1.82 (m, 3H), 1.63
(m, 1H), 1.26 (d, 3H, J = 6.1 Hz); 13C (125 MHz, CDC13) 8 171.7, 171.1, 74.8, 69.2,
57.8, 51.2, 45.9, 42.1, 35.7, 28.0, 23.8, 19.4. Resonances observed for the minor
isomer 77B: 'H NMR (500 MHz, CDCI3)

8

4.44 (dd, 1H, J = 2.7,

8 .6

Hz), 3.77 (s,

3H), 1.30 (d, 3H, J = 6.1 Hz); 13C NMR (125 MHz, CDCI3 ) 8 172.5, 171.7, 75.2, 68.5,
58.3, 51.6, 45.8, 43.0, 36.0, 23.5, 19.3.

(25)-Methyl
l-(2-(2-hydroxypropan-2-yl)-4-oxopentanoyl)pyrrolidine-2-carboxylate 78
A 100-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with 25 mL of methylene
chloride and diethyl zinc (1.0 M in hexanes, 10 mL, 10.0 mmol). The solution was
cooled to 0 °C and methylene iodide (0.80 mL, 10.0 mmol) was added slowly by
syringe. After stirring for 10 minutes, compound 56 (0.85 g, 4.0 mmol, in 4 mL of
methylene chloride) was added by syringe to the resulting white suspension. The
mixture was stirred for 30 minutes, at which time freshly distilled acetone (0.4 mL,
4.8 mmol) was added into the reaction mixture by syringe. After TLC analysis
(hexanes:ethyl acetate = 3:1, R/ = 0.10) indicated the chain extension intermediate
was consumed, the solution was quenched by cautious addition of saturated aqueous
ammonium chloride (15 mL). The mixture was extracted with diethyl ether (3 x 15
mL). The combined organic extracts were washed with brine (25 mL) and dried over
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anhydrous sodium sulfate. The organic solution was filtered and concentrated under
reduced pressure. The residue was chromatographed on silica (hexanes:ethyl acetate =
3:1, R / = 0.20) to yield 0.97 g (80%) of 78 as colorless oil in which one major
ring-opened form is present. Major isomer: 'H NMR (400 MHz, CDCI3)

8

4.46 (dd,

1H, J = 5.1, 8.9 Hz), 3.97 (m, 1H), 3.73 (s, 3H), 3.17-2.98 (m, 2H), 2.76 (dd, 1H, J =
3.0, 18.3 Hz), 2.39-1.91 (m, 5H), 2.14 (s, 3H), 1.74-1.62 (m, 1H), 1.32 (s, 3H), 1.19 (s,
3H); 13C (125 MHz, CDCI3)

8

208.1, 207.2, 175.3, 174.4, 174.2, 174.1, 173.0, 172.4,

172.3, 172.2, 105.1, 105.0, 84.2, 83.4, 71.4, 70.8, 59.3, 59.1, 58.7, 52.6, 52.4, 52.2,
51.8, 48.4, 47.9, 46.9, 45.8, 42.9, 42.5, 42.2, 42.1, 31.5, 31.4, 30.4, 30.2, 29.5, 29.4,
29.3, 28.8, 27.7, 27.0, 26.4, 26.3, 25.1, 25.0, 24.8; Resonances observed for the
another two isomers: ]H NMR (400 MHz, CDCI3 )

8

4.54 (dd, 1H, J = 3.1, 6.1 Hz),

3.75 (s, 3H), 3.72 (s, 3H), 2.21 (s, 3H), 1.52 (s, 6 H), 1.41 (s, 3H), 1.35 (s, 3H).

(2S)-Methyl
l-(2,2,5-trimethyltetrahydrofuran-3-carbonyl)pyrrolidine-2-carboxylate 80A and
80B
A 25-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with dichloromethane

(8

mL),

compound 78 (285 mg, 1.0 mmol). After the solution was cooled to the -78 °C,
triethylsilane (0.45 mL, 3.0 mmol) and boron trifluoride diethyl etherate (0.30 mL, 3.0
mmol) were added dropwise in the indicated order. The reaction solution was left
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stirring for forty minutes at -78 °C and twenty-one hours at room temperature. The
solution was quenched with saturated sodium bicarbonate solution (5 mL), extracted
with diethyl ether ( 3 x 1 5 mL). The combined organic layers were washed with brine
(15 mL) and dried over anhydrous sodium sulfate and concentrated in vacuo. The
product was purified by flash chromatography on silica (hexanes:ethyl acetate = 3:1,
R/ = 0.30) to offer 0.20 g (75%) of 80A and 80B as a yellow oily mixture of two
isomers in a 3.5:1 ratio. Major isomer 80A: ]H NMR (400 MHz, CDCI3)

8

4.54 (dd,

1H, J = 4.6, 8.7 Hz), 4.34 (m, 1H), 3.72 (s, 3H), 3.76 (m, 1H), 3.02 (dd, 1H, J = 7.4,
8.9 Hz), 2.56 (m, 1H), 2.29-1.89 (m, 5H), 1.74-1.62 (m, 1H), 1.47 (s, 3H), 1.24 (d, 3H,
J = 6.1 Hz), 1.21 (s, 3H); 13C (100 MHz, CDCI3) 5 172.9,171.3, 83.3, 73.2, 59.1, 52.3,
51.7, 47.8, 37.7, 30.4, 29.2, 25.3, 23.6, 22.3. Resonances observed for the minor
isomer 80B: 'H NMR (400 MHz, CDCI3)

8

4.46 (dd, 1H, J = 3.7, 8.1 Hz), 3.74 (s,

3H), 3.65 (m, 1H), 2.48 (m, 1H), 1.41 (s, 3H), 1.19 (s, 3H); 13C NMR (100 MHz,
CDCI3)

8

173.1, 171.7, 82.5, 73.9, 59.1, 52.4, 52.1, 46.6, 38.2, 30.9, 29.4, 25.1, 24.1,

22 . 0 .

((25')-l-((2,2,5-Trimethyltetrahydrofuran-3-yl)methyl)pyrrolidin-2-yl)methanol
81
A 25-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with tetrahydrofuran (10 mL),
lithium aluminum hydride (0.15 g, 4.0 mmol) and compound 80 (0.46 g, 1.7 mmol) in
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the indicated order. The solution was refluxed till TLC analysis (hexanes:ethyl acetate
= 3:1, R/ = 0.30) indicated that the starting material was consumed. The solution was
cooled to room temperature and quenched by cautious and sequential addition of
water (2 mL), 10% aqueous sodium hydroxide (2 mL), and water
stirring for

10

(6

mL). After

min, the solution was filtered and concentrated under reduced pressure.

The product was purified by flash chromatography on silica (hexanes:ethyl acetate =
5:1, R/ = 0.15) to offer 0.32 g (84%) of 81 as a colorless liquid with a mixture of two
isomers in a 3.5:1 ratio. Major isomer: 'H NMR (400 MHz, CDCI3) 5 4.04 (m, 1H),
3.50 (dd, 1H,.7=5.1, 10.7 Hz), 3.36 (dd, 1H, .7=2.5, 10.7 Hz), 3.14 (m, 1H), 2.88 (b,
-OH, 1H), 2.64 (dd, 1H, J = 8.4, 12.3 Hz), 2.46 (m, 1H), 2.25-1.97 (m, 3H), 1.88-1.58
(m, 6 H), 1.26 (s, 3H), 1.22 (d, 3H, J = 6.2 Hz), 0.97 (s, 3H); 13C (100 MHz, CDC13) 8
81.3, 70.0, 64.5, 61.5, 55.0, 53.9, 45.3, 37.6, 27.8, 26.6, 22.7, 22.2, 19.8. Resonances
observed for the minor isome: ’H NMR (400 MHz, CDCI3) 8 : 1.20 (s, 3H), 1.12 (d,
3H, J = 6.2 Hz), 0.94 (s, 3H); 13C NMR (100 MHz, CDCI3 )

8

80.3, 70.6, 64.1, 60.6,

54.3, 52.9, 45.8, 37.2, 27.5, 26.6, 22.4, 22.1, 20.6.

((25)-l-((2,2,5-Trimethyltetrahydrofuran-3-yl)methyl)pyrrolidin-2-yl)nietliyl
3,5-dinitrobenzoate 82
A 50-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with pyridine (10 mL),
compound 81 (1.0 g, 4.0 mmol), and 3,5-dinitrobenzoylchloride (2.0 g, 8.7 mmol) in
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the indicated order. After stirred overnight at room temperature, water (15 mL) was
added to the mixture and the solution was extracted with diethyl ether ( 3 x 1 5 mL).
The combined organic extracts were dried carefully over anhydrous sodium sulfate
and concentrated in vacuo. The residue was chromatographed on silica (hexanes:ethyl
acetate = 7:1, Rj = 0.20) to yield 1.35 g (80%) of 82 as a colorless oil. 'H NMR (400
MHz, CDCI3) 5 9.24 (t, 1H, J = 2.1 Hz), 9.16 (d, 2H, J = 2.1 Hz), 4.44 (dd, 1H, J =
4.6, 11.0 Hz), 4.31 (dd, 1H, J = 6.3, 11.0 Hz), 4.10 (m, 1H), 3.22 (m, 1H), 2.86-2.79
(m, 2H), 2.40 (dd, 1H, J = 6.0, 12.2 Hz), 2.24 (m, 1H), 2.14 (m, 1H), 2.00 (m, 1H),
1.88-1.69 (m, 5H), 1.34 (s, 3H),1.19 (d, 3H, J = 6.1 Hz), 1.05 (s, 3H); 13C NMR (100
MHz, CDCI3 )

8

162.7, 148.9, 134.2, 129.6, 122.6, 82.4, 71.3, 69.2, 63.0, 56.9, 54.8,

46.3, 38.8, 29.0, 28.5, 23.6, 23.4, 21.1.

(5)-Methyl
l-((5>2-(hydroxydiphenylmethyl)-4-oxopentanoyl)pyrrolidine-2-carboxylate 83
A 25-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with 8 mL of methylene chloride
and diethyl zinc (1.0 M in hexanes, 2.5 mL, 2.5 mmol). The solution was cooled to
0 °C and methylene iodide (0.20 mL, 2.5 mmol) was added slowly by syringe. After
stirring for 10 minutes, compound 55 (0.23 g, 1.0 mmol, in 1 mL of methylene
chloride) was added by syringe to the resulting white suspension. The mixture was
stirred for 30 minutes, at which time benzophenone (0.29 g 1.6 mmol) was added into
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the reaction mixture by syringe. After TLC analysis (hexanes:ethyl acetate = 1.5:1, R/
= 0 .2 0 ) indicated the chain extension intermediate was consumed, the solution was
quenched by cautious addition of saturated aqueous ammonium chloride (5 mL). The
mixture was extracted with diethyl ether ( 3 x 1 0 mL). The combined organic extracts
were washed with brine (15 mL) and dried over anjiydrous sodium sulfate. The
organic solution was filtered and concentrated under reduced pressure. The residue
was chromatographed on silica (hexanes:ethyl acetate = 3:1, R /= 0.30) to yield 0.26 g
(65%) of 83 as colorless oil in which one major ring-opening form is present.

(*S)-Methyl
l-((25',45)-4-hydroxy-2-(hydroxydiphenylmethyl)pentanoyl)pyrrolidine-2-carbox
ylate 85
A 25-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with dichloromethane

(8

mL),

compound 83 (286 mg, 0.7 mmol). After the solution was cooled to the -78 °C,
triethylsilane (0.39 mL, 2.4 mmol) and boron trifluoride diethyl etherate (0.30 mL, 3.0
mmol) were added dropwise in the indicated order. The reaction solution was left
stirring for forty minutes at -78 °C and twenty-one hours at room temperature. The
solution was quenched with saturated sodium bicarbonate solution (5 mL), extracted
with diethyl ether ( 3 x 1 0 mL). The combined organic layers were washed with brine
(10 mL) and dried over anhydrous sodium sulfate and concentrated in vacuo. The
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product was purified by flash chromatography on silica (hexanes:ethyl acetate = 4:1,
Rf = 0.20) to offer 0.20 g (70%) of 85 as a yellow oily mixture of two rotamers in a
3:1 ratio. Major rotamer: 'H NMR (500 MHz, CDC13) 8 7.59-7.14 (m, 10H), 4.05 (dd,
1H, J = 2.2, 8.4 Hz), 3.98 (m, 1H), 3.79 (s, 3H), 3.76 (dd, 1H, J = 1.8, 8.5 Hz), 3.40
(m, 1H), 2.85 (m, 1H), 2.24 (m, 1H), 2.00 (m, 1H), 1.81 (m, 1H), 1.65-1.52 (m, 2H),
1.59 (d, 3H, J = 6.1 Hz), 1.40-1.20 (m, 2H), 0.86 (m, 1H); 13C (100 MHz, CDC13) 8 :
173.0, 171.3, 143.5, 141.9, 128.5, 127.6, 127.4, 127.2, 126.8, 126.2, 90.9, 72.8, 59.1,
52.7, 51.1, 46.0, 35.5, 30.5, 22.0. 20.2. Resonances observed for the minor rotamer:
’H NMR (500 MHz, CDC13) 8 : 4.28 (dd, 1H, J = 4.9,

8 .6

Hz), 4.10 (m, 1H), 3.57 (s,

3H), 1.52 (d, 3H, J = 6.0 Hz); 13C NMR (100 MHz, CDC13)

8

172.5, 171.2, 146.2,

142.5, 128.4, 127.6, 127.1, 90.0, 73.1, 53.4, 52.1, 47.5, 37.6, 28.8, 25.1, 20.4.

(*S)-Methyl 2-(N-benzyl-3-oxobutanamido)-3-phenylpropanoate 94
A 100-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with (S)-methyl
2-(benzylamino)-3-methylbutanoate (2.50 g, 9.3 mmol), benzene (40 mL), sodium
bicarbonate (1.7 g, 20 mmol) and diketene (1.5 mL, 19 mmol) in the indicated order.
The suspension was stirred overnight at room temperature. The resulting liquid was
filtered through filter paper and ethyl acetate (40 mL) was added to the filtrate. The
organic solution was washed with 1 M HC1 (20 mL), brine (20 mL), saturated sodium
bicarbonate solution (20 mL), and brine (20 mL). The solution was concentrated
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under reduced pressure. The product was purified by flash chromatography on silica
(hexanes:ethyl acetate = 5:1, R/ = 0.20) to offer 2.0 g (61%) of 94 as a yellow oily
mixture of two rotamers with some minor enol forms present. (NMR spectrum
available in the CD)

(5)-Methyl 2-(N-benzyl-4-oxopentanamido)-3-phenylpropanoate 95
A 100-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with 40 mL of methylene
chloride and diethyl zinc (1.0 M in hexanes, 15 mL, 15.0 mmol). The solution was
cooled to 0 °C and methylene iodide (1.2 mL, 15.0 mmol) was added slowly by
syringe. After stirring for 10 minutes, compound 93 (1.06 g, 3.0 mmol, in 3 mL of
methylene chloride) was added by syringe to the resulting white suspension. The
mixture was stirred for 30 minutes. After TLC analysis (hexanes:ethyl acetate = 3:1;
Rf =

0 .2 0

) indicated that the starting material was consumed, the solution was

quenched by cautious addition of saturated aqueous ammonium chloride (25 mL). The
mixture was extracted with diethyl ether (2 x 30 mL), washed with brine (25 mL), and
dried over anhydrous sodium sulfate. The resulting liquid was filtered and
concentrated under reduced pressure. The residue was chromatographed on silica
(hexanes:ethyl acetate = 3:1; R/ = 0.15) to yield 0.80 g (73%) of 95 as a yellow oily
compound. ‘H NMR (400 MHz, CDCI3) 5 7.29-7.07 (m, 10H), 4.46 (d, 1 H , J = 16.8
Hz), 4.22 (dd, 1H, J = 5.8, 9.2 Hz), 3.81 (d, 1H, J = 16.9 Hz), 3.59 (s, 3H), 3.30 (dd,
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1H, J = 3.2, 13.9 Hz), 3.16 (dd, 1H, J = 9.2, 13.9 Hz), 2.84 (m, 1H), 2.71-2.58 (m,
2H), 2.45 (m, 1H), 2.18 (s, 3H); 13C NMR (100 MHz, CDCI3) 5 207.5, 172.5, 171.0,
138.3, 136.3, 129.6, 128.8, 127.8, 127.5, 126.8, 61.8, 52.6, 52.2, 38.2, 35.4, 30.2,
27.7.

(A)-Methyl 2-(N-benzyl-4-oxopentanamido)-3-methylbutanoate 96
A 100-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with 30 mL of methylene
chloride and diethyl zinc (1.0 M in hexanes, 15 mL, 15.0 mmol). The solution was
cooled to 0 °C and methylene iodide (1.2 mL, 15.0 mmol) was added slowly by
syringe. After stirring for 10 minutes, compound 94 (0.92 g, 3.0 mmol, in 3 mL of
methylene chloride) was added by syringe to the resulting white suspension. The
mixture was stirred for 30 minutes. After TLC analysis (hexanes:ethyl acetate = 3:1;
Rj =

0 .2 0

) indicated that the starting material was consumed, the solution was

quenched by cautious addition o f saturated aqueous ammonium chloride (25 mL). The
mixture was extracted with diethyl ether (3 x 30 mL), washed with brine (25 mL), and
dried over anhydrous sodium sulfate. The resulting liquid was filtered and
concentrated under reduced pressure. The residue was chromatographed on silica
(hexanes:ethyl acetate = 1.5:1, R/ = 0.15) to yield 0.69 g (72%) of 96 as a yellow oily
mixture of two rotamers in a 2.2:1 ratio. Major rotamer: *H NMR (400 MHz, CDCI3)
5 7.26-7.03 (m, 5H), 4.74 (d, 1H, J = 10.4 Hz), 4.61-4.53 (m,'2H), 3.29 (s, 3H),
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2.77-2.66 (m, 2H), 2.53 (m, 1H), 2.30-2.15 (m, 2H), 2.04 (s, 3H), 0.84 (d, 3H, J =
Hz), 0.76 (d, 3H, J =

6 .8

Hz); 13C (100 MHz, CDCI3 )

8

6 .6

207.4, 173.4, 171.0, 137.2,

128.7, 127.3, 126.2, 65.7, 62.3, 51.6, 48.5, 38.3, 27.9, 27.8, 20.0, 18.8. Resonances
observed for the minor rotamer: *H NMR (400 MHz, CDCI3 )
3H); ,3C NMR (100 MHz, CDC13)

8

8

3.20 (s, 3H), 2.10 (s,

172.8, 170.2, 137.8, 128.2, 127.6, 126.8, 51.8,

45.8, 38.3, 30.2, 27.5.

(S)-Methyl 2-(4-oxopentanamido)-3-phenylpropanoate 97
A 50-mL roimd-bottomed flask was equipped with a stir bar and charged with
acetonitrile (16 mL), water (4 mL), and the y-keto amide compound 100 (0.50 g, 1.25
mmol). To this solution was added eerie ammonium nitrate (2.6 g, 5.0 mmol) and the
mixture was allowed to stir for half hour under room temperature. The solution was
added water (10 mL), then extracted with Et2 0 (3 x 15 mL). The combined organic
extracts were dried carefully over anhydrous sodium sulfate and concentrated in
vacuo. The residue was chromatographed on silica (hexanes:ethyl acetate = 1.5:1, R/-=
0.20) yielded 0.20 g (58%) of 97 as a viscous colorless oil. 'H NMR (400 MHz,
CDCI3) 8 7.31-7.11 (m, 5H), 6.20 (d, 1H, J = 7.7 Hz), 4.84 (dd, 1H, J = 5.9, 13.7 Hz),
3.71 (s, 3H), 3.14 (dd, 1H, J = 5.8, 13.9 Hz), 3.06 (dd, 1H, J = 6.0, 13.9 Hz),
2.82-2.68 (m, 2H), 2.50-2.37 (m, 2H), 2.16 (s, 3H); 13C NMR (100 MHz, CDC13)
207.6,172.2, 171.7,136.1,129.5, 128.8, 127.3, 53.4, 52.5, 38.5, 38.1, 30.1, 29.9.
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8

(<S)-Methyl 2-(N-(4-methoxybenzyl)-3-oxobutanamido)-3-phenylpropanoate 98
A 100-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with (S)-methyl
2-(4-methoxybenzylamino)-3-phenylpropanoate (4.3 g, 16 mmol), benzene (40 mL),
sodium bicarbonate (2.4 g, 30 mmol) and diketene (3.4 mL, 40 mmol) in the indicated
order. The suspension was stirred overnight at room temperature. The resulting liquid
was filtered through filter paper and ethyl acetate (100 mL) was added to the filtrate.
The organic solution was washed with 1 M HC1 (50 mL), brine (50 mL), saturated
sodium bicarbonate solution (50 mL), and brine (50 mL). The solution was
concentrated under reduced pressure. The product was purified by flash
chromatography on silica (hexanes:ethyl acetate = 3:1, R/ = 0.25) to offer 4.5 g (73%)
of 98 as a yellow oily mixture of two rotamers, with some minor enol forms present.
Major rotamer: 'H NMR (400 MHz, CDC13)

8

7.31-6.78 (m, 9H), 4.50-4.28 (m, 3H),

3.78 (s, 3H), 3.66 (s, 3H), 3.49 (s, 2H), 3.38 (m, 1H), 3.23 (m, 1H), 2.23 (s, 3H); 13C
(100 MHz, CDC13)

8

202.1, 176.2, 172.9, 171.3, 170.6, 167.6, 159.5, 159.2, 138.0,

129.8, 129.6, 129.5, 129.0, 128.8, 128.6, 127.5, 127.0, 126.8, 114.3, 114.1, 113.9,
61.2, 60.8, 55.5, 52.6, 52.4, 51.5, 50.5, 35.8, 35.4, 30.4, 22.3. Resonances observed
for the enol forms: ‘H NMR (400 MHz, CDCI3)

8

5.06 (s, 1H), 3.66 (s, 3H), 1.92 (s,

3H); 13C NMR (100 MHz, CDC13) 8 87.8.
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(>S)-Methyl 2-(N-(4-methoxybenzyl)-3-oxobutanamido)-3-methylbutanoate 99
A 250-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with (<S)-methyl
2-(4-methoxybenzylamino)-3-methylbutanoate (5.0 g, 20 mmol), benzene (80 mL),
sodium bicarbonate (3.4 g, 40 mmol) and diketene (4.2 mL, 50 mmol) in the indicated
order. The suspension was stirred overnight at room temperature. The resulting liquid
was filtered through filter paper and ethyl acetate (100 mL) was added to the filtrate.
The organic solution was washed with 1 M HC1 (50 mL), brine (50 mL), saturated
sodium bicarbonate solution (50 mL), and brine (50 mL). The solution was
concentrated under reduced pressure. The product was purified by flash
chromatography on silica (hexanes:ethyl acetate = 5:1, R/ = 0.25) to offer 4.0 g (60%)
99 as a yellow oily mixture two rotamers with some minor enol forms present. Major
rotamer: ‘H NMR (400 MHz, CDC13) 5 7.21-6.79 (m, 4H), 4.86 (m, 1H), 4.57-4.50
(m, 2H), 3.80 (s, 3H), 3.48 (s, 3H), 3.41 (d, 2H, J = 10.9 Hz), 2.21 (s, 3H), 2.37-2.28
(m, 1H), 0.98 (d, 3H, J = 6.4 Hz), 0.94 (d, 3H, J = 6 . 8 Hz); 13C (100 MHz, CDCI3)

8

202.4, 176.2, 173.4, 168.5, 159.2, 129.8, 128.6, 127.7, 127.4, 114.4, 114.1, 113.7,
6 6 .6

, 62.3, 61.2, 55.5, 55.4, 52.2, 51.9, 51.1, 50.5, 48.6, 47.7, 45.8, 30.7, 30.2, 28.2,

27.9, 27.7, 22.3, 20.2, 20.1, 19.0, 18.9. Resonances observed for the minor rotamer:
'H NMR (400 MHz, CDC13) 8 3.77 (s, 3H), 3.49 (s, 3H), 2.31 (s, 3H), 0.86 (d, 3H, J =
6.7 Hz), 0.80 (d, 3H, J = 6.7 Hz). Resonances observed for the enol forms: 'H NMR
(400 MHz, CDCI3) 8 5.06 (s, 1H), 1.89 (s, 3H); 13C NMR (100 MHz, CDC13) 8 87.9.
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(S)-Methyl 2-(N-(4-methoxybenzyl)-4-oxopentanamido)-3-phenylpropanoate 100
A 100-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with 40 mL of methylene
chloride and diethyl zinc (1.0 M in hexanes, 15 mL, 15.0 mmol). The solution was
cooled to 0 °C and methylene iodide (1.2 mL, 15.0 mmol) was added slowly by
syringe. After stirring for 10 minutes, compound 98 (1.15 g, 3.0 mmol, in 3 mL of
methylene chloride) was added by syringe to the resulting white suspension. The
mixture was stirred for 30 minutes. After TLC analysis (hexanes:ethyl acetate = 3:1,
R/ = 0.25) indicated that the starting material was consumed, the solution was
quenched by cautious addition of saturated aqueous ammonium chloride (25 mL). The
mixture was extracted with diethyl ether (2 x 30 mL), washed with brine (25 mL), and
dried over anhydrous sodium sulfate. The resulting liquid was filtered and
concentrated under reduced pressure. The residue was chromatographed on silica
(hexanes:ethyl acetate = 3:1; R/ = 0.20) to yield 0.77 g (65%) of 100 as a yellow oily
mixture of two rotamers in a 7:1 ratio. Major rotamer: 'H NMR (500 MHz, CDCI3)

8

7.30-7.21 (m, 3H), 7.13 (d, 2H, J = 7.5 Hz), 7.09 (d, 2H, J = 8.4 Hz), 6.81 (d, 2H, J =
8.5 Hz), 4.42 (d, 1H, J = 16.5 Hz), 4.18 (dd, 1H, J = 5.6, 9.2 Hz), 3.77 (s, 3H), 3.74 (d,
1H, J = 16.4 Hz), 3.62 (s, 3H), 3.32 (dd, 1H, J = 5.7, 14.0 Hz), 3.18 (dd, 1H, J = 9.4,
13.8 Hz), 2.86 (m, 1H), 2.74-2.62 (m, 2H), 2.50 (m, 1H), 2.21 (s, 3H); 13C (100 MHz,
CDCI3)

8

207.5, 172.3, 171.0, 159.3, 138.4, 129.6, 128.9, 128.7, 126.8, 114.1, 61.5,

55.4, 52.2, 38.1, 35.4, 30.2, 27.7, 21.2. Resonances observed for the minor rotamer:
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'H NMR (500 MHz, CDC13) 8 : 4.68 (m, 1H), 3.38 (s, 3H), 3.04 (dd, 1H, J = 8.3, 14.1
Hz), 2.17 (s, 3H); 13C NMR (100 MHz, CDCI3)

8

172.7, 171.2, 137.0, 129.4, 127.1,

113.8, 60.5, 46.2, 38.5, 36.0, 27.5.

(iS)-Methyl 2-(N-(4-methoxybenzyl)-4-oxopentanamido)-3-methyIbutanoate 101
A 100-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with 40 mL of methylene
chloride and diethyl zinc (1.0 M in hexanes, 15 mL, 15.0 mmol). The solution was
cooled to 0 °C and methylene iodide (1.2 mL, 15.0 mmol) was added slowly by
syringe. After stirring for 10 minutes, compound 99 (1.0 g, 3.0 mmol, in 3 mL of
methylene chloride) was added by syringe to the resulting white suspension. The
mixture was stirred for 30 minutes. After TLC analysis (hexanes:ethyl acetate = 5:1,
Rf = 0.25) indicated that the starting material was consumed, the solution was
quenched by cautious addition of saturated aqueous ammonium chloride (25 mL). The
mixture was extracted with diethyl ether (3 x 20 mL), washed with brine (25 mL), and
dried over anhydrous sodium sulfate. The resulting liquid was filtered and
concentrated under reduced pressure. The residue was chromatographed on silica
(hexanes:ethyl acetate = 5:1, R/ = 0.20) to yield 1.04 g (84%) of 101 as a yellow oily
mixture of two rotamers in a 2.5:1 ratio. Major rotamer: 'H NMR (500 MHz, CDCI3)
8

7.05 (d, 2H, J = 8.5 Hz), 6.77 (d, 2H, J = 8.5 Hz), 4.68 (d, 1H, J = 10.3 Hz), 4.56 (d,

1H, J = 17.3 Hz), 4.59 (d, 1H, J = 17.2 Hz), 3.67 (s, 3H), 3.35 (s, 3H), 2.84-2.53 (m,
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3H), 2.37-2.20 (m, 2H), 2.07 (s, 3H), 0.86 (d, 3H, J = 6.5 Hz), 0.76 (d, 3H, J = 5.8
Hz); 13C (125 MHz, CDC13)

6

207.5, 173.3, 171.0, 158.9, 129.1, 127.5, 114.1, 77.8,

62.4, 55.4, 51.7, 48.3, 38.3, 30.1, 27.9, 20.1, 18.8. Resonances observed for the minor
rotamer: *H NMR (500 MHz, CDC13) 8 7.02 (d, 2 H , J =

8 .6

Hz),

6 .6 8

(d, 2 H , J =

8 .6

Hz), 4.75 (d, 1H, J = 15.2 Hz), 4.10 (d, 1H, J = 14.3 Hz), 3.97 (d, 1H, J = 10.9 Hz),
3.64 (s, 3H), 3.28 (s, 3H), 2.12 (s, 3H), 0.88 (d, 3H, J = 6 . 6 Hz); 13C NMR (125 MHz,
CDCI3)

8

207.5, 172.6, 170.3, 158.6, 130.0, 128.9, 113.5, 77.7, 65.6, 62.3, 55.3, 51.9,

51.6, 45.3, 27.5.

(£)-Methyl 3-methyl-2-(4-oxopentanamido)butanoate 102
A 50-mL round-bottomed flask was equipped with a stir bar and charged with
acetonitrile (16 mL), water (4.0 mL), and compound 101 (0.54 g, 1.5 mmol). To this
solution was added eerie ammonium nitrate (3.1 g, 6.0 mmol) and the mixture was
allowed to stir for half hour at room temperature. The solution was added water (10
mL), then extracted with Et2 0 ( 3 x 1 5 mL). The combined organic extracts were dried
carefully over anhydrous sodium sulfate and concentrated in vacuo. The residue was
chromatographed on silica (hexanes:ethyl acetate = 1:1, R / = 0.25) yielded 0.21 g
(60%) of 102 as a viscous colorless oil. 'H NMR (400 MHz, CDCI3 ) 8 6.35 (d, 1H, J
= 8.4 Hz), 4.44 (dd, 1H, J = 6.1,

8 .8

Hz), 3.66 (s, 3H), 2.82-2.65 (m, 2H), 2.51-2.40

(m, 2H), 2.12 (s, 3H), 2.08 (m, 1H), 0.86 (d, 3H, J = 6.9 Hz), 0.84 (d, 3H, J = 6.9 Hz);
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,3C NMR (100 MHz, CDC13) 8 207.8, 172.7, 172.1, 57.3, 52.2, 38.6, 31.3, 30.0, 29.9,
19.1,18.0.

(S)-Methyl
2-(2-(hydroxymethyl)-Ar-(4-methoxybenzyl)-4-oxopentanamido)-3-phenylpropan
oate 103A and 103B
A 25-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with

8

mL of methylene chloride

and diethyl zinc (1.0 M in hexanes, 2.5 mL, 2.5 mmol). The solution was cooled to 0
°C and methylene iodide (0.20 mL, 2.5 mmol) was added slowly by syringe. After
stirring for 10 minutes, compound 98 (0.38 g, 1.0 mmol, in 1 mL of methylene
chloride) was added by syringe to the resulting white suspension. The mixture was
stirred for 30 minutes. Paraformaldehyde (0.3 g) was placed in a dry one-necked
round-bottomed flask, which was capped with a rubber septum. One end of a cannula
was inserted through the septum in the flask that contained paraformaldehyde, and the
other end of the cannula was inserted through the septum in the flask that contained
the zinc reagent. The paraformaldehyde flask was heated with a heat gun to induce
formation of formaldehyde, which was bubbled into the zinc-carbenoid solution for
10 minutes. After TLC analysis (hexanes:ethyl acetate = 3:1, R/ = 0.25) indicated the
chain extension intermediate was consumed, the solution was quenched by cautious
addition of saturated aqueous ammonium chloride (5 mL). The solution was extracted
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with ethyl acetate (3 x 10 mL). The combined organic layers were washed with brine
(15 mL), and dried over anhydrous sodium sulfate. The resulting liquid was filtered
and concentrated under reduced pressure. The residue was chromatographed on silica
(hexanes:ethyl acetate = 2:1, R/ = 0.20) to yield 0.33 g (78%) of 103A and 103B as a
yellow oily mixture of two isomers with some minor hemiacetal forms present. 'H
NMR (500 MHz, CDC13) 5 7.31-6.96 (m, 7H), 6.83-6.79 (m, 2H), 4.56 (m, 1H),
4.38-3.85 (m, 2H), 3.78-3.60 (m, 8 H), 3.4-2.98 (m, 4H), 2.70 (m, 1H), 2.19-2.03 (m,
3H); 13C NMR (125 MHz, CDC13)

6

207.0, 175.5, 171.3, 170.5, 159.5, 138.5, 129.7,

129.4, 128.9, 128.4, 114.4, 69.9, 64.0, 63.3, 62.0, 61.6, 60.7, 55.5, 52.9, 52.1, 42.9,
41.2, 39.2, 35.8, 35.4, 30.2, 25.3. Resonance observed for hemiacetal: 13C NMR (125
MHz, CDC13) 6105.3.

(5)-Methyl
2-(2-((tt,r/-butyldimethylsil\ioxy)methyl)-Ar-(4-methoxybenzyl)-4-oxopentanamid
o)-3-phenylpropanoate 105A and 105B
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with iV^V-dimethylformamide (4
mL), compound 103 (0.21 g, 0.5 mmol), tert-butylchlorodimethylsilane (0.12g, 0.75
mmol) and imidazole (90 mg, 1.25 mmol) in the indicated order. After being stirred
overnight at room temperature, watpr (2 mL) was added to the mixture and the
solution was extracted with diethyl ether ( 3 x 5 mL). The combined organic extracts
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were dried carefully over anhydrous sodium sulfate and concentrated in vacuo. The
residue was chromatographed on silica (hexanes:ethyl acetate = 10:1,

= 0.25) to

yield 0.89 g (60%) of 105A (32%) and 105B (28%) as a colorless oil. 105A : 'H
NMR (500 MHz, CDC13) 5 7.30-7.38 (m, 4H), 7.24 (m, 1H), 7.12 (d, 2H, J = 8.4 Hz),
6.89 (d, 2H, J = 8.7 Hz), 4.62 (d, 1H, J = 16.3 Hz), 4.25 (d, 1H, J = 16.2 Hz), 4.21 (dd,
1H, J = 6.3, 7.8 Hz), 3.84 (s, 3H), 3.66 (dd, 1H, J = 5.3, 9.5 Hz), 3.63 (s, 3H),
3.48-3.38 (m, 3H), 3.08 (dd, 1H, J = 9.2, 16.4 Hz), 3.04 (dd, 1H, J = 3.0, 15.1 Hz),
3.04 (dd, 1H, J = 3.0, 11.1 Hz), 2.79 (dd, 1H, J = 3.8, 18.2 Hz), 2.24 (s, 3H), 0.88 (s,
9H), 0.03 (s, 3H), 0.00 (s, 3H); 13C NMR (125 MHz, CDC13) 5 213.1, 179.1, 176.4,
164.8, 144.1, 135.1, 134.8, 134.0, 133.9, 132.0, 119.6, 69.3, 67.0, 60.9, 57.6, 49.1,
46.4, 41.4, 35.7, 31.5, 23.8, 0.10, 0.00. 105B: 'H NMR (500 MHz, CDC13)

8

7.29-7.22 (m, 5H), 7.11 (d, 2H, J = 8.2 Hz), 6.84 (d, 2H, J = 8.7 Hz), 4.44 (d, 1H, J =
16.0 Hz), 4.08 (dd, 1H, J = 5.9,

8 .8

Hz), 3.79 (m, 1H), 3.79 (s, 3H), 3.72 (dd, 1H, J =

5.8, 9.6 Hz), 3.55 (m, 1H), 3.54 (s, 3H), 3.42 (m, 1H), 3.36 (dd, 1H, J = 6.0, 14.1 Hz),
3.10 (dd, 1H, 7= 8.9, 14.0 Hz), 2.92 (dd, 1H, J = 8 .8 , 17.8 Hz), 2.63 (dd, 1H, .7=4.4,
17.9 Hz), 2.14 (s, 3H), 0.88 (s, 9H), 0.88 (s, 3H), 0.07 (s, 3H); 13C NMR (125 MHz,
CDC13)

8

212.6, 178.6, 176.2, 164.7, 143.9, 135.0, 134.9, 133.9, 132.1, 119.3, 69.5,

66.0, 60.7, 57.3, 48.5, 46.2, 40.8, 35.7, 31.4, 23.8, 6.5, 0.0.
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(5)-MethyI
2-((5)-2-((ter/-butyldiphenylsilyloxy)methyl)-7V-(4-methoxybenzyl)-4-oxopentana
mido)-3-phenylpropanoate 107A and 107B
A 25-mL oven-dried, ronnd-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with A^V-dimethylformamide
(10 mL), compound 103 (0.80 g, 2.0 mmol), tert-butylchlorodiphenylsilane (1.4 mL,
5.0 mmol) and imidazole (0.14 mg, 4.0 mmol) in the indicated order. After being
stirred overnight at room temperature, water ( 6 mL) was added to the mixture and the
solution was extracted with diethyl ether ( 3 x 1 0 mL). The combined organic extracts
were dried carefully over anhydrous sodium sulfate and concentrated in vacuo. The
residue was chromatographed on silica (hexanes:ethyl acetate = 7:1, Rf = 0.40) to
yield 0.77 g (58%) of 107A and 107B as a colorless oil. 107B: 'H NMR (500 MHz,
CDC13)

8

7.65-7.63 (d, 2H, J = 7.9 Hz), 7.58-7.57 (d, 2H, J = 8.0 Hz), 7.44-7.38 (m,

3H), 7.31 (m, 1H), 7.28-7.24 (m, 2H), 7.13-7.09 (m, 3H), 7.04 (d, 1H, J = 7.6 Hz),
7.03 (d, 1H, J = 7.3 Hz), 6.94 (d, 2H, J = 8.3 Hz), 6.80 (d, 2H, J = 8.7 Hz), 4.16 (d,
1H, J = 15.9 Hz), 3.84 (dd, 1H, / = 5.6, 9.5 Hz), 3.78 (s, 3H), 3.70 (dd, 1H, J = 5.1,
10.1 Hz), 3.64 (dd, 1H, J = 9.1 Hz), 3.50 (s, 3H), 3.42 (m, 1H), 3.26 (dd, 1H, J = 5.6,
13.9 Hz), 3.19 (d, 1H, J = 15.8 Hz), 3.05 (d, 1H, J = 9.4 Hz), 3.02 (dd, 1H, J = 3.3,
9.4 Hz), 2.78 (dd, 1H, J = 3.8, 17.8 Hz), 2.16 (s, 3H), 1.04 (s, 9H); 13C NMR (125
MHz, CDCI3)

8

207.4, 172.2, 170.6, 159.2, 138.2, 135.6, 133.0, 130.0, 129.8, 129.3,

1-67
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128.4, 127.9, 127.8, 127.5, 126.5, 113.7, 64.3, 60.3, 55.2, 51.7, 42.9, 40.9, 35.0, 30.3,
26.9,19.2.

(S)-Methyl
2-(2-((/<?r/-butyldiphenylsilyloxy)niethyl)-4-oxopentanamido)-3-phenylpropanoat
e 108A
A 10-mL round-bottomed flask was equipped with a stir bar and charged with
acetonitrile (2 mL), water (0.5 mL), and 107A

(6 6

mg, 0.1 mmol). To this solution

was added eerie ammonium nitrate (0.22 g, 0.4 mmol) and the mixture was allowed to
stir for 30 min at room temperature. The solution was added water (1.5 mL), then
extracted with Et2 0 ( 3 x 5 mL). The combined organic extracts were dried carefully
over anhydrous sodium sulfate and concentrated in vacuo. The residue was
chromatographed on silica (hexanes:ethyl acetate = 3:1, R/ = 0.20) and yielded 33 mg
(60%) of 108A as a viscous colorless oil. ’H NMR (500 MHz, CDCI3) 5 7.62-7.60 (m,
4H), 7.47-7.35 (m, 6 H), 7.29-7.21 (m, 3H), 7.14 (d, 2H, J = 8.4 Hz), 6.74 (d, 1H, J =
7.8 Hz), 4.87 (dd, 1H, J = 6.2, 14.1 Hz), 3.80 (dd, 1H, J = 7.8, 10.1 Hz), 3.64 (s, 3H),
3.60 (dd, 1H, J = 5.7, 10.2 Hz), 3.13 (dd, 1H, J = 5.9, 13.8 Hz), 3.04 (dd, 1H, J = 6.3,
13.8 Hz), 2.94 (m, 1H), 2.80 (dd, 1H, J = 8.5, 18.1 Hz), 2.44 (dd, 1H, J = 4.6, 18.2
Hz), 2.08 (s, 3H), 1.00 (s, 9H); 13C NMR (125 MHz, CDC13)

8

207.4, 172.6, 171.7,

135.6,129.4,128.5, 127.8, 64.4, 53.4, 52.1,43.7, 41.7, 38.2, 30.1, 26.8, 19.1.
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(5>M ethyl
2-(2-((te/7-butyldiphenylsilyloxy)methyl)-4-oxopentanamido)-3-phenylpropanoat
e 108B
A 10-mL round-bottomed flask was equipped with a stir bar and charged with
acetonitrile (2 mL), water (0.5 mL), and compound 107B

(6 6

mg, 0.1 mmol). To this

solution was added eerie ammonium nitrate (0.22 g, 0.4 mmol) and the mixture was
allowed to stir for 30 min at room temperature. The solution was added water (1.5
mL), then extracted with Et2 0 ( 3 x 5 mL). The combined organic extracts were dried
carefully over anhydrous sodium sulfate and concentrated in vacuo. The residue was
chromatographed on silica (hexanes:ethyl acetate = 3:1, R/ = 0.25) and yielded 36 mg
(65%) of 108B as a viscous colorless oil. lH NMR (500 MHz, CDCI3) 8 7.64-7.60 (m,
4H), 7.47-7.43 (m, 2H), 7.41-7.37 (m, 4H), 7.18-7.17 (m, 3H), 7.08-7.05 (m, 2H),
6.76 (d, 1H, J = 7.9 Hz), 4.84 (dd, 1H, J = 6.4, 14.3 Hz), 3.76 (dd, 1H, J = 7.5, 10.3
Hz), 3.68 (s, 3H), 3.61 (dd, 1H, J = 6.0, 10.2 Hz), 3.09 (dd, 1H, J = 6.1, 13.8 Hz),
3.02 (dd, 1H, J =

6 .6

, 13.8 Hz), 2.96 (m, 1H), 2.76 (dd, 1H, J = 8.0, 18.0 Hz), 2.50

(dd, 1H, J = 5.0, 18.0 Hz), 2.09 (s, 3H), 1.03 (s, 9H); 13C NMR (125 MHz, CDCI3 ) 5
206.8, 172.6, 171.8, 136.1, 135.6, 129.9, 129.2, 128.5, 127.8, 127.0, 64.3, 53.3, 52.2,
43.7.41.8, 38.2, 30.1, 26.8,19.2..

169

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

(5)-Methyl
2-(/V-(4-methoxybenzyl)-2-((methylthiocarbonothioyloxy)methyl)-4-oxopentanam
ido)-3-phenylpropanoate 110A and HOB
A 10-mL oven-dried, ronnd-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with sodium hydride (40 mg, 1.0
mmol, 60 % in the mineral oil). Hexanes (2 mL) was added to the flask to wash the
sodium hydride. The hexane was removed by syringe, and then tetrahydrofuran (4 mL)
was added by syringe. The solution was cooled to 0 °C and carbon disulfide (0.06 g,
1.0 mmol) was added by syringe. After stirring for 5 minutes, compound 103 (0.21 g,
0.5 mmol, in 1 mL of tetrahydrofuran) was added by syringe, followed by methyl
iodide (0.14 g, 1.0 mmol). After TLC analysis (hexanes:ethyl acetate = 2:1, R/ = 0.20)
indicated that 103 was consumed, the solution was quenched with saturated aqueous
ammonium chloride (3 mL). The solution was extracted with diethyl ether ( 2 x 5 mL).
The combined organic layers were washed with brine (5 mL), and dried over
anhydrous sodium sulfate. The resulting liquid was filtered and concentrated under
reduced pressure. The residue was chromatographed on silica (hexanes:ethyl acetate =
3:1, R/ = 0.20) to yield 0.18 g (62%) of 110A (35%) and 110B (27%) as a yellow oily
mixture. 110A: two rotamers in a 5:1 ratio. Major rotamer: 'H NMR (500 MHz,
CDC13) 85 7. 32-7.24 (m, 3H), 7.20 (d, 2H, J = 8.7 Hz), 7.11 (d, 2H, J = 8.3 Hz), 6.83
(d, 2H, J = 8.7 Hz), 4.70 (dd, 1H, J = 6 .6 , 10.7 Hz), 4.62 (d, 1H, J = 16.0 Hz), 4.42
(dd, 1H, J = 7.4, 10.8 Hz), 4.18 (d, 1H, J = 16.0 Hz), 4.06 (dd, 1H, J = 6.0, 8.0 Hz),
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3.79 (s, 3H), 3.76 (m, 1H), 3.61 (s, 3H), 3.44 (dd, 1H, J = 5.9, 14.1 Hz), 3.17 (dd, 1H,
J = 9.3, 18.2 Hz), 3.02 (dd, 1H, J = 8.0, 14.1 Hz), 2.66 (dd, 1H, J = 4.2, 18.2 Hz),
2.55 (s, 3H), 2.22 (s, 3H); 13C (125 MHz, CDC13) 8 215.7, 206.2, 172.2, 170.9, 159.5,
138.7, 129.8, 129.7, 128.6, 127.8, 126.7, 114.3, 73.3, 61.7, 55.5, 52.7, 52.3, 43.5, 37.0,
35.7, 30.2, 19.5. Resonances observed for the minor rotamer: 'H NMR (500 MHz,
CDC13) 8 4.97 (m, 1H), 3.77 (s, 3H), 3.48 (s, 3H), 2.04 (s, 3H). HOB: mixture of two
rotamers in a 7:1 ratio. Major rotamer: ]H NMR (400 MHz, CDCI3) 87.26-7.20 (m,
5H), 7.05 (d, 2H, J = 8.3 Hz), 6.84 (d, 2H, J = 8.7 Hz), 4.75 (dd, 1H, J = 6.4, 10.7 Hz),
4.61 (d, 1H, J = 15.9 Hz), 4.50 (dd, 1H, J = 7.0, 10.7 Hz), 4.03 (dd, 1H, J = 5.3, 9.6
Hz), 3.78 (s, 3H), 3.74 (m, 1H), 3.66 (d, 1H, J = 15.9 Hz), 3.59 (s, 3H), 3.36 (dd, 1H,
J = 5.3, 14.0 Hz), 3.19 (dd, 1H, J = 9.7, 13.9 Hz), 3.04 (dd, 1H, J = 8.5, 17.9 Hz),
2.58 (s, 3H), 2.57 (m, 1H), 2.14 (s, 3H); 13C (100 MHz, CDC13) 8 215.8, 206.0, 171.8,
170.7, 159.5, 138.4, 129.9, 129.6, 128.9, 127.5, 126.9, 114.1, 73.3, 61.3, 55.5, 52.1,
52.3, 43.0, 37.1, 35.7, 30.2, 19.6. Resonances observed for the minor rotamer: 'H
NMR (400 MHz, CDC13) 8 4.98 (m, 1H), 3.77 (s, 3H), 3.36 (s, 3H), 2.54 (s, 3H), 2.11
(s, 3H).

(S)-Methyl
2-(A-(4-methoxybenzyl)-2-methyl-4-oxopentanamido)-3-phenylpropanoate 111A
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with toluene (4 mL). Compound
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110A ( 8 8 mg, 0.17 mmol), tributyltinhydride (0.10 mL, 0.4 mmol) and AIBN (10 mg,
0.06 mmol) were added sequentially to the flask. The solution was heated to 80 °C for
8

h. The mixture was concentrated in vacuo, and the resulting residue was purified by

column chromatography on silica gel (hexanes:ethyl acetate = 3:1, R /= 0.25) to give
50 mg (71%) of 111A. 'H NMR (500 MHz, CDC13) 5 7.27-7.18 (m, 5H), 7.10 (d, 2H,
J = 8.3 Hz), 6.83 (d, 2H, J = 8.7 Hz), 4.52 (d, 1H, J = 16.1 Hz), 4.09 (dd, 1H, J = 5.7,
18.3 Hz), 4.04 (d, 1H, J = 16.1 Hz), 3.79 (s, 3H), 3.62 (s, 3H), 3.42 (dd, 1H, J = 5.7,
14.1 Hz), 3.20-3.13 (m, 2H), 3.06 (dd, 1H, J = 8.4, 14.1 Hz), 2.42 (d, 1H, J = 4.0 Hz),
2.18 (s, 3H), 1.01 (d, 3H, J = 6.7 Hz); 13C NMR (125 MHz, CDCI3)

8

207.5, 176.0,

170.9, 159.2, 138.6, 129.5, 129.2, 128.9, 128.1, 126.4, 114.0, 61.2, 55.3, 52.0, 47.7,
35.6,31.8, 30.1, 17.2.

(iS)-Methyl
2-(yV-(4-methoxybenzyl)-2-((methylthiocarbonothioyloxy)(phenyl)methyl)-4-oxop
entanamido)-3-phenylpropanoate 113A and 113B
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with sodium hydride (40 mg, 1.0
mmol, 60 % in the mineral oil). Hexanes (2 mL) was added to the flask to wash the
sodium hydride. The hexane was removed by syringe, and then tetrahydrofuran (4 mL)
was added by syringe. The solution was cooled to 0 °C and carbon disulfide -(0.06 g,
1.0

mmol) was added by syringe. After stirring for 5 minutes, compound 112 (0.25 g,
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0.5 mmol, in 1 mL of tetrahydrofuran) was added by syringe, followed by methyl
iodide (0.14 g, 1.0 mmol). After TLC analysis (hexanes:ethyl acetate = 1:1, R/ = 0.30)
indicated

112

was consumed, the solution was quenched with saturated aqueous

ammonium chloride (3 mL). The solution was extracted with diethyl ether ( 2 x 5 mL).
The combined organic layers were washed with brine (5 mL), and dried over
anhydrous sodium sulfate. The resulting liquid was filtered and concentrated under
reduced pressure. The residue was chromatographed on silica (hexanes:ethyl acetate =
3:1, R/ = 0.20) to yield 0.12 g (40%) of 113A (20%) and 113B (20%) as a yellow oily
mixture. 113A: *H NMR (500 MHz, CDC13)
7.07-7.05 (m, 2H),

6 .8 8

8

7.35-7.18 (m, 5H), 7.14-7.12 (m, 2H),

(d, 2H, J = 8.7 Hz), 6.78-6.74 (m, 3H), 4.52 (d, 1H, J = 16.1

Hz), 3.91-3.83 (m, 3H), 3.78 (s, 3H), 3.54 (s, 3H), 3.40 (dd, 1H, J = 6.0, 14.1 Hz),
3.15-3.10 (m, 2H), 2.92 (dd, 1H, J = 7.8, 14.1 Hz), 2.79 (dd, 1H, J = 4.8, 17.9 Hz),
2.55 (s, 3H), 2.21 (s, 3H); ,3C NMR (125 MHz, CDC13) 8 214.2, 206.4, 171.6, 170.8,
159.5, 138.7, 137.5, 129.7, 129.6, 128.7, 128.6, 127.4, 126.7, 114.2, 84.2, 61.5, 58.5,
52.4, 52.2, 43.7,43.2, 35.3, 30.5, 19.2.
113B: 'H NMR (400 MHz, CDC13) 8 7.39-7.34 (m, 4H), 7.13-7.11 (m, 3H), 6.82-6.77
(m, 4H), 6.74-6.67 (m, 3H), 4.45 (d, 1H, J = 15.5 Hz), 4.06 (m, 1H), 3.98 (d, 1H, J =
15.6 Hz), 3.84 (dd, 1H, J = 6.5, 6.5 Hz), 3.77 (s, 3H), 3.76 (m, 1H), 3.56 (s, 3H), 3.36
(dd, 1H, J = 6.2, 14.1 Hz), 2.92 (dd, 1H, J = 6.5, 17.8 Hz), 2.79 (dd, 1H,J = 5.4, 17.8
Hz), 2.65 (dd, 1H, J = 7.4, 14.1 Hz), 2.53 (s, 3H), 2.17 (s, 3H); 13C NMR (100 MHz,
CDCI3)

8

214.4, 206.0, 171.8, 170.8, 159.5, 138.7, 137.8, 129.8, 129.5, 128.9, 128.8,
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128.6, 127.9, 127.4, 126.5, 114.1, 85.0, 61.3, 55.5, 52.5, 52.1, 43.9, 43.5, 35.8, 30.6,
19.4.

(5)-Methyl
2-(2-benzyl-7V-(4-methoxybenzyl)-4-oxopentanamido)-3-phenylpropanoate 114A
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with toluene (4 mL). Compound
113A (59 mg, 0.1 mmol), tributyltinhydride (0.05 mL, 0.2 mmol) and AIBN (5 mg,
0.03 mmol) were added to the flask in the indicated order. Then the solution was
heated to 80 °C for 8 hours. The mixture was concentrated in vacuo, and the resulting
residue was purified by column chromatography on silica gel (hexanes:ethyl acetate =
5:1, Rf = 0.10) to give 26 mg (54 %) of 114A as a yellow oil. 'H NMR (500 MHz,
CDCI3) 8 7.28-7.11 (m, 10H), 6.92 (d, 2H, J = 8.1 Hz), 6.82 (d, 2H, J = 8.7 Hz), 4.63
(d, 1H, J= 16.4 Hz), 4.12 (dd, 1H, J = 5.9, 8.2 Hz), 4.02 (d, 1H, J = 16.4 Hz), 3.78 (s,
3 H ) , 3.66 (s, 3H), 3.45 (dd, 1H, J = 5.8, 14.2 Hz), 3.32 (m, 1H), 3.06-3.01 (m, 2H),
2.86 (dd, 1H, .7=5.1, 13.6 Hz), 2.48 (dd, l H ,y = 9 .6 , 13.7 Hz), 2.38 (dd, 1H,7=4.0,
18.1 Hz), 2.12 (s, 3H); 13C (125 MHz, CDC13) 5 207.6, 175.5, 171.1, 159.4, 138.9,
138.8, 138.1, 129.7, 129.3, 129.2, 128.7, 128.6, 126.7, 114.3, 62.2, 55.6, 52.5, 52.2,
45.5, 39.3, 38.0, 35.8, 30.3.
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(*S)-Methyl
2-(2-benzyl-Ar-(4-methoxybenzyl)-4-oxopentanamido)-3-phenylpropanoate 114B
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with toluene (4 mL). Compound
113B (59 mg, 0.1 mmol), tributyltinhydride (0.05 mL, 0.2 mmol) and AIBN (5 mg,
0.03 mmol) were added to the flask in the indicated order. Then the solution was
heated to 80 °C for 8 hours. The mixture was concentrated in vacuo, and the resulting
residue was purified by column chromatography on silica gel (hexanes: ethyl acetate =
5:1, R /= 0.15) to give 29 mg (60%) of 114B as a yellow oil. 'H NMR (400 MHz,
CDC13) 6 7.30-7.19 (m, 9H), 7.08-6.99 (m, 3H), 6.80 (d, 2H, J =

8 .8

Hz), 4.51 (d, 1H,

J = 16.0 Hz), 4.10 (dd, 1H, J = 6.0, 8.7 Hz), 3.87 (d, 1H, J = 16.0 Hz), 3.79 (s, 3H),
3.58 (s, 3H), 3.41-3.35 (m, 2H), 3.04 (dd, 1H, J =

8 .6 ,

13.9 Hz), 2.94-2.87 (m, 2H),

2.61 (dd, 1H, J = 8 .8 , 13.4 Hz), 2.35 (dd, 1H, J = 5.0, 18.1 Hz), 2.06 (s, 3H); 13C (100
MHz, CDCI3 )

8

207.3, 175.1, 171.1, 159.4, 139.0, 138.6, 129.6, 129.4, 128.8, 128.7,

114.1, 61.3, 55.5, 52.2, 52.0, 45.3, 39.4, 38.4, 35.6, 30.4.

(A)-Methyl 2-(2-benzyl-4-oxopentanamido)-3-phenylpropanoate 114C
A 10-mL round-bottomed flask was equipped with a stir bar and charged with
acetonitrile (2 mL), water (0.5 mL), and compound 114A (50 mg, 0.1 mmol). To this
solution was added eerie ammonium nitrate (0.25 g, 0.4 mmol) and the mixture was
allowed to stir for 30 min under room temperature. To the solution was added water
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(2 mL), and the solution was extracted with Et2 0 (3 x 55 mL). The combined organic
extracts were dried carefully over anhydrous sodium sulfate and concentrated under
reduced pressure. The residue was chromatographed on silica (hexanes: ethyl acetate =
3:1, R/= 0.10) yielded 23 mg (63%) of 114C as a viscous colorless oil. 'H NMR (400
MHz, CDC13)

8

7.32-7.11 (m, 8 H), 6.80 (d, 2 H , J = 9.5 Hz), 6.05 (d, 1H, J = 7.7 Hz),

4.79 (dd, 1H, J = 5.7, 11.5 Hz), 3.66 (s, 3H), 3.30-2.83 (m, 5H), 2.66 (dd, 1H, J = 5.3,
11.9 Hz), 2.50 (dd, 1H, J = 1,2, 11.6 Hz), 2.10 (s, 3H); 13C NMR (100 MHz, CDC13) 8
207.4, 173.9, 171.8, 139.2, 135.9, 129.4, 128.8, 128.8,128.7, 127.2, 126.9, 53.2, 52.5,
45.7.43.7.38.3.38.1.30.4.

(5)-Methyl 2-(2-benzyl-4-oxopentanamido)-3-phenylpropanoate 114D
A 10-mL round-bottomed flask was equipped with a stir bar and charged with
acetonitrile (2 mL), water (0.5 mL), and the y-keto amide 114B (50 mg, 0.1 mmol).
To this solution was added eerie ammonium nitrate (0.25 g, 0.4 mmol) and the
mixture was allowed to stir for half hour under room temperature. The solution was
diluted with water (2 mL), then extracted with Et2 0 (3 x 55 mL). The combined
organic extracts were dried carefully over anhydrous sodium sulfate and concentrated
in vacuo. The residue was chromatographed on silica (hexanes:ethyl acetate = 1:1, R/
= 0.15) yielded 22 mg (60%) of 114D as a viscous colorless oil. 'H NMR (500 MHz,
CDCI3) 8 7.35-7.12 (m, 10H), 6.02 (d, 1H, J = 7.8 Hz), 4.79 (dd, 1H, J = 1.2, 6.0 Hz),
3.64 (s, 3H), 3.07 (dd, 1H, J = 4.6, 13.8 Hz), 3.00 (dd, 1H, J = 6.2, 13.8 Hz),
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2.93-2.84 (m, 3H), 2.64 (dd, 1H, J = 10.5, 16.2 Hz), 2.42 (d, 1H, J = 17.6 Hz), 2.06 (s,
3H).

b)

Preparation of Peptide Isostere through C-Terminus

(5)-tert-Butyl 2-(3-(benzvloxy)-3-oxopropanoyl)pyrrolidine-l-carboxylate 119
A 50-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with compound 118 (2 . 1 2 g,

10

mmol), anhydrous tetrahydrofuran (15 mL) and 1,1-carbonyl diimidazole (1.7 g, 11
mmol) in the indicated order. In a separate 250-mL oven-dried, round-bottomed flask,
equipped with a septum with a flow of nitrogen through a needle and a stir bar, was
charged with tetrahydrofuran (100 mL) and monobenzyl malonate (7.8 g, 40 mmol, in
10 mL of THF) in order. After the solution was cooled to 0 °C in the ice bath,
dibutylmagnesium (1 M in heptanes, 20 mL, 20 mmol,) was added. After stirring for
10

minutes, the acyl imidazole solution was transferred to the magnesium salt solution

using cannula. After stirring for 30 min, the reaction was quenched by cautious
addition of 1 M HC1 (25 mL). The solution was extracted with diethyl ether (3 x 50
mL) and the combined organic layers were washed by brine (50 mL). The organic
layers were dried over anhydrous sodium sulfate, filtered and concentrated in vacuo.
The residue was chromatographed on silica (hexanes:ethyl acetate = 6:1, R/ = 0.20) to
yield 1.7 g (50%) of 119 as a colorless liquid mixture of two rotamers in a ratio of 1:1
with some minor enol forms present. 'H NMR (500 MHz, CDCI3)

8

7.41-7.30 (m,
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5H), 5.23-5.13 (m, 2H), 4.41 (dd, 0.5H, J = 5.0, 8.3 Hz), 4.30 (dd, 0.5H, J = 5.6, 8.4
Hz), 3.67-3.41 (m, 2H), 3.66 (s, 2H), 2.27-1.86 (m, 4H), 1.48 (s, 9H); Both rotamers:
13C (125 MHz, CDC13) 8 202.8, 202.5, 167.1, 166.8, 166.5, 154.8, 153.8, 135.3, 128.6,
128.5, 128.4, 128.3, 128.2, 127.5, 126.9, 80.8, 80.2, 67.3, 67.2, 65.6, 65.2, 65.1, 48.9,
47.0, 46.8, 46.3, 45.3, 29.8, 28.5, 28.4, 28.3, 28.2, 24.5, 23.8. Resonances observed
for the minor rotomer: 'H NMR (500 MHz, CDCI3 )

8

3.58 (s, 2H), 1.42 (s, 9H).

Resonances observed for the enol forms: *H NMR (500 MHz, CDCI3)

8

12.0 (s, 1H),

4.71 (s, 1H); 13C NMR (125 MHz, CDC13) 8 195.1, 92.0.

(25)-terT-Butyl
2-(4-(benzyloxy)-3-(hydroxymethyl)-4-oxobutanoyl)pyrrolidine-l-carboxylate
120A and 120B
A 25-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with methylene chloride

(8

mL)

and diethyl zinc (1.0 M in hexanes, 5.0 mL, 5.0 mmol). The solution was cooled to 0
°C and methylene iodide (0.4 mL, 5.0 mmol) was added slowly by syringe. After
stirring for 10 minutes, compound 119 (0.35 g, 1.0 mmol, in 0.5 mL of methylene
chloride) was added by syringe to the resulting white suspension. The mixture was
stirred for 30 minutes. Paraformaldehyde (0.2 g) was placed in a dry one-necked
round-bottomed flask, which was capped with a rubber septum. One end of a cannula
was inserted through the septum in the flask that contained paraformaldehyde, and the
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other end of the cannula was inserted through the septum in the flask that contained
the zinc reagent. The paraformaldehyde flask was heated with a heat gun to induce
formation of formaldehyde, which was bubbled into the zinc-carbenoid solution for
10 minutes. After TLC analysis (hexanes:ethyl acetate = 6:1, R/ = 0.20) indicated the
chain extension intermediate was consumed, the solution was quenched by cautious
addition of saturated aqueous ammonium chloride (5 mL). The solution was extracted
with ethyl acetate ( 3 x 1 0 mL). The combined organic layers were washed with brine
(10 mL), and dried over anhydrous sodium sulfate. The resulting liquid was filtered
and concentrated under reduced pressure. The residue was chromatographed on silica
(hexanes:ethyl acetate = 4:1, R/ = 0.20) to yield 0.29 g (75%) of 120A and 120B as a
colorless oil in a mixture of two isomers in a
forms present. ]H NMR (400 MHz, CDC13)

8

1 :1

ratio with some minor hemiacetal

7.37-7.29 (m, 10H), 5.20-5.08 (m, 4H),

4.92-4.66 (m, 2H), 4.44-4.20 (m, 2H), 3.91-3.71 (m, 4H), 3.64-3.36 (m, 4H),
3.31-3.13 (m, 2H), 3.03-2.71 (m, 2H), 2.17-1.78 (m, 8 H); 1.46-1.38 (m, 18H); 13C
(100 MHz, CDC13)

8

208.2, 207.5, 173.5, 172.9, 154.8, 153.8, 135.7, 135.5, 128.6,

128.5, 128.1, 109.0, 108.8, 89.7, 80.4, 80.1,

6 6 .8

, 66.7,

6 6 .6

, 65.1, 64.6, 62.6, 62.2,

46.9, 42.4, 42.1, 37.7, 37.2, 29.7, 28.7, 28.6, 28.4, 28.3, 24.4, 24.2, 23.6.
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(25)-tert-Butyl
2-(4-(benzyloxy)-3-((tert-butyldimethylsilyloxy)methyl)-4-oxobutanoyl)pyrrolidin
e-l-carboxylate 121A and 121B
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with jV^V-dimethylformamide (5
mL), compound 120 (0.14 g, 0.36 mmol), tert-butylchlorodimethylsilane (0.1 lg, 0.72
mmol) and imidazole (48 mg, 0.72 mmol) in the indicated order. After being stirred
overnight at room temperature, water (2 mL) was added to the mixture and the
solution was extracted with diethyl ether ( 3 x 5 mL). The combined organic extracts
were dried carefully over anhydrous sodium sulfate and concentrated in vacuo. The
residue was chromatographed on silica (hexanes:ethyl acetate = 12:1; R/ = 0.20) to
yield 0.14 g (75%) of 121A and 121B as a colorless oily mixture of configuration
isomers and retainers. 'H NMR (400 MHz, CDC13)

8

7.36-7.32 (m, 10H), 5.13-5.10

(m, 4H), 4.58-4.14 (m, 2H), 4.02-3.67 (m, 4H), 3.59-3.33 (m, 4H), 3.27-2.93 (m, 4H),
2.86-2.54 (m, 2H), 2.44-2.01 (m, 2H), 1.94-1.77 (m, 6 H), 1.48-1.40 (m, 9H), 0.86 (s,
9H), 0.02-0.00 (m, 6 H); 13C (100 MHz, CDC13)

8

213.7, 213.4, 178.6, 178.3, 160.1,

159.6, 141.4, 134.1, 134.0, 133.8, 133.7, 85.8, 85.6, 85.4, 85.3, 72.2, 71.2, 70.5, 70.0,
69.1, 68.9,

6 8 .8

, 52.5, 52.4, 52.3, 48.4, 48.2, 43.8, 43.1, 42.2, 35.4, 35.2, 34.0, 33.9,

31.4, 29.8, 29.3, 29.1, 23.8, 6 .6 , 0.1.
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4-((5')-l-(ter/-Butoxycarbonyl)pyrrolidin-2-yl)-2-((ter/-butyldimethylsilyloxy)met
hyl)-4-oxobutanoic acid 122A and 122B
A 25-mL oven-dried, two-necked round-bottomed flask, equipped with a septum with
a flow of nitrogen through a needle and a stir bar, was charged with methanol (5 mL),
compound 121 (85 mg, 0.17 mmol, in 0.5 mL of methanol), and 10% Pd on carbon
(10 mg) in the indicated order. After 10 minutes under nitrogen, the vessel was purged
with hydrogen (in the main neck) via a balloon and the nitrogen inlet was removed
from the other neck. The solution was allowed to stir at room temperature for
overnight. Then the suspension was filtered and concentrated in vacuo to yield 67 mg
(95%) of 122A and 122B as a colorless oily mixture of two isomers in a 1:1 ratio. ]H
NMR (400 MHz, CDC13) 5 4.37-4.17 (m, 2H), 3.89-3.67 (m, 4H), 3.56-3.31 (m, 4H),
3.13-2.86 (m, 4H), 2.69-2.57 (m, 2H), 2.16-1.76 (m, 8 H); 1.41-1.36 (m, 18H), 0.82 (s,
18H), 0.00 (s, 12H); 13C (100 MHz, CDC13) 8 214.3, 213.8, 183.4, 183.3, 159.6, 159.5,
86.0, 85.8, 71.0, 70.6, 70.1,

6 8 .6

, 52.5, 52.4, 52.3, 48.1, 47.9, 42.6, 41.9, 35.4, 35.3,

34.2, 34.1, 33.9, 31.4, 29.8, 29.3, 29.2, 23.8, 0.0.

(2iS)-tert-Butyl
2-(3-((tert-butyldimethylsilyloxy)methyl)-4-((iS)-l-methoxy-l-oxo-3-phenylpropan
-2-ylamino)-4-oxobutanoyl)pyrrolidine-l-carboxylate 123A and 123B
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with compound

12 2 (6 6
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mg,

0.16 mmol), A^V-dimethylformamide (3 mL), EDC (31 mg, 0.16 mmol), HOBt (22
mg, 0.16 mmol), phenylalanine methyl ester hydrochloride (36 mg, 0.16 mmol) and
sodium bicarbonate (13 mg, 0.16 mmol) were added in the indicated order. The
reaction was stirred at room temperature for overnight and diethyl ether (5 mL) was
added to the solution. The organic phase was washed with 1M HC1 ( 2 x 3 mL), brine
(3 mL), sat. NaHC0 3 ( 2 x 3 mL) and brine (3 mL) in the indicated order. The
resulting liquid was filtered and concentrated under reduced pressure. The residue was
chromatographed on silica (hexanes:ethyl acetate = 8:1) to yield 73 mg (79 %) of
123A (48%) and 123B (31%) as a mixture. 123A (two rotamers with a ratio of 1:1),
one rotamer: 'H NMR (400 MHz, CDC13)

8

7.32-7.21 (m, 3H), 7.15 (d, 2H, J = 7.0

Hz), 7.02 (d, 1H, J = 7.9 Hz), 4.84 (m, 1H), 4.38 (dd, 1H, J = 4.3,

8 .8

Hz), 3.76-3.58

(m, 2H), 3.68 (s, 3H), 3.53-3.40 (m, 2H), 3.09-2.89 (m, 4H), 2.50 (m, 1H), 2.12 (m,
1H), 2.04-1.81 (m, 3H), 1.45 (s, 9H), 0.84 (s, 9H), 0.07-0.00 (m, 6 H); 13C (100 MHz,
CDCI3)

8

213.7, 213.4, 178.4, 178.1, 177.3, 160.2, 159.4, 141.7, 141.5, 134.9, 134.1,

132.6, 132.5, 85.6, 85.3, 70.5, 70.0, 69.3, 59.0, 58.9, 57.7, 52.5, 52.3, 48.9, 48.8, 43.8,
43.7, 43.6, 43.1, 35.4, 34.3, 34.0, 33.9, 31.4, 30.0, 29.2, 23.8,
observed for the other rotamer: *H NMR (400 MHz, CDCI3)
Hz), 4.26 (dd, 1H, J = 4.8,

8 .8

8

6 .6

, 5.6. Resonance

6.85 (d, 1H, J = 7.8

Hz), 3.65 (s, 3H), 1.41 (s, 9H), 0.84 (s, 9H). 123B (two

rotamers with a ratio of 1:1), one rotamer: 'H NMR (400 MHz, CDCI3 )

8

7.28-7.19

(m, 3H), 7.13 (d, 2H, J = 7.0 Hz), 7.00 (d, 1H, J = 7.9 Hz), 4.82 (m, 1H), 4.36 (dd, 1H,
J = 4.4, 8.7 Hz), 3.76-3.57 (m, 2H), 3.66 (s, 3H), 3.50-3.44 (m, 2H), 3.10-2.78 (m,
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4H), 2.52 (m, 1H), 2.12 (m, 1H), 2.02-1.79 (m, 3H), 1.44 (s, 9H), 0.86 (s, 9H),
0.05-0.00 (m, 6 H); 13C (100 MHz, CDC13)

8

213.7, 213.4, 178.1, 177.3, 159.4, 141.7,

134.9, 134.1, 134.0, 85.6, 85.3, 70.5, 69.3, 59.0, 57.7, 52.5, 43.8, 43.7, 35.4, 34.3,
34.0, 33.9, 31.4, 31.3, 31.2, 30.0, 29.4, 29.2, 23.7, 6 .6 . Resonance observed for the
other rotamer: 'H NMR (400 MHz, CDC13) 8 6.84 (d, 1H, J = 7.6 Hz), 4.25 (dd, 1H, J
= 4.7, 8.7 Hz), 3.64 (s, 3H), 1.39 (s, 9H), 0.82 (s, 9H).

(5)-Benzyl 4-(l,3-dioxoisoindolin-2-yl)-5-methyl-3-oxohexanoate 128
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with compound 127 (0.11 g,
0.46 mmol), anhydrous tetrahydrofuran (5 mL) and 1,1-carbonyldiimidazole (80 mg,
0.5 mmol) in the indicated order. In a separate 25-mL oven-dried, round-bottomed
flask, equipped with a septum with a flow of nitrogen through a needle and a stir bar,
was charged with tetrahydrofuran

(8

mL) and monobenzyl malonate (0.36 g, 1.84

mmol) in order. After the solution was cooled to 0 °C in the ice bath,
dibutylmagnesium (1 M in heptanes, 0.92 mL, 1.84 mmol,) was added. After stirring
for

10

minutes, the acyl imidazole solution was transferred to the magnesium salt

solution using cannula. After stirring for 30 min, the reaction was quenched by
cautious addition of 1 M HC1 (5 mL). The solution was extracted with diethyl ether (3
x 10 mL) and the combined organic layers were washed by brine (10 mL). The
organic layers were dried over anhydrous sodium sulfate, filtered and concentrated in
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vacuo. The residue was chromatographed on silica (hexanestethyl acetate = 10:1, R/ =
0.20) to yield 95 mg (55%) of 128 as a colorless liquid with some minor enol forms
present. (NMR spectrum available in the CD)

(l^,45,10bkS)-Benzyl
10b-hydroxy-4-isopropyl-3,6-dioxo-l,2,3,4,6,10b-hexahydropyrido[2,l-a]isoindol
e-l-carboxylate 130
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with methylene chloride (4 mL)
and diethyl zinc (1.0 M in hexanes, 0.5 mL, 0.5 mmol). The solution was cooled to 0
°C and methylene iodide (0.04 mL, 0.5 mmol) was added slowly by syringe. After
stirring for 10 minutes, compound 128 (38 mg, 0.1 mmol, in 0.5 mL of methylene
chloride) was added by syringe to the resulting white suspension. The mixture was
stirred for 30 minutes. After TLC analysis (hexanes:ethyl acetate = 10:1, R/ = 0.20)
indicated that the starting material was consumed, the solution was quenched by
cautious addition of saturated aqueous ammonium chloride (5 mL). The mixture was
extracted with diethyl ether ( 2 x 5 mL), washed with brine (10 mL), and dried over
anhydrous sodium sulfate. The resulting liquid was filtered and concentrated under
reduced pressure. The residue was chromatographed on silica (hexanes:ethyl acetate =
5:1, R/ = 0.10) to yield 22 mg (58%) of 130 as a white solid. (NMR spectrum
attached)

184

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

(S)-2-((Benzyloxycarbonyl)(4-methoxybenzyl)amino)propanoic acid 136
A 100-mL round-bottomed flask was equipped with a stir bar and charged with water
(40 mL), compound 132 (4.0 g, 20 mmol) and sodium hydroxide (1.6 g, 40 mmol) in
the indicated order. After stirring for 10 min, the solution was cooled to 0 °C using ice
bath and benzyl chloroformate (3.6 mL, 25 mmol) was add dropwise to it. The
mixture was warmed to room temperature and allowed to stir for 1 hour. After being
extracted with diethyl ether (3 x 10 mL), the solution was brought to pH = 1.0 with
cautious addition of conc. HC1, and then extracted with ethyl acetate (3 x15 mL). The
combined organic layers were dried carefully over anhydrous sodium sulfate and
concentrated in vacuo to yield 6.5 g (95%) of 136 as a colorless oily mixture of two
rotamers with a ratio of 1:1. 'H NMR (400 MHz, CDCI3)

8

10.4 (broad, 1H, OH),

7.35-6.84 (m, 9H), 5.20 (m, 2H, J = 1.8 Hz), 4.64-4.18 (m, 3H), 3.79 (s, 3H),
1.42-1.34 (m, 3H); 13CNM R (100 MHz, CDC13)

8

177.7, 177.5, 159.1, 156.6, 136.4,

136.3, 130.1, 129.9, 129.6, 128.8, 128.7, 128.5, 128.3, 128.1, 114.2, 68.0, 67.9, 55.6,
55.5, 55.1,50.9, 49.9, 16.1,15.4.

(S)-Allyl 4-((benzyloxycarbonyl)(4-methoxybenzyl)amino)-3-oxopentanoate 137
A 25-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with compound 136 (1.3 g, 3.8
mmol), anhydrous tetrahydrofuran (10 mL) and 1,1-carbonyldiimidazole (0.64 g, 4.0
mmol) in the indicated order. In a separate 100-mL oven-dried, round-bottomed flask,
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equipped with a septum with a flow of nitrogen through a needle and a stir bar, was
charged with tetrahydrofuran (40 mL) and monoallyl malonate (2.18 g, 15.2 mmol, in
5 mL of THF) in order. After the solution was cooled to 0 °C in the ice bath,
dibutylmagnesium (1 M in heptanes, 7.6 mL, 15.2 mmol,) was added. After stirring
for

10

minutes, the acyl imidazole solution was transferred to the magnesium salt

solution using cannula. After stirring for 30 min, the reaction was quenched by
cautious addition of 1 M HC1 (10 mL). The solution was extracted with diethyl ether
(3 x 25 mL) and the combined organic layers were washed by brine (25 mL). The
organic layers were dried over anhydrous sodium sulfate, filtered and concentrated in
vacuo. The residue was chromatographed on silica (hexanes:ethyl acetate = 7:1, R/ =
0.20) to yield 1.4 g (84%) of 137 as a colorless liquid mixture of two rotamers in a
ratio of 1:1. One rotamer: 'H NMR (400 MHz, CDCl'3) 8 7.27-7.05 (m, 7H), 6.79-6.73
(m, 2H), 5.77 (m, 1H), 5.28-5.03 (m, 4H), 4.60-4.23 (m, 3H), 4.04 (m, 1H), 3.74 (m,
1H), 3.71 (s, 3H), 3.35 (d, 1H, J = 18.2 Hz), 3.22 (d, 1H, J = 15.8 Hz), 1.19 (d, 3H, J
= 7.2 Hz); ,3C (100 MHz, CDC13)

8

200.7, 167.4, 167.1, 159.6, 159.4, 156.0, 136.3,

135.8, 130.3, 129.6, 128.8, 128.6, 128.4, 118.9, 114.3, 68.1, 61.8, 61.6, 55.5, 51.4,
50.3, 45.3, 44.8, 13.9, 13.3. Resonances observed for the other rotamer: 'H NMR (400
MHz, CDCI3)

8

3.85 (m, 1H), 3.14 (d, 1H, J = 16.0 Hz), 3.05 (d, 1H, J = 15.9 Hz),

1.14 (d, 3H, J = 6.7 Hz).
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(£)-Allyl
5-((benzyloxycarbonyl)(4-methoxybenzyl)amino)-2-(hydroxymethyl)-4-oxohexan
oate 138A and 138B
A 50-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with methylene chloride (15 mL)
and diethyl zinc (1.0 M in hexanes, 10.0 mL, 10.0 mmol). The solution was cooled to
0 °C and methylene iodide (0.80 mL, 10.0 mmol) was added slowly by syringe. After
stirring for 10 minutes, compound 137 (0.85 g, 2.0 mmol, in 1 mL of methylene
chloride) was added by syringe to the resulting white suspension. The mixture was
stirred for 30 minutes. Paraformaldehyde (0.4 g) was placed in a dry one-necked
round-bottomed flask, which was capped with a rubber septum. One end of a cannula
was inserted through the septum in the flask that contained paraformaldehyde, and the
other end of the cannula was inserted through the septum in the flask that contained
the zinc reagent. The paraformaldehyde flask was heated with a heat gun to induce
formation of formaldehyde, which was bubbled into the zinc-carbenoid solution for
10 minutes. After TLC analysis (hexanes:ethyl acetate = 7:1, R/ = 0.10) indicated the
chain extension intermediate was consumed, the solution was quenched by cautious
addition of saturated aqueous ammonium chloride (10 mL). The solution was
extracted with ethyl acetate ( 3 x 1 5 mL). The combined organic layers were washed
with brine (15 mL), and dried over anhydrous sodium sulfate. The resulting liquid
was

filtered and concentrated under reduced pressure.

The residue was
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chromatographed on silica (hexanes:ethyl acetate = 4:1, R/ = 0.20) to yield 0.74 g
(79%) of 138A and 138B as a colorless oil in a mixture of two isomers in a 1:1 ratio.
'H NMR (400 MHz, CDC13) 5 7.31-7.10 (m, 7H), 6.83-6.75 (m, 2H), 5.84 (m, 1H),
5.28-5.09 (m, 4H), 4.73-3.32 (m, 5H), 3.71 (s, 3H), 3.16-1.97 (m, 6 H), 1.28-0.85 (m,
3H); 13C (100 MHz, CDC13)

8

206.7, 206.6, 206.5, 173.6, 173.4, 159.4, 159.3, 156.3,

156.2, 136.4, 136.2, 129.4, 129.2, 128.7, 128.4, 128.2, 118.4, 114.2, 68.0, 66.4, 65.8,
65.6, 62.7, 62.4, 61.9, 61.7, 55.5, 50.4, 50.0, 43.0, 37.1, 37.0, 14.5, 14.2, 13.8, 13.5.

(5S)-Allyl
5-((benzyloxycarbonyl)(4-methoxybenzyl)amino)-2-((ter/-butyldiphenylsilyloxy)
methyl)-4-oxohexanoate 139A and 139B
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with A/^V-dimethylformamide (5
mL), compound 138 (0.30 g, 0.64 mmol), tert-butylchlorodiphenylsilane (0.36 mL,
1.4mmol) and imidazole (0.10 g, 1.4 mmol) in the indicated order. After stirred for
overnight at room temperature, water (3 mL) was added to the mixture and the
solution was extracted with diethyl ether ( 3 x 1 0 mL). The combined organic extracts
were dried carefully over anhydrous sodium sulfate and concentrated in vacuo. The
residue was chromatographed on silica (hexanes:ethyl acetate = 16:1; R /= 0.20) to
yield 0.32 g (71%) of 139A and 139B as a colorless oily mixture of two isomers with
a ratio of 1:1. 'H NMR (400 MHz, CDC13)

8

7.64-7.60 (m, 8 H), 7.43-7.23 (m, 27 H),
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6.80 (s, 3H), 5.86 (m, 2H), 5.31-5.07 (m, 8 H), 4.66-4.17 (m, 7H), 3.92-3.64 (m, 3H),
3.74 (s, 6 H), 3.11-1.78 (m, 6 H), 1.26-1.17 (m, 6 H), 1.06 (s, 9H), 1.02 (s, 9H); ,3C
(100 MHz, CDC13)

8

206.9, 206.5, 173.2, 173.1, 172.9, 159.4, 159.3, 159.1, 156.4,

156.1, 135.8, 133.4, 132.3, 130.0, 129.3, 128.9, 128.5, 128.3, 128.2, 128.0, 118.4,
114.2,'67.8, 65.7, 64.7, 64.4, 62.0, 61.6, 55.4, 50.2, 49.7, 43.6, 43.2, 37.7, 37.6, 37.4,
27.0,19.5, 14.7,14.3,14.2, 13.7.

(5iS)-5-((Benzyloxycarbonyl)(4-methoxybenzyl)amino)-2-((ter*-butyldiphenylsilyl
oxy)methyl)-4-oxohexanoic acid 140A and 140B
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with terahydrofuran (4 mL),
compound 139 (0.30 g, 0.42 mmol, in 0.8 mL of tetrahydrofuran), pyrrolidine (0.33
mL) and tetrakis(triphenylphosphine)-palladium (25 mg) in the indicated order. The
solution was allowed to stir at room temperature for 30 minute. Then the suspension
was filtered and concentrated in vacuo. The residue was chromatographed on silica
(hexanes:ethyl acetate = 3:1; R /= 0.20) to yield 0.24 g (80%) of 140A and 140B as a
oily mixture of two isomers with a ratio of 1:1. 'H NMR (400 MHz, CDCI3)

8

7.69-7.07 (m, 16H), 6.79 (s, 3H), 5.20-4.77 (m, 3H), 4.54 (m, 1H), 4.18 (m, 1H),
3.92-3.50 (m, 2H), 3.74 (s, 3H), 3.34-2.65 (m, 3H), 2.16 (m, 1H), 1.27-1.17 (m, 3H),
1.06-1.01 (m, 9H); 13C (100 MHz, CDC13) 8 205.5, 175.5, 158.0, 155.1, 154.8, 134.4,
131.6, 131.1, 131.0, 130.6, 128.8, 128.0, 127.6, 127.4, 127.1, 126.9, 126.8, 112.9,
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89.3,

6 6 .6

, 63.1, 62.8, 60.7, 60.4, 54.2, 50.3, 42.0, 36.0, 35.9,, 25.7, 25.6, 18.2, 13.1,

12.4.

(2iS)-Methyl
2-((5S)-5-((benzyloxycarbonyl)(4-methoxybenzyl)amino)-2-((terf-butyldiphenylsil
yloxy)methyl)-4-oxohexanamido)propanoate 141A and 141B
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with compound 140 (87 mg,
0.13 mmol), A^V-dimethylformamide (3 mL), EDC (27 mg, 0.13 mmol), HOBt (19
mg, 0.13 mmol), alanine methyl ester hydrochloride salt (19 mg, 0.13 mmol) and
sodium bicarbonate (11 g, 0.13 mmol) were added in the indicated order. The reaction
was stirred at room temperature for overnight and diethyl ether (5 mL) was added to
the solution. The organic phase was washed with 1M HC1 ( 2 x 3 mL), brine (3 mL),
sat. NaHCCb ( 2 x 3 mL) and brine (3 mL) in the indicated order. The resulting liquid
was

filtered and concentrated under reduced pressure.

The

residue was

chromatographed on silica (hexanes:ethyl acetate = 5:1; Rf = 0.10) to yield 0.23 g
(73%) of 141A and 141B as a colorless oily mixture of two isomers with a ratio of
1:1. 'H NMR (400 MHz, CDCI3) 5 7.64 (b, 8 H), 7.43-7.38 (m, 12 H), 7.30-7.10 (m,
13H), 6.89-6.79 (m, 5H), 5.21-4.96 (m, 4H), 4.63-4.05 (m, 8 H), 3.92-3.50 (m, 2H),
3.95-3.34 (m, 4H), 3.75 (s, 6 H), 3.70 (s, 6 H), 3.02 (m, 1H), 2.88-2.37 (m, 3H), 2.20
(m, 1H), 1.86 (m, 1H), 1.38-1.36 (m, 6 H), 1.26-1.12 (m, 6 H), 1.06 (s, 18H); ,3C (100
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MHz, CDCI3)

8

206.7, 173.4, 172.9, 172.8, 159.3, 159.1, 156.2, 156.0, 135.8, 133.0,

130.1, 129.9, 129.4, 129.0, 128.7, 128.3, 128.1, 114.2, 67.8, 65.0, 64.8, 62.4, 62.2,
61.7, 55.4, 52.5, 51.7, 51.2, 50.7, 50.0, 48.4, 44.4, 44.3, 43.9, 37.5, 37.2, 37.0, 27.0,
19.4,18.6, 14.7, 14.4, 14.0,13.7.

(S)-Benzyl 2-(terf-butoxycarbonylamino)-4-(dimethylamino)-4-oxobutanoate 143
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with compound 142 (0.32 g, 1.0
mmol) A,jV-dimethylformide

(5

mL), EDC (0.20 g, 1.0 mmol), HOBt (0.15 g, 1.0

mmol), A^V-dimethylamine hydrochloride salt (81 mg, 1.0 mmol) and sodium
bicarbonate (84 mg, 1.0 mmol) were added in the indicated order. The reaction was
stirred at room temperature for overnight and diethyl ether (3 mL) was added to the
solution. The organic phase was washed with 1M HC1 ( 2 x 3 mL), brine (3 mL), sat.
NaHCC>3 ( 2 x 3 mL) and brine (3 mL) in the indicated order. The resulting liquid was
filtered and concentrated under reduced pressure to yield 0.31 g (90%) of 143 as
colorless oil. ]H NMR (500 MHz, CDC13)

8

5.89 (d, 1H, -NH, J = 9.3 Hz), 5.17 (d,

1H, J = 12.5 Hz), 5.11 (d, 1H, J = 12.4 Hz), 4.58 (m, 1H), 3.11 (dd, 1H, .7=4.0, 16.7
Hz), 2.90 (s, 3H), 2.86 (s, 3H), 2.73 (dd, 1H, J = 4.0, 16.7 Hz), 1.39 (s, 9H); 13C NMR
(125 MHz, CDCI3)

8

171.6, 170.1, 155.8, 135.7, 128.4, 128.0, 127.9, 79.6,66.9, 50.2,

37.0,35.7, 35.1,28.3.

191

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

(.S)-3-(4-Benzyl-2-oxooxazolidin-3-yl)-3-oxopropanoic acid 149
A 25-mL oven-dried, two-necked round-bottomed flask, equipped with a septum with
a flow of nitrogen through a needle and a stir bar, was charged with compound 152
(50 mg, 0.20 mmol), methanol

(6

mL), and 10 % Pd on carbon (15 mg) in the

indicated order. The vessel was purged with hydrogen and the nitrogen was removed.
The suspension was allowed to stir at room temperature for overnight. The suspension
was filtered and concentrated in vacu to yield 50 mg (95%) of 149 as a colorless oil.
'H NMR (500 MHz, CD3 OD) 5 7.37-7.27 (m, 5H), 4.70 (m, 1H), 4.35 (dd, 1H, J =
8.9, 8.9 Hz), 4.27 (dd, 1H, J = 2.5, 8.9 Hz), 3.35 (s, 2H), 3.22 (dd, 1H, J = 3.2, 13.8
Hz), 2.99 (dd, 1H, J = 8.1, 13.5 Hz); 13C NMR (100 MHz, CD3 OD)

8

171.2, 165.9,

153.8,135.2, 129.7,129.2, 127.6, 6 6 .8 , 55.3,42.8, 37.7.

1,3-Bis((iS)-4-Benzyl-2-oxooxazolidin-3-yl)-2-chloropropane-l ,3-dione 150
A 25-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with compound 148 (0.25 g, 1.0
mmol), toluene (5 mL), Meldrum’s acid (0.22 g, 1.5 mmol), copper (II) chloride (0.20
g, 1.5 mmol), and copper powder (64 mg, 1.0 mmol) were added in the indicated
order. The mixture was heated at reflux for overnight. After cooling to room
temperature, the solution was filtered and concentrated in vacuo to yield 0.2 g (43%)
of 150. ’H NMR (400 MHz, CDCI3)

8

7.35 (d, 2H, J = 7.8 Hz), 7.34 (d, 2H, J = 7.2

Hz), 7.27 (m, 4H), 7.23 (d, 2H, J = 7.2 Hz), 6.94 (s, 1H), 4.78 (m, 1H), 4.70 (m, 1H),
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4.34 (dd, 1H, 7 = 8.9, 17.4 Hz), 4.29-4.22 (m, 3H), 3.45 (dd, 1H, 7 = 3.2, 13.6 Hz),
3.32 (dd, 1H, 7 = 3.4, 13.6 Hz), 2.86 (dd, 1H, 7 = 9.3, 13.6 Hz), 2.78 (dd, 1H, 7 = 9.2,
13.6 Hz); 13C NMR (100 MHz, CDCI3)
129.5, 129.1, 127.6, 127.4, 67.1,

6 6 .8 ,

163.9, 163.2, 153.3, 153.0, 135.1, 134.6,

6

57.6, 56.0, 55.1, 37.5, 37.1.

(S)-Benzyl 3-(4-benzyl-2-oxooxazolidin-3-yl)-3-oxopropanoate 152
A 25-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen

through

a

needle

and

(S)-4-benzyloxazolidin-2-one (0.18 g,

a

stir

bar,

was

charged

with

1.0 mmol), dichloromethane (5 mL),

triethylamine (0.23 mL, 1.5 mmol), and 4-dinethylaminopyridine (12 mg, 0.1 mmol),
were added in the indicated order. After cooling to 0 °C, malonic acid monobenzyl
ester chloride (0.56 g, 2.0 mmol, in 2 mL of dichloromethane) was added in one
portion and the solution was allowed to stir for overnight and diethyl ether (10 mL)
was added to the solution. The organic phase was washed with 1M HC1 ( 2 x 5 mL),
brine (5 mL), sat. NaHCC>3 ( 2 x 5 mL) and brine (5 mL) in the indicated order. The
resulting liquid was filtered and concentrated under reduced pressure to yield
(60%) of 152 as colorless oil. ‘H NMR (400 MHz, CDC13)

8

0 .2 1

g

7.37-7.27 (m, 8 H), 7.19

(d, 2H, 7 = 8.2 Hz), 5.18 (d, 2H, 7 = 3.3 Hz), 4.67 (m, 1H), 4.20-4.11 (m, 2H), 4.06 (d,
1H, 7 = 16.5 Hz), 4.00 (d, 1H, 7 = 16.5 Hz), 3.32 (dd, 1H, 7 = 3.3, 13.5 Hz), 2.65 (dd,
1H, 7 = 9.9, 13.5 Hz); 13C NMR (100 MHz, CDC13)
129.6, 129.2, 128.8, 128.7, 127.6, 67.6,

6 6 .6

8

166.8, 165.8, 153.7, 135.3,

, 55.3, 43.2, 37.7.
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Benzyl
(U)-5-((*S)-4-benzyl-2-oxooxazolidin-3-yl)-3,5-dioxopentan-2-yl(4-methoxybenzyl)
carbamate 154
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with anhydrous tetrahydrofuran
(4 mL), compound 136 (0.40 g, 1.0 mmol, in 1 mL of tetrahydrofuran), and
1,1-dicarbonyl imidazole (0.18 g, 1.1 mmol) in the indicated order. In a separate
50-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with tetrahydrofuran (15 mL)
and diisopropylamine (0.56 mL, 4 mmol) in order. After the solution was cooled to 0
°C in the ice bath, n-BuLi (2 M in hexanes, 2 mL, 4 mmol,) was added. After stirring
for 10 min, the reaction mixture was cooled to -78 °C, compound 153 (0.88 g, 4.0
mmol, in 5 mL of THF) was added in half hour using syringe pump. The acyl
imidazole solution was transferred to the enolate solution using cannula. After stirring
for half hour at -78 °C, the reaction was quenched by cautious addition of 1 M HC1 (5
mL). The solution was extracted with diethyl ether (3 x 10 mL) and the combined
organic layers were washed by brine (5 mL). The organic layers were dried over
anhydrous sodium sulfate, filtered and concentrated in vacuo. The residue was
chromatographed on silica (hexanes:ethyl acetate = 3:1; R /= 0.30) to yield 0.46 g
(85%) of 154 a colorless oily mixture of two rotamers with a ratio of 1:1. 'H NMR
(400 MHz, CDC13)

8

7.35-7.16 (m, 12H), 6.86-6.81 (m, 2H), 5.24-5.12 (m, 2H),
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4.71-4.59 (m, 2H), 4.36-4.04 (m, 5H), 3.93 (d, 0.5H, J = 16.6 Hz), 3.75 (s, 3H), 3.60
(d, 0.5H, J = 16.5 Hz), 3.24 (dd, 1H, J = 14.0, 14.0 Hz), 2.74 (m, 1H), 1.30 (2d, 3H, J
= 6.5 Hz and J = 6.5 Hz), 1.22 (d, 3H, J = 7.2 Hz); ,3C NMR (100 MHz, CDC13) 5
201.2, 166.8, 159.2, 155.8, 153.6, 135.1, 130.1, 129.6, 129.5, 129.4, 129.3, 129.0,
128.6, 128.4, 128.2, 128.1, 127.4, 114.0, 67.9, 67.8, 66.4, 66.1, 61.9, 60.4, 55.2, 55.1,
55.0, 54.9, 51.6, 51.4, 50.3, 47.4, 47.3, 47.1, 37.8, 37.7, 37.6, 23.8, 21.0, 14.2, 13.9,
13.2.

Benzyl
(2/f)-4-(2-((5)-4-benzyl-2-oxooxazolidin-3-yl)-2-hydroxycyclopropyl)-3-oxobutan2-yl(4-methoxybenzyl)carbamate 159
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with dichloromethane (4 mL)
and diethyl zinc (1.0 M in hexanes, 1.5 mL, 1.5 mmol,). The solution was cooled to 0
°C in the ice bath and diiodomethane (0.12 mL, 1.5 mmol) was added dropwise. After
stirring for 10 min, compound 154 (0.20 mmol, in 0.5 mL of dichloromethane) was
added to the resulting white suspension in order. The mixture was stirred for 1 hour.
After TLC analysis (hexanes:ethyl acetate = 3:1; R /= 0.30) indicated that the starting
material was consumed, the solution was quenched by cautious addition of saturated
aqueous ammonium chloride (4 mL) and the mixture extracted with diethyl ether (3 x
5 mL). The combined organic layers were washed with brine (5 mL), and dried over
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anhydrous sodium sulfate. The resulting liquid was filtered and concentrated under
reduced pressure. The residue was chromatographed on silica (hexanesrethyl acetate =
1:1; R/ = 0.20) to yield 74 mg (65%) of 159 as a colorless oily mixture of two
rotamers with a ratio of 1:1. 'H NMR (400 MHz, CDCI3)

8

7.40-7.15 (m, 12H), 6.82

(s, 2H), 5.10 (s, 2H), 4.76 (d, 1H, J = 15.4 Hz), 4.21-4.12 (m, 2H), 4.05-3.96 (m, 3H),
3.78 (s, 3H), 3.44 (m, 1H), 2.71-2.49 (m, 3H), 1.58 (m, 1H), 1.39-1.21 (m, 4H), 0.95
(m, 1H); 13C NMR (100 MHz, CDCI3 ) 5 207.9, 159.4, 157.4, 156.6, 136.8, 136.0,
130.1, 129.8, 129.7, 129.5, 129.4, 129.2, 128.8, 128.5, 128.3, 127.0, 114.3, 68.3,

6 6 .6

,

64.7, 61.4, 57.7, 55.5, 50.3, 39.4, 37.1, 22.1, 20.1, 13.3.

Benzyl 5-oxo-2-phenyltetrahydrofuran-3-carboxylate 166
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with methylene chloride (3 mL)
and diethyl zinc (1.0 M in hexanes, 1.0 mL, 1.0 mmol). The solution was cooled to 0
°C and methylene iodide (0.08 mL, 1.0 mmol) was added slowly by syringe. After
stirring for 10 minutes, compound 152 (70 mg, 0.20 mmol, in 0.5 mL of methylene
chloride) was added by syringe to the resulting white suspension. The mixture was
stirred for 30 minutes, at which time freshly distilled benzaldehyde (0.03 g, 0.3 mmol)
was added into the reaction mixture by syringe. After TLC analysis (hexanes:ethyl
acetate = 5:1, R /= 0.20) indicated the chain extension intermediate was consumed,
the solution was quenched by cautious addition of saturated aqueous ammonium
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chloride (1 mL). The mixture was extracted with diethyl ether ( 2 x 5 mL). The
combined organic extracts were washed with brine (5 mL) and dried over anhydrous
sodium sulfate. The organic solution was filtered and concentrated under reduced
pressure. The residue was chromatographed on silica (hexane:ethyl acetate = 1:1, R/ =
0.25) to yield XX g (XX%) of 166.

Benzyl
(2/?,5/?)-6-((S)-4-benzyl-2-oxooxazolidin-3-yl)-5-(hydroxymethyl)-3,6-dioxohexan
-2-y l(4-methoxybenzyl)carbamate 167
A 25-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with dichloromethane (4 mL)
and diethyl zinc (1.0 M in hexanes, 1.5 mL, 1.5 mmol,). The solution was cooled to 0
°C in the ice bath and diiodomethane (0.12 mL, 1.5 mmol) was added dropwise. After
stirring for 10 min, paraformaldehyde (0.5 g,

6

mmol) and compound 159 (0.20 mmol,

in 0.5 mL of dichloromethane) were added to the resulting white suspension in order.
The mixture was stirred for 1 hour. After TLC analysis (hexanes:ethyl acetate = 3:1;
R/ = 0.30) indicated that the starting material was consumed, the solution was
quenched by cautious addition of saturated aqueous ammonium chloride (4 mL) and
the mixture extracted with diethyl ether ( 3 x 5 mL). The combined organic layers
were washed with brine (5 mL), and dried over anhydrous sodium sulfate. The
resulting liquid was filtered and concentrated under reduced pressure. The residue was
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chromatographed on silica (hexanes:ethyl acetate = 1:1; R/ = 0.25) to yield 83 mg
(71%) of 167 as a colorless oily mixture of two rotamers with a ratio of 1:1, with
some minor hemiacetal form. 'H NMR (400 MHz, CDCI3 )

8

7.33-7.14 (m, 12H),

6.88-6.79 (m, 2H), 5.34-5.10 (m, 2H), 4.78-4.04 (m, 7H), 3.78 (s, 3H), 3.60 (m, 1H),
3.22 (m, 1H), 3.02-2.72 (m, 2H), 2.59-2.11 (m, 2H), 1.29-1.26 (m, 3H); 13C NMR
(100 MHz, CDCI3 )

8

206.1, 205.7, 172.9, 172.8, 158.2, 158.0, 157.7, 156.7, 154.9,

153.0, 152.1, 135.2, 134.2,134.0, 133.9, 129.3, 128.9, 128.7, 128.4, 128.0, 127.8,
127.6, 127.4, 127.0, 126.8, 126.4, 126.3, 113.0, 112.9, 112.7, 66.7, 66.5, 62.7, 60.2,
54.4, 54.2, 50.2, 48.7, 42.5, 40.4, 40.0, 37.0, 36.9, 36.6, 13.2, 12.9, 12.7. Hemiacetal:
13C NMR (100 MHz, CDC13) 107.0, 106.7.

(iS)-4-Benzyl-3-((l?)-5-oxotetrahydrofuran-3-carbonyl)oxazolidin-2-one 169
A 25-mL round-bottom flask was equipped with a stir bar and charged with THF (10
mL), water (2.5 mL), and compound 167 (0.11 g, 0.2 mmol). To this solution was
added eerie ammonium nitrate (0.43 g, 0.8 mmol) and the mixture was allowed to stir
for 30 min under room temperature. The solution was added water (5.0 mL), then
extracted with Et2 <D (3 x 10 mL).

The combined organic extracts were dried

carefully over anhydrous sodium sulfate and concentrated in vacuo. The residue was
chromatographed on silica (hexanes:ethyl acetate = 3:1; R/ = 0.20) yielded 0.15 g
(70%) of 169 as a viscous colorless oil. 'H NMR (500 MHz, CDCI3)

8

7.36-7.17 (m,

5H), 4.71 (m, 1H), 4.68 (m, 1H), 4.62 (t, 3H, J = 7.9 Hz), 4.42-4.26 (m, 4H), 3.24 (dd,
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1H, J= 3.3, 13.6 Hz), 3.03 (dd, 1H, J = 5.1, 17.7 Hz), 2.88 (dd, 1H, J = 9.1, 13.5 Hz),
2.72 (dd, 1H, J = 9.1, 17.9 Hz); 13C NMR (125 MHz, CDCI3) 5 175.4, 170.7, 153.3,
134.6, 129.4, 129.1, 127.7, 69.3, 67.0, 55.2, 40.1, 37.8, 30.1.

(/?)-5-Ootetrahydrofuran-3-carboxylic acid 170
A 10-mL round-bottom flask was equipped with a stir bar and charged with THF (4.0
mL), water (1 mL), and compound 169 (26 mg, 0.09 mmol) To this solution was
added lithium hydroxide monohydrate (9 mg, 0.2 mmol) and hydrogen peroxide (35
wt. % in water, 0.02 mL, 0.2 mmol). The mixture was allowed to stir for 1 hour under
room temperature and extracted with Et2 0 ( 3 x 5 mL). The solution was brought to
pH = 1.0 with conc. HC1, then extracted with ethyl acetate ( 5 x 5 mL). The combined
organic extracts were dried carefully over anhydrous sodium sulfate and concentrated
in vacuo to yield 7 mg (60%) of 170. ([<x]25D = + 40.0 (c = 0.001 g/mL, MeOH)). 'H
NMR (500 MHz, CDCI3)
17.9

8

4.59-4.49 (m, 2H), 3.52 (m, 1H), 2.90 (dd, 1H, J = 7.0,

Hz), 2.80 (dd, 1H, J = 9.7,17.9 Hz); 13C NMR (125 MHz, CDC13) 8 174.7,174.7,

68.7, 39.6, 30.7.
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(S)-Benzyl
2-(3-((5)-5-benzyl-2-oxooxazolidin-3-yl)-3-oxopropanoyl)pyrrolidine-l-carboxyla
te 171
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen

through

a

needle

and

a

stir

bar,

was

charged

with

(S)-1-(benzyloxycarbonyl)pyrrolidine-2-carboxylic acid (0.25 g, 0.5 mmol, in 1 mL of
tetrahydrofuran), anhydrous tetrahydrofuran (3 mL) and 1,1-dicarbonyl imidazole
(0.17 g, 1.1 mmol) in the indicated order. In a separate 50-mL oven-dried,
round-bottomed flask, equipped with a septum with a flow of nitrogen through a
needle and a stir bar, was charged with tetrahydrofuran (15 mL) and diisopropyl
amine (0.56 mL, 4 mmol) in order. After the solution was cooled to 0 °C in the ice
bath, w-BuLi (2 M in hexanes, 2.0 mL, 4.0 mmol,) was added. After stirring for 10
min, the reaction mixture was cooled to -78 °C, compound 153 (0.88 g, 4.0 mmol, in
3 mL of THF) was added in half hour using syringe pump. The acyl imidazole
solution was transferred to the enolate solution using cannula. After stirring for half
hour, the reaction was quenched by cautious addition of 5 mL 1 M HC1 solution. The
solution was extracted with diethyl ether ( 3 x 1 0 mL) and the combined organic layers
were washed by brine (5 mL). The organic layers were dried over anhydrous sodium
sulfate, filtered and concentrated in vacuo. The residue was chromatographed on
silica (hexanes:ethyl acetate = 4:1; R/= 0.20) to yield 0.36 g (80%) of 171 a colorless
oily mixture of two rotamers with a ratio of 1:1. 'H NMR (400 MHz, CDCI3)
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8

7.37-7.20 (m, 20H), 5.18-5.08 (m, 4H), 4.73-4.67 (m, 2H), 4.50 (dd, 1H,J = 3.4, 8.1
Hz), 4.42 (dd, 1H, J= 4.5, 8.3 Hz), 4.31-4.04 (m, 8 H), 3.72-3.47 (m, 4H), 3.36 (d, 2H,
J = 13.5 Hz), 2.86-2.74 (m, 2H), 2.28-1.85 (m, 8 H); 13C NMR (100 MHz, CDC13)

8

201.1, 165.4, 165.2, 154.3, 153.4, 152.6, 152.5, 135.5, 135.2, 134.1, 128.4, 127.9,
127.5, 127.2, 126.8, 126.3, 66.4, 66.2, 65.3, 64.2, 64.0, 54.0, 47.3, 46.7, 46.3, 45.8,
36.6, 28.6, *27.3, 23.3, 22.5.

(iS)-benzyl
2-((/?)-4-((iS)-5-benzyl-2-oxooxazolidin-3-yl)-3-(hydroxymethyl)-4-oxobutanoyl)p
yrrolidine-l-carboxylate 172
A 25-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with dichloromethane

(6

mL)

and diethyl zinc (1.0 M in hexanes, 1.5 mL, 1.5 mmol). The solution was cooled to 0
°C in the ice bath and diiodomethane (0.12 mL, 1.5 mmol) was added dropwise. After
stirring for 10 min, paraformaldehyde (0.2 g, 2.2 mmol) and compound 171 (0.15 g,
0.3 mmol, in 0.5 mL of dichloromethane) were added to the resulting white
suspension in order. The mixture was stirred for 1 hour. After TLC analysis
(hexanes:ethyl acetate = 4:1; R / = 0.20) indicated that the starting material was
consumed, the solution was quenched by cautious addition of saturated aqueous
ammonium chloride (5 mL) and the mixture extracted with diethyl ether ( 3 x 5 mL).
The combined organic layers were washed with brine (5 mL), and dried over
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anhydrous sodium sulfate. The resulting liquid was filtered and concentrated under
reduced pressure. The residue was chromatographed on silica (hexanesrethyl acetate =
2:1; R /= 0.20) to yield 0.10 g (70%) of 172 a colorless oily mixture of two retainers
with a ratio of 1:1. 'H NMR (400 MHz, CDC13) 8 : 7.38-7.18 (m, 10H), 5.24-5.01 (m,
2H), 4.66 (m, 1H), 4.38-3.98 (m, 5H), 3.79-3.56 (m, 2H), 3.27-2.96 (m, 2H), 2.79 (m,
2H), 2.50 (m, 1H), 2.21-1.86 (m, 4H); 13C NMR (100 MHz, CDC13) 209.1, 208.9,
175.0, 155.5, 154.6, 154.2, 153.4, 136.8, 135.4, 135.3, 129.7, 129.3, 129.2, 129.1,
128.8, 128.7, 128.6, 128.3, 128.1, 127.6, 67.4, 67.3, 67.2,

6 6 .6

, 65.9, 65.4, 63.8, 63.7,

55.6, 47.6, 41.6, 41.2, 38.2, 38.1, 37.9, 37.5, 30.2, 29.2, 24.8, 24.0. two retainers:
Hemiceral:

13CNM R(100

MHz, CDC13) 109.1.

(iS)-Benzyl
2-((2/?,4/?)-4-((5)-4-benzyl-2-oxooxazolidine-3-carbonyl)tetrahydrofuran-2-yl)py
rrolidine-l-carboxylate 173A and 173B
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with dichloromethane (3 mL),
compound 172 (74 mg, 0.15 mmol). After the solution was cooled to the -78 °C,
triethylsilane (0.1 mL, 0.5 mmol) and boron trifluoride diethyl etherate (0.05 mL, 0.5
mmol) were added dropwise in the indicated order. The reaction solution was left
stirring for forty minutes at -78 °C and two hours at room temperature. The solution
was quenched with saturated sodium bicarbonate solution (2 mL), extracted with
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diethyl ether ( 3 x 5 mL). The combined organic layers were washed with brine (5 mL)
and dried over anhydrous sodium sulfate and concentrated in vacuo. The product was
purified by flash chromatography on silica (hexanes:ethyl acetate = 2:1, R/ = 0.20) to
offer 83 mg (69%) of 173A and 173B as a mixture of two isomers in a 1:1 ratio. 'H
NMR (500 MHz, CDC13)

8

7.39-7.16 (m, 10H), 5.19-5.06 (m, 2H), 4.66 (m, 1H),

4.28-3.85 (m, 7H), 3.62 (m, 1H), 3.40 (m, 1H), 3.26 (m, 1H), 2.76 (m, 1H), 2.32-1.70
(m, 6 H); 13C (100 MHz, CDC13) 5 173.4, 172.2, 154.4, 152.3, 152.2, 135.9, 134.0,
81.1, 80.2, 79.4, 69.6, 69.1, 65.8, .65.6, 65.3, 59.1, 58.6, 57.4, 54.5, 54.2, 46.0, 45.8,
43.0, 42.8, 36.8, 31.0, 27.0, 24.9, 23.0.

(45)-4-Benzyl-3-((3/?)-5-(pyrrolidin-2-yl)tetrahvdrofuran-3-carbonyl)oxazolidin2-one 174A and 174B
A 25-mL oven-dried, two-necked round-bottomed flask, equipped with a septum with
a flow of nitrogen through a needle and a stir bar, was charged with compound 173
(30 mg, 0.06 mmol), methanol

(6

mL), and 10 % Pd on carbon ( 8 mg) in the indicated

order. The vessel was purged with hydrogen and the nitrogen was removed. The
suspension was allowed to stir at room temperature for overnight. The suspension was
filtered and concentrated in vacu to yield 17 mg (80%) of 174A and 174B as a
mixture of two isomers in a 1:1 ratio. 'H NMR (500 MHz, CDC13)

8

7.23-7.11 (m,

10H), 4.67-4.63 (m, 2H), 4.26 (m, 1H), 4.20 (m, 1H), 4.16-4.05 (m, 3H), 3.97 (m, 1H),
3.90 (m, 1H), 3.81 (m, 1H), 3.49 (m, 1H), 3.00 (m, 1H), 2.92 (m, 1H), 2.77 (d, 1H, J
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= 3.7 Hz), 2.49 (m, 1H), 2.20 (m, 1H), 2.13-1.89 (m, 5H), 1.76 (m, 1H), 1.66 (m, 1H);
13C (100 MHz, CDC13) 8 174.0, 173.0, 154.2, 154.1, 135.6, 129.5, 128.6, 127.1, 79.2,
77.9, 71.4, 70.8, 67.0,

6 6 .8 ,

63.6, 61.9, 55.3, 55.1, 46.0, 45.4, 44.1, 37.2, 37.0, 31.8,

29.5, 26.7, 25.0, 24.0, 23.6.

Benzyl 5-oxotetrahydrofuran-3-carboxyIate 177
A 5-mL round-bottomed flask was equipped with a stir bar and charged with
acetonitrile (2 mL), water (0.5 mL), and compound 176 (50 g, 0.1 mmol). To this
solution was added eerie ammonium nitrate (0.21 g, 0.4 mmol) and the mixture was
allowed to stir for 30 min under room temperature. The solution was added water (1
mL), then extracted with Et2 0 ( 3 x 5 mL). The combined organic extracts were dried
carefully over anhydrous sodium sulfate and concentrated in vacuo. The residue was
chromatographed on silica (hexanes:ethyl acetate = 3:1, R /= 0.20) to yield 14 mg
(65%) of 177 as a colorless oil. 'H NMR (400 MHz, CDC13)

8

7.40-7.30 (m, 5H),

5.20 (s, 2H), 4.52 (dd, 1H, J = 9.4, 17.8 Hz), 4.57 (dd, 1H, J = 9.1, 18.4 Hz), 3.50 (m,
1H), 2.90 (dd, 1H, J = 7.4, 17.9 Hz), 2.76 (dd, 1H, J = 9.6, 17.9 Hz); 13C NMR (100
MHz, CDCI3) 8 175.2, 171.1, 135.1, 129.0,128.8, 128.5, 69.2, 67.8, 40.2, 31.1.
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(*S)-l-((5)-4-Benzyl-2-oxooxazolidin-3-yl)-2-(hydroxymethyl)pentane-l,4-dione
181
A 25-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with methylene chloride

(6

mL)

and diethyl zinc (1.0 M in hexanes, 2.5 mL, 2.5 mmol). The solution was cooled to 0
°C and methylene iodide (0.20 mL, 2.5 mmol) was added slowly by syringe. After
stirring for 10 minutes, (iS)-l-(4-Benzyl-2-oxooxazolidin-3-yl)butane-l,3-dione (0.13
g, 0.5 mmol, in 3 mL of methylene chloride) was added by syringe to the resulting
white suspension. The mixture was stirred for 30 minutes. Paraformaldehyde (0.2 g)
was added to the solution at one portion. After TLC analysis (hexanes:ethyl acetate =
5:1, R/ = 0.20) indicated the chain extension intermediate was consumed, the solution
was quenched by cautious addition of saturated aqueous ammonium chloride (2 mL).
The solution was extracted with ethyl acetate ( 3 x 5 mL). The combined organic
layers were washed with brine (5 mL), and dried over anhydrous sodium sulfate. The
resulting liquid was filtered and concentrated under reduced pressure. The residue was
chromatographed on silica (hexanesethyl acetate = 5:1, R/ = 0.10) to yield 0.11 g
(70%) of 181 as a colorless oil with some minor hemiacetal forms. *H NMR (400
MHz, CDC13)

6

7.33-7.20 (m, 5H), 4.69 (m, 1H), 4.30-4.13 (m, 3H), 3.81 (d, 1H, J =

5.9 Hz), 3.36-3.07 (m, 2H), 2.84-2.71 (m, 2H), 2.36 (d, 1H, J = 14.3 Hz), 2.16 (s, 3H);
13C NMR (100 MHz, CDC13)

8

207.3, 174.3, 154.1, 135.4, 129.7, 129.1, 127.5, 66.7,

63.6, 55.7, 42.7, 41.7, 38.2, 30.0. Hemiacetal: 13C NMR (100 MHz, CDC13) 8 105.9.
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3-((terf-Butyldiphenylsilyloxy)methyl)dihydrofuran-2,5-dione 195
A 10-mL round-bottom flask was equipped with a stir bar and charged with THF (4.0
mL), water (1 mL), and compound 191 (71 mg, 0.10 mmol) To this solution was
added lithium hydroxide monohydrate (9 mg, 0.2 mmol) and hydrogen peroxide (35
wt. % in water, 0.02 mL, 0.2 mmol). The mixture was allowed to stir for 1 hour at
room temperature and extracted with Et2 0 ( 3 x 5 mL). The solution was brought to
pH =1.0 with cone. HC1, then extracted with ethyl acetate ( 3 x 5 mL). The combined
organic extracts were dried carefully over anhydrous sodium sulfate and concentrated
in vacuo to yield 19 mg (50%) of 195. 'H NMR (400 MHz, CDC13) 8 7.62 (d, 4H, J =
6.4 Hz), 7.42-7.37 (m, 6 H), 3.90 (s, 2H), 3.06 (m, 1H), 2.91 (m, 1H), 2.67 (dd, 1H, J
= 2.4, 18.3 Hz), 1.04 (s, 9H).

c)

Synthesis of a Proposed Inhibitor for Human Cytomegalovirus (HCMV)
Protease

Benzyl
(25,55)-6-((R)-4-benzyl-2-oxooxazolidin-3-yl)-5-(hydroxymethyl)-3,6-dioxohexan2-yl(4-methoxybenzyl)carbamate 182
A 25-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with dichloromethane (4 mL)
and diethyl zinc (1.0 M in hexanes, 2.0 mL, 2.0 mmol,). The solution was cooled to 0
°C in the ice bath and diiodomethane (0.16 mL, 2.0 mmol) was added dropwise. After
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stirring

for

10

min,

paraformaldehyde

(0.5

g,

mmol)

6

and

benzyl

(S)-5-((R)-4-benzyl-2-oxooxazolidin-3-yl)-3,5-dioxopentan-2-yl(4-methoxybenzyl)ca
rbamate (0.40 mmol, in 0.5 mL of dichloromethane) were added to the resulting white
suspension in order. The mixture was stirred for 1 hour. After TLC analysis
(hexanes:ethyl acetate = 3:1; R/ = 0.20) indicated that the starting material was
consumed, the solution was quenched by cautious addition of saturated aqueous
ammonium chloride (4 mL) and the mixture extracted with diethyl ether ( 3 x 5 mL).
The combined organic layers were washed with brine (5 mL), and dried over
anhydrous sodium sulfate. The resulting liquid was filtered and concentrated under
reduced pressure. The residue was chromatographed on silica (hexanes:ethyl acetate =
1:1; R/ = 0.20) to yield 0.16 g (6 8 %) of 182 as a colorless oily mixture of two
rotamers with a ratio of 1:1. *H NMR (400 MHz, CDCI3)

8

7.38-7.14 (m, 12H),

6.88-6.79 (m, 2H), 5.29-4.89 (m, 2H), 4.69-4.02 (m, 6 H), 3.85-3.37 (m, 5H), 3.22 (m,
1H), 2.89-2.03 (m, 5H), 1.26-1.19 (2d, 3H, J = 6.9, 6.9 Hz); 13C NMR (100 MHz,
CDCI3)

8

201.2, 166.8, 159.4, 159.3, 159.1, 155.8, 153.6, 135.3, 130.1, 129.5, 129.3,

129.0, 128.6, 128.5, 128.2, 127.3, 114.1, 114.0, 67.9, 67.8, 66.3, 62.0, 55.3, 55.1, 51.6,
50.3, 47.4, 42.2, 37.5, 13.9, 13.5, 13.2.

(/?)-4-Benzyl-3-((S)-5-oxotetrahydrofuran-3-carbonyl)oxazoIidin-2-one 183
A 25-mL round-bottomed flask was equipped with a stir bar and charged with THF
(10 mL), water (2.5 mL), and compound 182 (0.35 g, 0.6 mmol). To this solution was
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added eerie ammonium nitrate (1.3 g, 2.4 mmol) and the mixture was allowed to stir
for 30 min at room temperature. The solution was added water (5.0 mL), then
extracted with Et2 0 (3 x 10 mL).

The combined organic extracts were dried

carefully over anhydrous sodium sulfate and concentrated in vacuo. The residue was
chromatographed on silica (hexanes:ethyl acetate = 3:1; R/ = 0.20) yielded 0.13 g
(75%) of 183 as a viscous colorless oil. 'H NMR (500 MHz, CDC13)

8

7.36-7.17 (m,

5H), 4.71 (m, 1H), 4.62 (t, 3H, J = 7.9 Hz), 4.42-4.26 (m, 4H), 3.24 (dd, 1H, J = 3.3,
13.6 Hz), 3.03 (dd, 1H, J = 5.1, 17.7 Hz), 2.88 (dd, 1H, J = 9.1, 13.5 Hz), 2.72 (dd,
1H, J = 9.1, 17.9 Hz); 13C NMR (125 MHz, CDCI3)

8

175.4, 170.7, 153.3, 134.6,

129.4,129.1, 127.7, 69.3, 67.0, 55.2, 40.1, 37.8, 30.1.

(5)-5-Oxotetrahydrofuran-3-carboxylic acid 184
A 10-mL round-bottomed flask was equipped with a stir bar and charged with THF
(4.0 mL), water (1 mL), and compound 183 (62 mg, 0.20 mmol) To this solution was
added lithium hydroxide monohydrate (17 mg, 0.4 mmol) and hydrogen peroxide (35
wt. % in water, 0.04 mL, 0.4 mmol). The mixture was allowed to stir for 1 hour under
room temperature and extracted with Et2 0 ( 3 x 5 mL). The solution was brought to
pH =1. 0 with conc. HC1, then extracted with ethyl acetate ( 5 x 5 mL). The combined
organic extracts were dried carefully over anhydrous sodium sulfate and concentrated
in vacuo to yield 14 mg (50%) of 184, [a]25D = -35 (c = 0.002 g/mL, MeOH). ]H
NMR (500 MHz, CDC13)

8

4.59-4.49 (m, 2H), 3.52 (m, 1H), 2.90 (dd, 1H, J = 7.0,
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17.9 Hz), 2.80 (dd, 1H, J = 9.7, 17.9 Hz); 13C NMR (125 MHz, CDC13)

8

174.71,

174.66, 68.7, 39.6, 30.7.

(5)-Benzyl
2-(3-((/?)-4-benzyl-2-oxooxazolidin-3-yl)-3-oxopropanoyl)pyrrolidine-l-carboxyla
te 187
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen

through

a

needle

and

a

stir

bar,

was

charged

with

(5)-l-(benzyloxycarbonyl)pyrrolidine-2-carboxylic acid (125 mg, 0.5 mmol, in 1 mL
of tetrahydrofuran), anhydrous tetrahydrofuran (3 mL) and 1,1-carbonyldiimidazole
(85 mg, 0.55 mmol) in the indicated order. In a separate 50-mL oven-dried,
round-bottomed flask, equipped with a septum with a flow of nitrogen through a
needle and a stir bar, was charged with tetrahydrofuran (15 mL) and diisopropyl
amine (0.28 mL, 2 mmol) in order. After the solution was cooled to 0 PC in the ice
bath, w-BuLi (2 M in hexanes, 1.0 mL, 2.0 mmol,) was added. After stirring for 10
min,

the

reaction

mixture

was

cooled

to

-78

°C,

(R)-3-acetyl-5-benzyloxazolidin-2-one (0.44 g, 2.0 mmol, in 3 mL of THF) was added
over 30 min using a syringe pump. The acyl imidazole solution was transferred to the
enolate solution using cannula. After stirring for 30 min, the reaction was quenched
by cautious addition of 5 mL 1 M HC1 solution. The solution was extracted with
diethyl ether ( 3 x 1 0 mL) and the combined organic layers were washed by brine (5
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mL). The organic layers were dried over anhydrous sodium sulfate, filtered and
concentrated in vacuo. The residue was chromatographed on silica (hexanes:ethyl
acetate = 4:1; R/-= 0.25) to yield 0.20 g (90%) of 187 a colorless oily mixture of two
rotamers with a ratio of 1:1. 'H NMR (400 MHz, CDCI3)

8

7.37-7.16 (m, 10H),

5.14-5.07 (m, 2H), 4.71 (dd, 1H, J = 9.4, 14.3 Hz), 4.40 (m, 1H), 4.32-4.03 (m, 4H),
3.64-3.35 (m, 2H), 2.88-2.75 (m, 2H), 2.28-1.84 (m, 4H); 13C NMR (100 MHz,
CDCI3)

8

203.5, 203.4, 166.6, 166.4, 155.5, 154.6, 153.9, 153.8, 136.8, 136.5, 135.5,

129.7, 129.5, 129.2, 128.8, 128.7, 128.5, 128.4, 128.3, 128.1, 128.0, 127.9, 127.6,
127.5, 69.5, 67.7, 67.4,

6 6 .6

, 66.3, 65.5, 65.3, 55.3, 54.0, 48.7, 48.0, 47.6, 47.1, 41.7,

37.9, 29.8, 28.7, 24.6, 23.8.

(5)-Benzyl
2-((S)-4-((R)-4-benzyl-2-oxooxazolidin-3-yl)-3-(hydroxymethyl)-4-oxobutanoyl)p
yrrolidine-l-carboxylate 188
A 100-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with dichloromethane (30 mL)
and diethyl zinc (1.0 M in hexanes, 10.0 mL, 10.0 mmol). The solution was cooled to
0 °C in the ice bath and diiodomethane (0.80 mL, 10.0 mmol) was added dropwise.
After stirring for 10 min, paraformaldehyde (1.0 g, 11.0 mmol) and compound 187
(0.9 g, 2.0 mmol, in 3 mL of dichloromethane) were added to the resulting white
suspension in order. The mixture was stirred for 1 hour. After TLC analysis
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(hexanes:ethyl acetate = 4:1; R/ = 0.25) indicated that the starting material was
consumed, the solution was quenched by cautious addition of saturated aqueous
ammonium chloride (10 mL) and the mixture extracted with diethyl ether ( 3 x 1 5 mL).
The combined organic layers were washed with brine (15 mL), and dried over
anhydrous sodium sulfate. The resulting liquid was filtered and concentrated under
reduced pressure. The residue was chromatographed on silica to yield 0.78 g (79%) of
188 a colorless oily mixture of rotamaric and hemiacetal forms. ’H NMR (400 MHz,
CDC13)

8

7.37-7.19 (m, 10H), 5.16-5.00 (m, 2H), 4.66 (m, 1H), 4.50-4.11 (m, 3H),

4.04-3.45 (m, 5H), 3.25-3.06 (m, 2H), 2.88-2.70 (m, 2H), 2.58-1.84 (m, 5H); 13C
NMR (100 MHz, CDCI3)

8

208.3, 208.0, 174.1, 173.9, 173.4, 158.6, 155.2, 154.4,

154.2, 154.1, 153.4, 153.3, 136.8, 136.7, 136.5, 135.6, 135.4, 135.3, 135.2, 129.7,
129.6, 129.3, 129.2, 129.1, 128.8, 128.7, 128.5, 128.4, 128.2, 128.1, 127.9, 127.7,
127.6, 127.5, 109.3, 108.9, 69.9, 69.6, 67.9, 67.6, 67.3, 66.7,

6 6 .6

, 64.7, 64.4, 64.0,

63.7, 55.7, 55.6, 55.4, 55.3, 48.0, 47.5, 47.0, 44.2, 42.7, 41.6, 41.3, 39.3, 39.0, 38.2,
38.1, 37.9, 30.0, 28.9, 27.8, 27.7, 24.6, 24.5, 23.9.

Benzyl
(25,55)-6-((J?)-4-benzyl-2-oxozolidin-3-yl)-5-((tert-butyldiphenylsilyloxy)methyl)3,6-dioxohexan-2-yl(4-methoxybenzyl)carbamate 191
A 25-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with A^-dimethylformamide
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(10 mL), compound 182 (0.81 g, 1.38 mmol), terf-butylchlorodiphenylsilane (0.73
mL, 2.8 mmol) and imidazole (0.19 g, 2.8 mmol) in the indicated order. After stirring
for overnight at room temperature, water (5 mL) was added to the mixture and the
solution was extracted with diethyl ether ( 3 x 1 0 mL). The combined organic extracts
were dried carefully over anhydrous sodium sulfate and concentrated in vacuo. The
residue was chromatographed on silica (hexanes:ethyl acetate = 7:1; R/ = 0.20) to
yield 0.89 g (78%) of 191 as a colorless oily mixture of two rotamers with a ratio of
1:1. ’H NMR (400 MHz, CDC13) 5 7.64-7.40 (m, 4H), 7.45-7.39 (m, 7H), 7.28-7.11
(m, 11H), 6.82-6.78 (m, 2H), 5.22-5.02 (m, 2H), 4.65-4.05 (m, 6 H), 3.90-3.72 (m,
5H), 3.56-2.25 (m, 5H), 1.24-1.15 (2d, 3H, J = 7.4, 6.4 Hz), 1.04 (s, 9H); ,3C NMR
(100 MHz, CDCI3) 5 207.1, 207.0, 173.5, 159.2, 159.0, 155.9, 155.8, 153.0, 135.8,
135.6, 133.1, 129.8, 129.7, 129.4, 129.3, 129.0, 128.8, 128.6, 128.5, 128.3, 128.1,
128.0, 127.8, 127.2, 114.0, 67.7, 66.1, 64.2, 61.3, 61.2, 55.2, 51.1, 49.5, 41.4, 41.3,
38.4, 38.2, 38.2, 26.8, 19.3, 13.9, 13.4.

Benzyl
(25',5iS)-6-((i?)-4-benzyI-2-oxooxazolidin-3-yl)-5-((tert-butyldiphenylsilyloxy)meth
yl)-3,6-dioxohexan-2-ylcarbamate 192
A 50-mL round-bottom flask was equipped with a stir bar and charged with THF (20
mL), water (5 mL), and compound 191 (1.48 g, 1.8 mmol). CAN (4.0 g, 7.2 mmol)
was added to this solution in one portion and the mixture was allowed to stir for 30
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min at room temperature. The solution was added by water (5 mL) and extracted with
diethyl ether (3 x 10 mL).
anhydrous

sodium

The combined organic layers were dried carefully over

sulfate

and

concentrated

in

vacuo.

The

residue

was

chromatographed on silica (hexanes:ethyl acetate = 3:1; R/-= 0.20) to yield 1.1 g (87%)
of 192 as a colorless oil. *H NMR (500 MHz, CDCI3) 5 7.65 (d, 4H, J = 6.9 Hz),
7.43-7.22 (m, 14H), 7.14 (d, 2H, J = 7.0 Hz), 5.47 (d, 1H, NH, J = 6.9 Hz), 5.08 (s,
2H), 4.68 (m, 1H), 4.42-4.34 (m, 2H), 4.20 (dd, 1H, J= 8.4,

8 .8

Hz), 4.10 (dd, 1H, J =

2.9, 9.1 Hz), 3.98 (dd, 1H, J = 5.2, 10.1 Hz), 3.90 (dd, 1H, J = 4.9, 10.0 Hz), 3.34 (dd,
1H, J= 10.8,18.4 Hz), 3.24 (dd, 1H, .7=3.1, 13.4 Hz), 2.61-2.51 (m, 2H), 1.40 (d,3H,
J = 7.1 Hz), 1.06 (s, 9H); 13C NMR (500 MHz, CDCI3)

8

207.6, 173.0, 155.6, 153.2,

135.7, 135.6, 135.4, 133.1, 133.0, 130.0, 129.4, 129.0, 128.9, 128.6, 128.2, 128.1,
127.9,127.3, 66.9, 66.2, 64.2, 55.3, 55.2, 41.2, 38.2, 26.8, 19.4,18.0.

(55,8S)-5,12,12-Trimethyl-3,6-dioxo-l,l 1,11-triphenyl-2,10-dioxa-4-aza-l 1-silatri
decane-8 -carboxylic acid 197
A 10-mL oven-dried, round-bottomed flask equipped with a stir bar was charged with
tetrahydrofuran (2 mL), compound 192 (70 mg, 0.10 mmol, in 0.5 mL of THF) in the
indicated order. Lithium hydroxide monohydrate (5.0 mg, 0.11 mmol, in 2 mL of
deionized water) was added in 10 min using syringe pump. The solution was stirred
till TLC analysis (hexanes:ethyl acetate = 3:1; R/ = 0.20) indicated that the starting
material was consumed. The mixture was acidified to pH = 1 using 1 M HC1, then
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extracted with ethyl acetate ( 3 x 2 mL). The combined organic layers were washed
with brine (5 mL), and dried over anhydrous sodium sulfate. The resulting liquid was
filtered and concentrated under reduced pressure. The residue was chromatographed
on silica (hexanes:ethyl acetate = 1:1; R /= 0.20) to yield 40 mg (70%) of 197 as a
colorless oil. *H NMR (400 MHz, MeOD)

8

7.64 (d, 4H, J = 6.3 Hz), 7.44-7.23 (m,

11H), 5.06 (s, 2H), 4.90 (s, 1H), 4.24 (m, 1H), 3.96 (dd, 1H, J = 4.9, 9.6 Hz), 3.77 (dd,
1H, J = 3.6,

8 .8

Hz), 3.17 (dd, 1H, J = 8.9, 17.9 Hz), 3.04 (dd, 1H, J = 4.2, 18.6 Hz),

2.77 (dd, 1H, J = 3.7, 17.9 Hz), 1.29 (d, 3H, J = 7.2 Hz), 1.02 (s, 9H); 13C NMR (100
MHz, CDC13)

8

208.9, 175.4, 157.1, 137.0, 135.5, 133.2, 133.1, 129.8, 128.3, 127.8,

127.7,127.6, 66.5, 64.4, 55.7,43.0, 37.5, 26.1, 19.0,15.4.

(5)-Methyl
2-((2iS',55,)-5-(benzyloxycarbonylamino)-2-((fert-but\idiphenylsilyloxy)methyl)-4oxohexanamido)propanoate 198
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with AyV-dimethylformamide (3
mL), compound 197 (0.27 g, 0.5 mmol), EDC (0.20 g, 1.0 mmol), HOBt (0.15 g, 1.0
mmol), alanine methyl ester hydrochloride (0.15 g, 1.0 mmol) and sodium
bicarbonate (0.08 g, 1.0 mmol) were added in the indicated order. The reaction was
stirred at room temperature for overnight and diethyl ether (5 mL) was added to the
solution. The organic phase was washed with 1M HC1 ( 2 x 3 mL), brine (3 mL), sat.
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NaHC0 3 ( 2 x 3 mL) and brine (3 mL) in the indicated order. The resulting liquid was
filtered and concentrated under reduced pressure. The residue was chromatographed
on silica (hexanes:ethyl acetate = 5:1; R/ = 0.30) to yield 0.23 g (73%) of 198 as
colorless oil. 'H NMR (500 MHz, CDC13)

8

7.64 (d, 4H, J = 7.8 Hz), 7.45-7.26 (m,

11H), 6.84 (d, 1H, -NH, J= 7.5 Hz), 5.45 (d, 1H, -NH, J=

6 .8

Hz), 5.08 (d, 2H, 1H, J

= 2.0 Hz), 4.55 (q, 1H, J = 7.2 Hz), 4.31 (q, 1H, J = 7.1 Hz), 3.85 (dd, 1H, J = 10.1,
10.1 Hz), 3.70 (s, 3H), 3.64 (dd, 1H, J = 4.8, 9.9 Hz), 3.05-2.95 (m, 2H), 2.42 (dd, 1H,
J = 3.0, 16.9 Hz), 1.38 (d, 3H, J = 7.2 Hz), 1.35 (d, 3H, J = 7.2 Hz), 1.05 (s, 9H); 13C
NMR (125 MHz, CDC13)

8

207.4, 173.3, 172.4, 155.8, 135.8, 132.9, 130.2, 128.7,

128.4,128.3, 128.1, 67.0, 64.7, 55.7, 52.5, 48.3, 43.8, 37.9, 27.0,19.3,18.5,18.0.

(25)-Methyl
2-((55)-2-((tert-butyldiphenylsilyloxy)methyl)-4-oxo-5-(tosyloxyamino)hexanami
do)propanoate 199
A 25-mL oven-dried, two-necked round-bottomed flask, equipped with a septum with
a flow of nitrogen through a needle and a stir bar, was charged with 2 -propanol

(6

mL), compound 198 (0.25 g, 0.40 mmol, in 0.5 mL of THF), anhydrous
p-toluenesulfonic acid (69 mg, 0.40 mmol) and 10 % Pd on carbon (15 mg) in the
indicated order. The vessel was purged with hydrogen and the nitrogen was removed.
The suspension was allowed to stir at room temperature for overnight. The suspension
was filtered and concentrated in vacuo to yield 0.24 g (90%) of 199 as a colorless oil.
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’H NMR (400 MHz, MeOD)

8

7.72-7.22 (m, 14H), 4.40 (q, 1H, J = 7.3 Hz), 4.12 (q,

1H, J = 7.4, Hz), 3.86 (dd, 1H, J = 6.4, 9.8 Hz), 3.74 (dd, 1H, J = 5.7, 15.6 Hz), 3.62
(s, 3H), 3.18-3.06 (m, 2H), 2.58 (dd, 1H, J = 3.1, 17.5 Hz), 2.34 (s, 3H), 1.48 (d, 3H,
J = 7.3 Hz), 1.36 (d, 3H, J = 7.2 Hz), 1.04 (s, 9H); 13C NMR (100 MHz, MeOD)

8

204.6, 173.4, 173.1, 140.5, 135.6, 133.1, 129.9, 128.7, 128.3, 127.8, 127.6, 125.8,
64.9, 63.6, 54.5, 51.6, 43.7, 37.1, 26.2, 24.2, 20.3, 19.0, 16.7, 14.8.

(25)-methyl
2-((35)-5-((iS)-l-(benzyloxycarbonylamino)ethyl)-5-hydroxytetrahydrofuraii-3-ca
rboxamido)propanoate 199A
A 5-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with THF (2 mL) and compound
198 (32 mg, 0.05 mmol, in 0.5 mL of THF) in order. After the solution was cooled to
0 °C in the ice bath, TBAF (1 M in THF, 0.10 mL, 0.10 mmol) was added. After TLC
analysis (hexanes:ethyl acetate = 5:1; R/ = 0.30) indicated that the starting material
was consumed, the solution was quenched by cautious addition of saturated aqueous
ammonium chloride (2 mL). The mixture was extracted with ethyl acetate ( 2 x 5 mL).
The combined organic layers were washed with brine (5 mL), and dried over
anhydrous sodium sulfate. The resulting liquid was filtered and concentrated under
reduced pressure. The product was purified by flash chromatography on silica
(hexanes:ethyl acetate = 1:1, R/ = 0.10) to offer 15 mg (76%) of 199A as a colorless
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liquid. ‘H NMR (400 MHz, CDC13)

8

7.38-7.29 (m, 5H), 6.59 (d, 1H, J = 7.3 Hz),

5.17-5.03 (m, 3H), 4.55 (q, 1H, J = 7.3 Hz), 4.14 (m, 2H), 4.00-3.55 (m, 2H), 3.75 (s,
3H), 3.02 (m, 1H), 2.50 (m, 1H), 2.20 (m, 1H), 1.42 (d, 3H, J = 7.2 Hz), 1.28 (d, 3H,
J = 7.7 Hz); 13C NMR (100 MHz, CDCI3)

8

176.0, 173.3, 156.2, 156.0, 136.8, 128.7,

128.3,107.0, 71.2, 66.9, 53.6, 53.0, 52.9, 51.5, 48.8,48.7,44.4,43.5, 40.1, 18.4, 15.8.

(6S,9S, 12S, 155)- M ethyl
12-((terf-butyldiphenylsilyloxy)methyl)-6-(2-(dimethylamino)-2-oxoethyl)-2,2,9,l
5-tetramethyl-4,7,10,13-tetraoxo-3-oxa-5,8,14-triazahexadecan-16-oate 200
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with compound 199 (0.27 g, 0.5
mmol), A,jV-dimethylformide (3 mL), EDC (0.20 g, 1.0 mmol), HOBt (0.15 g, 1.0
mmol), compound 144 (0.15 g, 1.0 mmol) and sodium bicarbonate (0.08 g, 1.0 mmol)
were added in the indicated order. The reaction was stirred at room temperature for
overnight and diethyl ether (5 mL) was added to the solution. The organic phase was
washed with 1M HC1 ( 2 x 3 mL), brine (3 mL), sat. NaHCC>3 ( 2 x 3 mL) and brine (3
mL) in the indicated order. The resulting liquid was filtered and concentrated under
reduced pressure. The residue was chromatographed on silica (ethyl acetate; Rf =
0.10) to yield 0.23 g (73%) of 200 as a colorless oil. 'H NMR (500 MHz, CDC13)

8

7.65-7.64 (d, 4H, J = 7.8 Hz), 7.46-7.37 (m, 6 H), 6.85 (d, 1H, -NH, J = 7.5 Hz), 6.08
(d, 1H, -NH, J = 7.9 Hz), 4.58-4.38 (m, 3H), 3.84 (dd, 1H, J = 8.4, 10.1 Hz), 3.70 (s,
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3H), 3.63 (dd, 1H, J = 5.3, 10.1 Hz), 3.16-2.85 (m, 3H), 2.97 (s, 3H), 2.87 (s, 3H),
2.53 (dd, 1H, J = 7.6, 18.1 Hz), 2.40 (dd, 1H, J = 3.9, 17.4 Hz), 1.45 (s, 9H), 1.37 (d,
3H, J = 7.2 Hz), 1.32 (d, 3H, J = 7.2 Hz), 1.05 (s, 9H); 13C NMR (500 MHz, CDC13) 8
207.1, 173.3, 172.5, 171.4, 171.2, 155.8, 135.7, 133.0, 130.1, 128.7, 128.4, 128.4,
128.3, 128.1, 127.9, 80.3, 64.8, 54.5, 52.5, 50.9, 48.3, 43.8, 37.9, 37.4, 35.5, 29.9,
28.5, 27.0, 19.3,18.5, 17.1.

(2 S)-methyl
2-((35)-5-((5)-l-((5)-2-(tert-butoxycarbonyIamino)-4-(dimethylainino)-4-oxobuta
namido)ethyl)-5-hydroxytetrahydrofuran-3-carboxamido)propanoate 202
A 5-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with THF (2 mL) and compound
200 (20 mg, 0.026 mmol) in order. After the solution was cooled to 0 °C in the ice
bath, tetrabutylammonium fluoride (1 M in THF, 0.05 mL, 0.05 mmol) was added.
After TLC analysis (ethyl acetate; R/ = 0.10) indicated that the starting material was
consumed, the solution was quenched by cautious addition of saturated aqueous
ammonium chloride (1 mL). The mixture was extracted with ethyl acetate ( 3 x 5 mL).
The combined organic layers were washed with brine (2 mL) and dried over
anhydrous sodium sulfate. The resulting liquid was filtered and concentrated under
reduced pressure. The product was purified by flash chromatography on silica (ethyl
acetate:methanol = 5:1, R/ = 0.10) to offer 5 mg (38%) of 202. 'H NMR (500 MHz,
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CDC13) 8 6.83 (d, 1H, J= 9.8 Hz), 6.49 (d, 1H, J= 7.2 Hz), 6.30 (s, 1H), 6.17 (d, 1H,
J = 8.3 Hz), 5.26 (d, 1H, J = 8.3 Hz), 5.04 (d, 1H, J = 3.7 Hz), 4.54 (dd, 1H, J = 7.2.
7.2 Hz), 4.42 (m, 1H), 4.18-4.11 (m, 2H), 3.77-3.73 (m, 4H), 3.22-2.90 (m,

8 H),

2.65-2.54 (m, 2H), 2.15 (m, 1H), 1.60-1.22 (m, 15H).

d)

Formal Synthesis of (+)-Brefeldin A

(2£',6»S',10£',1 la^O .S', 14a/?)-13-(Methoxymethoxy)-6-methyl-6,7,8,9,12,13,14,14aoctahydro-1 H-cyclopenta[f] [1 ]oxacyclotridecine-l,4(l laH)-dione 260
A 10-mL oven-dried, round-bottomed flask equipped with a stir bar and a septum
with a flow of nitrogen through a needle was charged with 3 mL of methylene
chloride and diethyl zinc (1.0 M in hexanes, 0.5 mL, 0.5 mmol). The solution was
cooled to 0 °C and compound 294A (25 mg, 0.08 mmol, in 1 mL of methylene
chloride) was added to the solution. After stirring for 10 minutes, methylene iodide
(0.02 mL, 0.5 mmol) was added dropwise by syringe. The mixture was stirred for 0.5
hour at room temperature. Diethyl zinc (1.0 M in hexanes, 0.25 mL, 0.25 mmol) was
added to the solution at room temperature and after

10

minutes, methylene iodide

(0.02 mL, 0.25 mmol) was added dropwise by syringe. The mixture was stirred for
0.5 hour at room temperature. Iodine (0.5 g, 2.0 mmol) was added to the reaction
mixture in a single portion and allowed to stir until a pink color persisted for 30
seconds. A saturated solution of sodium thiosulfate (2 mL) was added and the mixture
was stirred until the pink color had disappeared. To this solution was added DBtJ
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(0.15 mL, 1.0 mmol) and the mixture was stirred for 1 minute, washed with saturated
aqueous ammonium chloride (5 mL) and extracted with diethyl ether ( 3 x 5 mL). The
combined organic layers were dried with anhydrous sodium sulfate and concentrated
in vacuo. The residue was chromatographed on silica (hexanes:ethyl acetate =7:1; R/
= 0.25) to yield 12 mg (46%) of 260 as a yellow oil. 'H NMR (500 MHz, CDC13)

8

7.76 (d, 1H,J = 16.0 Hz), 6.44 (d, 1 H ,J= 15.8 Hz), 5.86 (ddd, 1H, .7=4.1, 10.9, 15.1
Hz), 5.52 (ddd, 1H, J = 1.3, 9.6, 15.2 Hz), 4.56 (m, 1H), 4.63 (s, 2H), 4.10 (m, 1H),
3.36 (s, 3H), 2.88 (q, 1H, J = 9.1 Hz), 2.56 (q, 1H, J = 9.1 Hz), 2.30-2.21 (m, 2H),
2.14 (m, 1H), 2.02 (m, 1H), 1.96-1.88 (m, 2H), 1.80 (m, 1H), 1.68-1.58 (m, 2H), 1.33
(d, 3H, J = 6.1 Hz), 1.22 (m, 1H); 13C NMR (125 MHz, CDC13) 8 200.5, 166.1, 140.2,
135.7, 132.9, 128.3, 95.2, 77.2, 73.7, 56.0, 55.3, 45.2, 40.3, 34.2, 32.7, 32.2, 25.6,
20 . 2 .

(10aS,13a/?,4i)-5,6,7,8,ll;12,13,13a-C)ctahydrocyclopenta[e][l]oxacyclododecinel,3(2H,10aH)-dione 262A
Procedure 1:
A 250-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with dichloromethane (100 mL),
compound 263

(0.16 g, 0.6 mmol,

in

1 mL of dichloromethane) and

bis(cyclohexylphosphine)benzylidine ruthenium (IV) dichloride (20 mg, 0.024 mmol)
in the indicated order. This solution was heated to reflux for

8

hours and another
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portion of catalyst was added (20 mg, 0.024 mmol). Reflux was continued for an
additional

8

hours till TLC analysis (hexanes:ethyl acetate = 15:1, R/ = 0.20)

indicated that the starting material was consumed. The solution was allowed to cool
and concentrated in vacuo. The residue was chromatographed on silica (hexanes:ethyl
acetate = 10:1, R/ = 0.20) to yield 100 mg (70 %) of two isomers 262A (55%) and
262B (15%). The compounds were produced in E.Z = 3.5:1 ratio (based on ]H NMR
of the crude reaction mixture ). 'H NMR (500 MHz, CDC13)

8

5.41 (ddd, 1H, J = 5.0,

9.8, 15.0 Hz), 5.26 (dd, 1H, J = 8.9, 16.6 Hz), 4.42 (m, 1H), 3.82 (m, 1H), 3.41 (s,
2H), 3.02 (dd, 1H, J = 8.7, 18.7 Hz), 2.64 (m, 1H), 2.16 (m, 1H), 1.94-1.56 (m, 9H),
1.44-1.32 (m, 2H); 13C (100 MHz, CDCI3)

8

205.7, 167.5, 133.1, 131.9, 65.8, 57.3,

50.9,48.7, 33.8, 31.6, 29.7, 26.7, 25.1, 24.7.
(10a£, 13aJf,Z)-5,6,7,8,ll, 12,13,13a-Octahydrocyclopenta[e][l]oxacyclododecinel,3(2H,10aH)-dione 262B (hexanes:ethyl acetate = 7:1, R/ = 0.20)
*H NMR (500 MHz, CDCI3)

8

5.34 (dd, 1H, J = 9.9, 9.9 Hz), 5.22 (dd, 1H, J = 10.9,

10.9 Hz), 4.54 (m, 1H), 3.84 (m, 1H), 3.52 (d, 1H, J= 14.3 Hz), 3.38 (d, 1H, J = 14.3
Hz), 3.18 (m, 1H), 2.50 (m, 1H), 2.42 (m, 1H), 2.03-1.53 (m, 8 H), 1.45-1.38 (m, 1H);
,3C (100 MHz, CDCI3 ) 8 205.6, 166.8, 133.5, 130.4, 67.4, 60.1, 47.2, 41.8, 34.5, 29.5,
28.0, 26.1,25.4, 25.3.
Procedure 2:
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with toluene (4 mL). Compound
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262B (10 mg, 0.04 mmol), thiophenol (0.014 mL, 0.14 mmol) and AIBN (10 mg,
0.06 mmol) were added sequentially to the flask. The solution was heated to 80 °C for
8

hours. The mixture was concentrated in vacuo, and the resulting residue was

purified by column chromatography on silica gel (hexanes:ethyl acetate = 10:1, R/ =
0.20) to give

6

mg (60%, based on 75% conversion) o f 262A.

Hex-5-enyl 3-oxo-3-((l/?,2A)-2-vin\icyclopentyl)propanoate 263
A 5-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with anhydrous THF (2 mL),
compound 264 (0.14 g, 1.0 mmol, in 1 mL of THF), and 1,1-carbonyldiimidazole
(0.17 g, 1.1 mmol) in the indicated order. A separate 50-mL oven-dried,
round-bottomed flask, equipped with a septum with a flow of nitrogen through a
needle and a stir bar, was charged with tetrahydrofuran (10 mL), and
diisopropylamine (0.56 mL, 4 mmol) in order. After the solution was cooled to 0 °C in
the ice bath, n-BuLi (2.0 M in hexanes, 2.0 mL, 4.0 mmol) was added dropwise. After
stirring for 10 min, the reaction mixture was cooled to -78 °C, compound 283 (0.56 g,
4 mmol, in 5 mL of THF) was added in 1 h using a syringe pump. The acyl imidazole
solution was transferred to the enolate solution by cannula. After stirring for 30 min,
the reaction was quenched by cautious addition of 1 M HC1 (5 mL). The solution was
extracted with diethyl ether ( 3 x 1 0 mL) and the combined organic layer was washed
by brine (15 mL). The organic layers were dried over anhydrous sodium sulfate,
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filtered and concentrated in vacuo. The residue was chromatographed on silica
(hexanesrethyl acetate = 15:1, R/ = 0.20) to yield 0.21 g (80%) of 263 as a colorless
liquid with some minor enol forms present. 'H NMR (400 MHz, CDCI3)

8

5.84-5.71

(m, 2H), 5.08-4.95 (m, 4H), 4.14-4.11 (m, 2H), 3.47 (s, 2H), 2.80 (m,lH), 2.70 (m,
1H), 2.10-2.05 (m, 2H), 1.96-1.86 (m, 2H), 1.74-1.62 (m, 4H), 1.51-1.41 (m, 4H); 13C
(100 MHz, CDCI3)

8

203.5, 166.5, 140.0, 113.8, 113.8, 64.2, 56.5, 48.2, 46.7, 32.4,

32.2, 27.9, 26.9, 24.0, 23.8. Resonances observed for the enol forms: *H NMR (400
MHz, CDCI3 ) 8 12.1 (s, 1H).

(l/?,2S)-2-Vinylcyclopentanecarboxylic acid 264
Compound 274 (0.25 g, 1.5 mmol) was dissolved in a 25-mL round-bottomed flask
with 3 mL of THF. Water (3 mL) and lithium hydroxide monohydrate (0.27 g, 6.0
mmol) were added to the solution in the indicated order. The mixture was allowed to
stir overnight at room temperature and the solution was brought to pH = 1.0 with 1M
HC1, then extracted with diethyl ether ( 3 x 5 mL). The combined organic layers were
dried carefully over anhydrous sodium sulfate and concentrated in vacuo to yield 0.18
g (85%) of 264 as a colorless liquid. 'H NMR (500 MHz, CDCI3) 8 5.80 (m, 1H), 5.08
(dd, 1H, J = 1.2, 17.1 Hz), 4.99 (d, 1H, J = 10.3 Hz), 2.76 (m, 1H), 2.54 (dd, 1H, J
=8.7, 17.4 Hz), 2.06-1.88 (m, 3H), 1.74 (m, 2H), 1.46 (m, 1H); 13C NMR (100 MHz,
CDCI3) 8 170.2, 137.3, 113.8, 63.4, 32.3, 27.0, 24.2, 19.9.
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(1/?,2S)-Ethyl 2-vinylcyclopentanecarboxylate 272
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with tetrahydrofuran (2 mL) and
compound 280 (0.19 g, 0.5 mmol, in 0.5 mL of tetrahydrofuran) in order. After the
solution was cooled to 0 °C in the ice bath, TBAF (1.0 mL, 1.0 mmol, 1.0 M in
tetrahydrofuran) was added in one portion. After TLC analysis (hexanesrethyl acetate
= 7:1, R/ = 0.25) indicated that the starting material was consumed, the solution was
quenched by cautious addition of saturated aqueous ammonium chloride (1 mL). The
mixture was extracted with diethyl ether ( 2 x 5 mL). The combined organic layers
were washed with brine (5 mL) and dried over anhydrous sodium sulfate. The
resulting liquid was filtered and concentrated under reduced pressure. The product
was purified by flash chromatography on silica (hexanes:ethyl acetate = 15:1, R/ =
0.30) to offer 76 mg (90%) of 272 as a colorless liquid. 'H NMR (500 MHz, CDCI3 ) 8
5.78 (m, 1H), 5.04 (d, 1H, J = 17.1 Hz), 4.95 (d, 1H, J= 10.2 Hz), 4.18-4.08 (m, 2H),
2.73 (m, 1H), 2.56 (m, 1H), 2.01-1.83 (m, 3H), 1.75-1.65 (m, 2H), 1.42 (m, 1H), 1.24
(t,3H, J =7 . 1 Hz).

(H?,21f)-Ethyl
2 -((l/?)-l-(p-tolylsulfinyl)- 2

-(trimethylsilyl)ethyl)cyclopentanecarboxylate 280

A 25-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with tetrahydrofuran
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(6

mL),

and diisopropyl amine (0.2 mL, 1.5 mmol) in order. After the solution was cooled to 0
°C, n-BuLi (2.0 M in hexanes, 0.75 mL, 1.5mmol) was added in one portion. After
stirring for 10 min, the reaction mixture was cooled to -78 °C using dry ice in acetone,
compound 276 (0.12 g, 0.50 mmol, in 0.5 m of THF) was added. After the solution
was allowed to stir for 15 min, compound 279 (0.22 g, 1.0 mmol, in 1 mL o f THF)
was added in one portion. The solution was allowed to stir for 15 min at -78 °C and
then warm to 0 °C. After TLC analysis (hexanes:ethyl acetate = 3:1; R/ = 0.20)
indicated that the starting material was consumed, the solution was quenched by
cautious addition of saturated aqueous ammonium chloride (5 mL). The mixture was
extracted with diethyl ether ( 3 x 1 0 mL), washed with brine (10 mL). The combined
organic layers were dried over anhydrous sodium sulfate. The resulting liquid was
filtered and concentrated under reduced pressure. The product was purified by flash
chromatography on silica (hexanes:ethyl acetate = 7:1, R/ = 0.25) to offer 0.15 g
(78%) of 280 as a colorless liquid. 'H NMR (500 MHz, CDC13) 5 7.56 (d, 2H, J = 8.3
Hz), 7.47 (d, 2H, J = 8.3 Hz), 4.36 (q, 2H, J = 7.1 Hz), 3.35 (dd, 1H, J = 8 .6 , 18.6 Hz),
3.00 (ddd, 1H, J = 2.7, 2.7, 11.7 Hz), 2.67 (m, 1H), 2.58 (s, 3H), 2.30-1.87 (m, 6 H),
1.48 (t, 3H, J = 7.1 Hz), 1.03 (dd, 1H, 7 = 11.7, 15.1 Hz), 0.92 (dd, 1H, J = 2.7, 15.0
Hz), 0.00 (s, 9H); 13C (125 MHz, CDC13)

6

176.8, 141.7, 131.0, 129.9, 125.4, 67.3,

62.0,49.4, 49.2, 30.8, 28.9, 25.8, 22.7,15.8, 10.6, 0.0.
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(55',10a5',125',13a/?r£^-12-(Methoxymethoxy)-5-methyl-5,6,7,8,ll,12,13,13a-octah
ydrocyclopenta[e] |l]oxacyclododecine-l,3(2H,10aH)-dione 284A
Procedure 1:
A 250-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with dichloromethane (100 mL),
compound 285 (169 mg, 0.5 mmol, in

1 mL of dichloromethane) and

bis(cyclohexylphosphine)benzylidine ruthenium (IV) dichloride (20 mg, 0.024 mmol)
in the indicated order. This solution was heated to reflux for

8

hours and another

portion of catalyst was added (20 mg, 0.024 mmol). Reflux was continued for an
additional

8

hours till TLC analysis (hexanes:ethyl acetate =10:1; R/ = 0.20) indicated

that the starting material was consumed. The solution was allowed to cool and
concentrated in vacuo.

The residue was chromatographed on silica (hexanes:ethyl

acetate =10:1; R/ = 0.15) to yield 100 mg (64%) of 284A (50%) and 284B (14%) as a
mixture of two isomers existing in E:Z = 3.6:1 ratio (based on ’H NMR of crude
reaction mixture). 284A : 'H NMR (500 MHz, CDCI3) 8 5.38 (m, 1H), 5.30 (dd, 1H, J
= 8.5, 16.2 Hz), 5.04 (m,lH), 4.61 (s, 2H), 4.15 (m, 1H), 3.44 (m, 1H), 3.40-3.38 (m,
2H), 3.36 (s, 3H), 2.59 (m, 1H), 2.26-2.15 (m, 2H), 2.04-1.92 (m, 2H), 1.72-1.52 (m,
5H), 1.33 (m, 1H), 1.19 (d, 3H, J = 6.5 Hz); 13C NMR (125 MHz, CDCI3) 5 205.4,
167.3, 133.6, 131.7, 95.4, 77.4, 71.6, 55.6, 53.9, 50.8, 46.0, 40.3, 36.0, 32.0, 31.6,
20.7, 18.5.
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(5S,9aS,l\S,\2aR^)-\ l-(Methoxymethoxy)-5-methyl-5,6,7,9a,10,l l,12,12a-octah
ydro-1 H-cyclopenta [e] [1] oxacycloundecine-l,3(2H)-dione
284B (hexanes:ethyl acetate =7:1; R/ = 0.15)
'H NMR (500 MHz, CDCI3) 6 5.42 (ddd, 1H, J = 1.4, 5.4, 5.4 Hz), 5.30 (ddd, 1H, J =
1.4, 5.4, 5.4 Hz), 5.05 (m, 1H), 4.62 (s, 2H), 4.24 (m, 1H), 3.50 (d, 1H, J = 14.0 Hz),
3.38 (d, 1H, J = 14.2 Hz), 3.35 (s, 3H), 3.16 (m, 1H), 2.98 (dd, 1H, J = 8.2, 16.4 Hz),
2.37-2.22 (m, 2H), 2.04-1.74 (m, 5H), 1.58-1.43 (m, 3H), 1.23 (d, 3H, J = 6.4 Hz);
13C NMR (125 MHz, CDC13) 5 203.8, 165.0, 132.1, 129.8, 94.4, 76.6, 72.0, 56.4, 54.4,
47.8, 39.3, 38.8, 35.2, 30.7, 25.8, 22.9,17.8.
Procedure 2:
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with toluene (4 mL). Compound
284B (10 mg, 0.03 mmol), thiophenol (0.014 mL, 0.14 mmol) and AIBN (10 mg,
0.06 mmol) were added sequentially to the flask. The solution was heated to 80 °C for
8

hours. The mixture was concentrated in vacuo, and the resulting residue was

purified by column chromatography on silica gel (hexanes:ethyl acetate =10:1; R/ =
0.15) to give 5 mg (50%, based on 78% conversion) of 284A.
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(5)-Hept-6-en-2-yl
3-((li?,25',45)-4-(methoxymethoxy)-2-vinylcyclopentyl)-3-oxopropanoate 285
A 5-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with anhydrous THF (2 mL),
compound 286 (0.10 g, 0.5 mmol, in 1 mL of THF), and 1,1-dicarbonylimidazole
(0.10 g, 0.6 mmol) in the indicated order. In a separate 25-mL oven-dried,
round-bottomed flask, equipped with a septum with a flow of nitrogen through a
needle and a stir bar, was charged with tetrahydrofuran ( 8 mL), and diisopropyl amine
(0.28 mL, 2 mmol) in order. After the solution was cooled to 0 °C in the ice bath,
w-BuLi (2.0 M in hexanes, 1.0 mL, 2.0 mmol) was added dropwise. After stirring for
10 min, the reaction mixture was cooled to -78 °C, compound 313 (0.31 g, 2 mmol, in
3 mL of THF) was added in 1 hour using syringe pump. The acyl imidazole solution
was transferred to the enolate solution by cannula. After stirring for 30 min, the
reaction was quenched by cautious addition of 1 M HC1 (2 mL). The solution was
extracted with diethyl ether ( 3 x 5 mL) and the combined organic layers were washed
by brine (5 mL). The organic layers were dried over anhydrous sodium sulfate,
filtered and concentrated in vacuo. The residue was chromatographed on silica
(hexanes:ethyl acetate = 10:1, R/ = 0.20) to yield 0.14 g (85%) of 285 as a colorless
liquid. 'H NMR (500 MHz, CDCI3)

8

5.87-5.74 (m, 2H), 5.08-4.93 (m, 4H), 4.62 (s,

2H), 4.17 (m, 1H), 3.44 (s, 2H), 3.35 (s, 3H), 3.04 (dd, 1H, J = 8.9, 17.6 Hz), 2.70 (m,
1H), 2.26 (m, 1H), 2.11-1.96 (m, 4H), 1.64-1.35 (m, 6 H), 1.23 (d, 3H, J = 6.3 Hz);
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13C NMR (125 MHz, CDC13)

8

204.3, 167.0, 141.8, 138.6, 115.4, 115.0, 95.5, 77.4,

72.4, 55.7, 55.6, 49.9, 45.8,40.0, 36.1, 35.4, 33.6, 24.8, 20.1.

(l/?,2S,4S)-4-(Methoxymethoxy)-2-vinylcyclopentanecarboxylic acid 286
Compound 309 (0.46 g, 2.0 mmol) was dissolved in a 25-mL round-bottomed flask
with 4 mL of THF. Water (4 mL), and lithium hydroxide monohydrate (0.38 g, 8.0
mmol) were added to the solution in the indicated order. The mixture was allowed to
stir for overnight at room temperature and the solution was brought to pH = 1.0 with
1M HC1, then extracted with diethyl ether ( 3 x 5 mL). The combined organic layers
were dried carefully over anhydrous sodium sulfate and concentrated in vacuo to yield
0.32 g (80%) of 286 as a colorless liquid. 'H NMR (500 MHz, CDC13) 8 5.85 (m, 1H),
5.09 (d, 1H, J = 7.2 Hz), 5.01 (d, 1H, J = 10.2 Hz), 4.63 (s, 2H), 4.25 (m, 1H), 3.36 (s,
3H), 2.78-2.76 (m, 2H), 2.32 (m, 1H), 2.12-2.10 (m, 2H), 1.62 (m, 1H); 13C NMR
(100 MHz, CDCI3 ) 8 180.5, 140.4, 115.1, 95.5, 55.6, 48.2,46.3, 39.7, 37.2.

(S,£)-Ethyl 6-bromo-5-(methoxymethoxy)hex-2-enoate 294
Procedure 1:
A 100-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with dichloromethane (40 mL),
compound 303 (2.12 g, 9.0 mmol, in 4.5 mL of dichloromethane), and MOM-C1 (1.0
mL, 13.5 mmol) in the indicated order. After the solution was cooled to 0 °C in the ice
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bath, diisopropylethylamine (2.4 mL, 13.5 mmol) was added in one portion. After
overnight reaction at room temperature, diethyl ether (25 mL) was added to the
mixture and the solution was washed with 1M HC1 (3 x 10 mL) and dried over
anhydrous sodium sulfate. The resulting liquid was filtered and concentrated under
reduced pressure. The product was purified by flash chromatography on silica
(hexanesrethyl acetate = 7:1, Rj - 0.25) to offer 2.0 g (79%) of 294 as a colorless
liquid. 'H NMR (400 MHz, CDCI3) 5 6.93 (m, 1H), 5.95 (d, 1H, J = 15.6 Hz),
4.75-4.68 (m, 2H), 4.22-4.17 (m, 2H), 3.89 (m, 1H), 3.46 (d, 2H, J = 5.5 Hz), 3.41 (s,
3H), 2.63-2.58 (m, 2H), 1.29 (t, 3H, J = 7.1 Hz); 13C NMR (100 MHz, CDC13)

8

166.1,143.3, 124.6, 96.1, 75.4, 60.3, 56.0, 36.0, 34.6, 14.2.
Procedure 2:
Compound 302 (74 mg, 0.2 mmol) was dissolved in a 5-mL round-bottomed flask
with 2 mL of THF. Sodium bromide (0.1 g, 1.0 mmol) was added to the solution and
the mixture was allowed to stir for overnight under room temperature and extracted
with diethyl ether ( 3 x 5 mL). The combined organic layers were dried carefully over
anhydrous sodium sulfate and concentrated in vacuo to yield 44 mg (79%) 294 of as a
colorless liquid.

(/?,£")-Ethyl 5-(methoxymethoxy)-6-(tosyloxy)hex-2-enoate 302
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with dichloromethane (3 mL),
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compound 301 (82 mg, 0.25 mmol, in 0.5 mL of dichloromethane), and MOM-C1
(0.05 mL, 0.68 mmol) in the indicated order. After the solution was cooled to 0 °C in
the ice bath, Diisopropylethylamine (0.18 mL, 1.0 mmol,) was added in one portion.
After overnight reaction at room temperature, diethyl ether (25 mL) was added to the
mixture and the solution was washed with 1M HC1 ( 3 x 5 mL), and dried over
anhydrous sodium sulfate. The resulting liquid was filtered and concentrated under
reduced pressure. The product was purified by flash chromatography on silica
(hexanes:ethyl acetate = 7:1, R/ = 0.30) to offer 60 mg (65%) of 302 as a colorless
liquid. ‘H NMR (500 MHz, CDC13) 5 7.79 (d, 2H, J = 8.1 Hz), 7.36 (d, 2H, J = 8.1
Hz), 6.83 (m, 1H), 5.84 (d, 1H, J = 16.8 Hz), 4.62 (d, 1H ,7= 7.1 Hz), 4.57 (d, 1H ,7 =
7.1 Hz), 4.17 (q, 2H, J = 7.1 Hz), 4.02-4.01 (m, 2H), 3.87 (m, 1H), 3.31 (s, 3H), 2.46
(s, 3H), 2.46-2.42 (m, 2H), 1.28 (q, 3H, J = 7.2 Hz); 13C (125 MHz, CDC13)

8

166.0,

145.1,142.9, 132.7,129.9,128.0, 124.6, 96.1, 73.5, 70.5,60.4, 55.8, 34.4, 21.7, 14.3.

(i5,£)-Ethyl 6-bromo-5-hydroxyhex-2-enoate 303
A 100-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with dichloromethane (30 mL),
compound 300 (0.87 g, 5.0 mmol, in 5 mL of dichloromethane), and carbon
tetrabromide (2.0 g, 6.0 mmol) in the indicated order. After the solution was cooled to
0 °C in the ice bath, triphenylphosphine (1 . 6 g, 6.0 mmol, in 5 mL of dichloromethane)
was added in 30 minutes using syringe pump. After TLC analysis (hexanes:ethyl
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acetate = 1:1; R/ = 0.15) indicated that the starting material was consumed, the
solution was quenched by cautious addition of saturated aqueous ammonium chloride
(15 mL). The mixture was extracted with diethyl ether ( 2 x 1 5 mL). The combined
organic layers was washed with brine (10 mL), and dried over anhydrous sodium
sulfate. The resulting liquid was filtered and concentrated under reduced pressure.
The product was purified by flash chromatography on silica (hexanes:ethyl acetate =
3:1, Rf = 0.30) to offer 0.83 g (70%) of 303 as a colorless liquid. 'H NMR (500 MHz,
CDC13)

8

6.95 (m, 1H), 5.94 (d, 1H, J = 16.6 Hz), 4.20 (q, 2H, J = 7.2 Hz), 3.98 (m,

1H), 3.64 (dd, 1H, J = 3.9, 11.3 Hz), 3.52 (dd, 1H, J = 6.5, 11.2 Hz), 2.53-2.48 (m,
2H), 2.36 (m, 1H, OH), 1.29 (t, 3H, J = 7.2 Hz); ,3C NMR (125 MHz, CDCI3) 8 166.2,
143.3,124.5, 69.7, 60.5, 39.0, 37.8, 14.2.

(4/?)-Ethyl
4-(methoxymethoxy)-2-(-l-(p-tolylsulf!nyl)-2-(trimethylsilyl)ethyl)cyclopentaneca
rboxylate 304
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with tetrahydrofuran (3 mL),
and diisopropylamine (0.1 mL, 0.75 mmol) in order. After the solution was cooled to
0 °C, n-BuLi (2.0 M in hexanes, 0.37 mL, 0.75 mmol) was added in one portion. After
stirring for 10 min, the reaction mixture was cooled to -78 °C using dry ice in acetone,
compound 276 (0.07 g, 0.30 mmol, in 0.5 mL of THF) was added. After the solution
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was allowed to stir for 15 min, 294 (0.12 g, 0.45 mmol, in 0.33 mL of THF) was
added in one portion. The solution was allowed to stir for 15 min at -78 °C and then
warm to 0 °C. After TLC analysis (hexanes:ethyl acetate = 3:1; R/ = 0.20) indicated
that the starting material was consumed, the solution was quenched by cautious
addition of saturated aqueous ammonium chloride (2 mL). The mixture was extracted
with diethyl ether ( 3 x 5 mL), washed with brine (5 mL). The combined organic
layers were dried over anhydrous sodium sulfate. The resulting liquid was filtered and
concentrated under reduced pressure. The product was purified by flash
chromatography on silica (hexane: ethyl acetate = 4:1; R/ = 0.30) to offer 95 mg (72%)
of 304 as a colorless liquid. 'H NMR (400 MHz, CDCI3 ) 5 7.57 (d, 2H, J = 8.2 Hz),
7.50 (d, 2H, J = 8.2 Hz), 4.82 (s, 2H), 4.48 (m, 1H), 4.44-4.37 (m, 2H), 3.56 (d, 1H, J
= 11.8 Hz), 3.55 (s, 3H), 3.44 (m, 1H), 3.10-3.03 (m, 2H), 2.60 (s, 3H), 2.43-2.30 (m,
2H), 2.22 (m, 1H), 1.50 (t, 3H, J = 1 2 Hz), 1.06 (dd, 1H, J = 11.7, 15.0 Hz), 0.90 (dd,
1H, J = 2.5, 15.0 Hz), 0.05 (s, 9H); 13C NMR (100 MHz, CDCI3 )

6

175.8, 141.8,

141.3, 131.0, 125.4, 96.3, 77.3, 66.7, 62.2, 56.7, 47.5, 46.3, 37.1, 35.8, 22.7, 15.7,
10.4,1.4.

(4S)-Ethyl 4-(methoxymethoxy)-2-vinylcyclopentanecarboxylate 305
A 5-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with tetrahydrofuran (1 mL) and
compound 304 (0.09 g, 0.2 mmol, in 0.5 mL of tetrahydrofuran) in order. After the
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solution was cooled to 0 °C in the ice bath, TBAF (1.0 M in tetrahydrofuran. 0.4 mL,
0.4 mmol,) was added in one portion. After TLC analysis (hexane: ethyl acetate = 4:1;
Rf = 0.30) indicated that the starting material was consumed, the solution was
quenched by cautious addition of saturated aqueous ammonium chloride (1 mL). The
mixture was extracted with diethyl ether ( 3 x 5 mL). The combined organic layers
were washed with brine (5 mL), and dried over anhydrous sodium sulfate. The
resulting liquid was filtered and concentrated under reduced pressure. The product
was purified by flash chromatography on silica ((hexanes:ethyl acetate = 12:1, R/ =
0.30) to offer 36 mg (80%) of 305 as a colorless liquid. 'H NMR (400 MHz, CDC13) 5
5.82 (m, 1H), 5.04 (dd, 1H, J = 0.8, 15.5 Hz), 4.98 (dd, 1H, J = 1.1, 10.1 Hz), 4.62 (s,
2H), 4.23 (m, 1H), 4.14 (m, 2H), 3.36 (s, 3H), 2.75-2.69 (m, 2H), 2.30 (m, 1H), 2.05
(m, 2H), 1.71 (m, 1H), 1.24 (t, 3H, J = 7.1 Hz); 13C NMR (100 MHz, CDC13) 8 176.4,
141.7,115.8, 96.5, 69.2, 61.7, 56.6,49.5,47.6, 40.7, 38.2,15.5.

(H?,2*,4.R)-Ethyl
4-(methoxymethoxy)-2-((l/?)-l-(p-tolylsulfinyl)-2-(triniethylsilyl)ethyl)cyclopenta
necarboxylate 308
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with tetrahydrofuran (3 mL),
and diisopropylamine (0.1 mL, 0.75 mmol) in order. After the solution was cooled to
0 °C, n-BuLi (2.0 M in hexanes, 0.37 mL, 0.75 mmol) was added in one portion. After
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stirring for 10 min, the reaction mixture was cooled to -78 °C using dry ice in acetone,
compound 307 (0.06 g, 0.25 mmol, in 0.5 mL of THF) was added. After the solution
was allowed to stir for 15 min, compound 294 (0.09 g, 0.33 mmol, in 0.33 mL of THF)
was added in one portion. The solution was allowed to stir for 15 min at -78 °C and
then warm to 0 °C. After TLC analysis (hexanes:ethyl acetate = 3:1; R/ = 0.20)
indicated that the starting material was consumed, the solution was quenched by
cautious addition of saturated aqueous ammonium chloride (2 mL). The mixture was
extracted with diethyl ether ( 3 x 5 mL), washed with brine (5 mL). The combined
organic layers were dried over anhydrous sodium sulfate. The resulting liquid was
filtered and concentrated under reduced pressure. The product was purified by flash
chromatography on silica (hexane: ethyl acetate = 3:1, R/ = 0.15) to offer 8 8 mg (80%)
of 308 as a colorless liquid. [a]25o = -52 (c = 0.003 g/mL, THF). ]H NMR (400 MHz,
CDC13) 5 7.60-7.58 (d, 2H, J = 8.0 Hz), 7.50-7.48 (d, 2H, J = 8.0 Hz), 4.91-4.84 (dd,
2H, J = 6.9, 25.3 Hz), 4.44 (m, 1H), 4.41-4.37 (q, 2H, J = 7.1, Hz), 3.66-3.54 (m, 2H),
3.58 (s, 3H), 3.02 (m, 1H), 2.69 (m, 1H), 2.60 (s, 3H), 2.60-2.34 (m, 3H), 1.52-1.49 (t,
3H, J = 7.1 Hz), 0.99-0.97 (m, 2H), 0.20 (s, 9H); 13C NMR (100 MHz, CDC13)
176.2, 141.8, 141.8, 131.0, 125.4, 96.4, 77.1,

6 6 .8 ,

8

62.2, 56.9, 47.4, 47.0, 37.9, 35.0,

22.7, 15.8, 10.6, 0.0. IR(neat, cm'1): 2964, 2882, 1727, 1614, 1596.
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(1 /?,2»S',4^)-Ethyl 4-(methoxymethoxy)-2-vinylcyclopentanecarboxylate 309
A 25-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with tetrahydrofuran (5 mL) and
compound 308 (0.09 g, 2 mmol, in 2 mL of tetrahydrofuran) in order. After the
solution was cooled to 0 °C in the ice bath, TBAF (1.0 M in tetrahydrofuran, 3.0 mL,
3.0 mmol) was added in one portion. After TLC analysis (hexanes:ethyl acetate = 3:1;
R/ = 0.15) indicated that the starting material was consumed, the solution was
quenched by cautious addition of saturated aqueous ammonium chloride (3 mL). The
mixture was extracted with diethyl ether ( 2 x 5 mL). The combined organic layers
were washed with brine (5 mL) and dried over anhydrous sodium sulfate. The
resulting liquid was filtered and concentrated under reduced pressure. The product
was purified by flash chromatography on silica (hexanes:ethyl acetate = 10:1, R/ =
0.25) to offer 0.39 g (85%) of 309 as a colorless liquid. 'H NMR (400 MHz, CDCI3 ) 5
5.80 (m, 1H), 5.04 (dd, 1H, J = 0.9, 16.4 Hz), 4.98 (dd, 1H, J = 1.0, 10.1 Hz), 4.62 (s,
2H), 4.23 (m, 1H), 4.18-4.10 (m, 2H), 3.36 (s, 3H), 2.76-2.68 (m, 2H), 2.30 (m, 1H),
2.08-2.02 (m, 2H), 1.58 (m, 1H), 1.26-1.23 (t, 3H, J = 7.1 Hz); 13C NMR (100 MHz,
CDCI3) 8 175.3, 140.6, 114.8, 95.5, 66.1, 60.6, 55.6, 48.4, 46.6, 39.7, 37.2,14.5.

((!/?,25,45)-4-(Methoxymethoxy)-2-vinylcyclopentyl)methanol 310
A 10-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with tetrahydrofuran (3 mL),
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lithium aluminum hydride (15 mg, 0.4 mmol) and compound 309 (18 mg, 0.075
mmol) in the indicated order. The solution was refluxed till TLC analysis
(hexanes:ethyl acetate = 3:1; R/ = 0.20) indicated that the starting material was
consumed. The solution was cooled to room temperature and quenched by cautious
and sequential addition of water (1 mL), 10% aqueous sodium hydroxide (1 mL), and
water (3 mL). After stirred for 10 min, the solution was filtered and concentrated
under reduced pressure. The product was purified by flash chromatography on silica
(hexanes:ethyl acetate = 7:1, R/ = 0.10) to offer 7 mg (50%) 310 as a colorless liquid.
'H NMR (500 MHz, CDC13) 8 5.82 (m, 1H), 5.04 (dd, 1H, J = 1.0, 17.1 Hz), 4.96 (dd,
1H, J = 1.7, 10.1 Hz), 4.63 (s, 2H), 4.16 (m, 1H), 3.68 (dd, 1H, J = 5.4, 10.8 Hz), 3.54
(dd, 1H, J = 6.1, 10.8 Hz), 3.36 (s, 3H), 2.27-2.18 (m, 3H), 2.05 (m, 1H), 1.92 (m,
1H), 1.67 (m, 1H), 1.56 (m, 1H); 13C NMR (100 MHz, CDC13)

8

142.5, 114.5, 95.5,

76.9, 65.7, 55.5, 46.0, 45.8, 40.4, 36.2.

(5>Hept-6-en-2-yl acetate 313
A 100-mL oven-dried, round-bottomed flask, equipped with a septum with a flow of
nitrogen through a needle and a stir bar, was charged with Mg° (0.6 g, 25 mmol),
THF (30 mL) and a crystal of iodine. 4-Bromo-l-butene (1.3 mL, 13 mmol) was
dissolved in tetrahydrofuran (10 mL). A portion of the bromobutene solution (1 mL)
was added and the mixture was allowed to stir until the brown color of the mixture
disappeared. The solution was allowed to stir for an additional 10 min, then
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4-bromo-l-butene solution was added dropwise over a 1-hour period using a syringe
pump. The mixture was allowed to stir for an additional 1 h and was brought to -40 °C
and copper(I) iodide (50 mg, 0.26 mmol) was added. The resulting light green mixture
was allowed to stir for an additional

10

minutes, at which time (S)-propylene oxide

(0.35 mL, 5 mmol) was added in a single portion. The mixture was allowed to warm
to -15 °C and allowed to stir for an additional 2.5 hours, then quenched with saturated
aqueous ammonium chloride (10 mL). The layers were separated and the organic
layer was washed with H2 O (10 mL) and brine (10 mL). The layers were separated
and the combined aqueous layers were extracted with diethyl ether (3 x 50 mL) and
the combined organic layers were dried over anhydrous sodium sulfate. The solution
was filtered and concentrated under reduced pressure. The resulting crude residue was
dissolved in a 25-mL oven-dried round-bottomed flask with

8

mL diethyl ether.

Acetyl chloride (0.71 mL, 10 mmol, freshly distilled) was added to the solution
followed with addition of pyridine (0.80 mL, 10 mmol). The solution was allowed to
reflux till TLC analysis (hexane: ethyl acetate = 3:1; R/ = 0.10) indicated that the
starting material was consumed. After cooling to the room temperature, the solution
was washed with 1M HC1 ( 3 x 1 0 mL). The organic layer was dried over anhydrous
sodium sulfate, filtered and concentrated under reduced pressure. The residue was
chromatographed on silica (hexanes:ethyl acetate = 15:1, R/ = 0.15) to yield 0.66 g
(85%) of 313 as a colorless liquid. 'H NMR (500 MHz, CDCI3) 5 5.71 (m, 1H), 4.93
(dd, 1H, J = 1.7, 17.1 Hz), 4.88 (dd, 1H, J = 0.9, 11.2 Hz), 4.83 (m, 1H), 2.01-1.96
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(m,2H), 1.95 (s, 3H), 1.56-1.18 (m, 4H), 1.14 (d, 3H, J = 6.3 Hz); 13C NMR (125
MHz, CDCI3 ) 8 169.7, 137.4, 113.7, 69.8, 34.3, 32.5, 23.7, 20.2, 18.9.

(6S,llaS,13S,14a/?,£)-13-(Methoxyinethoxy)-6-methyl-2,3,6,7,8,9,12,13,14,14a-de
cahydro-lH-cyclopenta[f] [l]oxacyclotridecine-l,4(l laH)-dione 314
A 10-mL oven-dried, round-bottomed flask equipped with a stir bar and a septum
with a flow of nitrogen through a needle was charged with 3 mL of methylene
chloride and diethyl zinc (1.0 M in hexanes, 1.0 mL, 1.0 mmol). The solution was
cooled to 0 °C and compound 294A (62 mg, 0.2 mmol, in 1 mL of methylene chloride)
was added to the solution. After stirring for 10 minutes, methylene iodide (0.08 mL,
1.0 mmol) was added dropwise by syringe. The mixture was stirred for 0.5 hour at
room temperature. Diethyl zinc (1.0 M in hexanes, 0.5 mL, 0.5 mmol) was added to
the solution at room temperature and after 10 minutes, methylene iodide (0.04 mL,
0.5 mmol) was added dropwise by syringe. The mixture was stirred for 0.5 hour at
room temperature and quenched by cautious addition of saturated aqueous ammonium
chloride (2 mL). The mixture was extracted with diethyl ether ( 3 x 5 mL). The
combined organic extracts were washed with brine (5 mL) and dried over anhydrous
sodium sulfate. The resulting liquid was filtered and concentrated under reduced
pressure. The product was purified by flash chromatography on silica (hexanes:ethyl
acetate =7:1; R/ = 0.20) to offer 49 mg (75%) of 314 as a colorless liquid. 'H NMR
(500 MHz, CDCI3) 5 5.56 (ddd, 1H, J = 5.0, 10.0, 15.0 Hz), 5.31 (dd, 1H, J =
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8 .8 ,

15.2 Hz), 4.78 (m, 1H), 4.62 (s, 2H), 4.21 (m, 1H), 3.36 (s, 3H), 3.01-2.91 (m, 2H),
2.80 (m, 1H), 2.66-2.54 (m, 2H), 2.39-2.28 (m, 2H), 2.05-1.81 (m, 4H), 1.64-1.46 (m,
2H), 1.28-1.10 (m, 3H), 1.19 (d, 3H, J = 6.3 Hz); 13C NMR (125 MHz, CDCI3)

8

210.9, 172.9, 133.2, 132.2, 95.5, 71.8, 56.6, 55.6, 46.7, 40.3, 38.8, 36.6, 32.6, 31.1,
29.5,24.2, 19.6.

e)

Preparation of P-Substituted-y-Keto Carbonyl Compounds

Methyl 3-methyl-4-oxopentanoate 346A
A 25-mL oven-dried, round-bottomed flask equipped with a stir bar and a septum
with a flow of nitrogen through a needle was charged with

8

mL of methylene

chloride and diethyl zinc (1.0 M in hexanes, 2.5 mL, 2.5 mmol). The solution was
cooled to 0 °C and 347A (58 mg, 0.5 mmol, in 1 mL of methylene chloride) was
added to the solution. After stirring for 10 minutes, 1,1-diiodoethane (0.25 mL, 2.5
mmol) was added dropwise by syringe. The mixture was stirred for 1 hour at room
temperature and quenched by cautious addition of saturated aqueous ammonium
chloride (5 mL). The mixture was extracted with diethyl ether ( 3 x 8 mL). The
combined organic extracts were washed with brine (5 mL) and dried over anhydrous
sodium sulfate. The resulting liquid was filtered and concentrated under reduced
pressure. The product was purified by flash chromatography on silica (hexanes:ethyl
acetate = 7:1; R /= 0.3) to offer 55 mg (76%) of 346A as a colorless liquid. ’H NMR
(500 MHz, CDCI3 ) 5 3.64 (s, 3H), 2.99 (m, 1H), 2.74 (dd, 1H, J = 8 .6 , 16.7 Hz), 2.28
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(dd, 1H, J = 5.5, 16.8 Hz), 2.20 (s, 3H), 1.14 (d, 3H, J = 7.3 Hz); 13C NMR (100 MHz,
CDC13) 6 210.7, 172.7, 51.7, 42.7, 36.6, 28.4, 16.5. IR (neat, cm'1): 2955, 1737, 1716,
1437.

Methyl 3,5,5-trimethyl-4-oxohexanoate 346B
A 25-mL oven-dried, round-bottomed flask equipped with a stir bar and a septum
with a flow of nitrogen through a needle was charged with

8

mL of methylene

chloride and diethyl zinc (1.0 M in hexanes, 2.5 mL, 2.5 mmol). The solution was
cooled to 0 °C and compound 347B (79 mg, 0.5 mmol, in 1 mL of methylene chloride)
was added to the solution. After stirring for 10 minutes, 1,1-diiodoethane (0.25 mL,
2.5 mmol) was added dropwise by syringe. The mixture was stirred for 1 hour at room
temperature and quenched by cautious addition of saturated aqueous ammonium
chloride (5 mL). The mixture was extracted with diethyl ether ( 3 x 8 mL). The
combined organic extracts were washed with brine (5 mL) and dried over anhydrous
sodium sulfate. The resulting liquid was filtered and concentrated under reduced
pressure. The product was purified by flash chromatography on silica (hexanes:ethyl
acetate = 7:1; R/-= 0.64) to offer 76 mg (82%) of 346B as a colorless liquid. 'H NMR
(500 MHz, CDCI3) 8 3.61 (s, 3H), 3.43 (m, 1H), 2.66 (dd, 1H, J = 8.0, 16.4 Hz), 2.28
(dd, 1H, J = 6.3, 16.4 Hz), 1.16 (s, 9H), 1.05 (d, 3H, J = 7.0 Hz); 13C NMR (100 MHz,
CDCI3)

8

218.1, 172.5, 51.5, 44.5, 38.1, 36.2, 26.5, 18.3. IR (neat, c m 1): 2972-2956,

1740, 1703, 1480, 1437.
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Ethyl 3-methyl-4-oxo-4-phenylbutanoate 346C
A 25-mL oven-dried, round-bottomed flask equipped with a stir bar and a septum
with a flow of nitrogen through a needle was charged with

8

mL of methylene

chloride and diethyl zinc (1.0 M in hexanes, 2.5 mL, 2.5 mmol). The solution was
cooled to 0 °C and compound 347C (96 mg, 0.5 mmol, in 1 mL of methylene chloride)
was added to the solution. After stirring for 10 minutes, 1,1-diiodoethane (0.25 mL,
2.5 mmol) was added dropwise by syringe. The mixture was stirred for 1 hour at room
temperature and quenched by cautious addition of saturated aqueous ammonium
chloride (5 mL). The mixture was extracted with diethyl ether ( 3 x 8 mL). The
combined organic extracts were washed with brine (5 mL), and dried over anhydrous
sodium sulfate. The resulting liquid was filtered and concentrated under reduced
pressure. The product was purified by flash chromatography on silica (hexanes:ethyl
acetate = 7:1; R/= 0.52) to offer 92 mg (84%) of 346C as a colorless liquid. 'H NMR
(500 MHz, CDCI3) 8 7.98-7.96 (m, 2H), 7.54 (m, 1H), 7.47-7.44 (m, 2H), 4.08 (q, 2H,
J = 7.1 Hz), 3.94 (m, 1H), 2.94 (dd, 1H, J = 8.5, 16.7 Hz), 2.44 (dd, 1H, J = 5.7, 16.7
Hz), 1.20 (t, 3H, J = 7.3 Hz), 1.18 (d, 3H, J = 7.1 Hz); 13C NMR (125 MHz, CDCI3) 8
202.7, 172.2, 135.9, 133.0, 128.6, 128.3, 60.5, 37.5, 37.1, 17.7, 14.0. IR (neat, cm'1):
2979,1733,1683,1448, 1377.
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Benzyl 3-methyl-4-oxopentanoate 346D
A 25-mL oven-dried, round-bottomed flask equipped with a stir bar and a septum
with a flow of nitrogen through a needle was charged with

8

mL of methylene

chloride and diethyl zinc (1.0 M in hexanes, 2.5 mL, 2.5 mmol). The solution was
cooled to 0 °C and compound 347D (96 mg, 0.5 mmol, in 1 mL of methylene chloride)
was added to the solution. After stirring for 10 minutes, 1,1-diiodoethane (0.25 mL,
2.5 mmol) was added dropwise by syringe. The mixture was stirred for 1 hour at room
temperature and quenched by cautious addition of saturated aqueous ammonium
chloride (5 mL). The mixture was extracted with diethyl ether ( 3 x 8 mL). The
combined organic extracts washed with brine (5 mL), and dried over anhydrous
sodium sulfate. The resulting liquid was filtered and concentrated under reduced
pressure. The product was purified by flash chromatography on silica (hexanes:ethyl
acetate = 7:1; R/= 0.30) to offer 8 8 mg (80%) of 346D as a colorless liquid. *H NMR
(500 MHz, CDC13) 6 7.38-7.30 (m, 5H), 5.11-5.08 (d, 2H, J = 4.7 Hz), 3.03 (m, 1H),
2.82 (dd, 1H, J = 8.7, 16.8 Hz), 2.34 (dd, 1H, J = 5.4, 16.8 Hz), 2.20 (s, 3H), 1.15 (d,
3H, J = 7.3 Hz); 13C NMR (125 MHz, CDC13) 5 210.6, 172.1, 135.8, 128.5, 128.2,
128.1, 66.4, 42.7, 36.8, 28.3,16.5. IR (neat, cm'1): 2969-2934, 1734, 1715, 1456.

/-/-Butyl 3-methyl-4-oxopentanoate 346E
A 25-mL oven-dried, round-bottomed flask equipped with a stir bar and a septum
with a flow of nitrogen through a needle was charged with

8

mL of methylene
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chloride and diethyl zinc (1.0 M in hexanes, 2.5 mL, 2.5 mmol). The solution was
cooled to 0 °C and compound 347E (79 mg, 0.5 mmol, in 1 mL of methylene chloride)
was added to the solution. After stirring for 10 minutes, 1,1-diiodoethane (0.25 mL,
2.5 mmol) was added dropwise by syringe. The mixture was stirred for 1 hour at room
temperature and quenched by cautious addition of saturated aqueous ammonium
chloride (5 mL). The mixture was extracted with diethyl ether ( 3 x 8 mL). The
combined organic extracts were washed with brine (5 mL) and dried over anhydrous
sodium sulfate. The resulting liquid was filtered and concentrated under reduced
pressure. The product was purified by flash chromatography on silica (hexane: ethyl
acetate = 7:1; R /= 0.50) to offer 82 mg (8 8 %) of 346E as a colorless liquid. 'H NMR
(500 MHz, CDCI3) 8 2.95 (m, 1H), 2.66 (dd, 1 H ,J= 8 .6 , 16.5 Hz), 2.23 (dd, 1H, J =
5.5, 16.5 Hz), 2.21 (s, 3H), 1.43 (s, 9H), 1.13 (d, 3H, J = 7.2 Hz); 13C NMR (100
MHz, CDCI3)

8

210.8, 171.4, 80.6, 42.9, 38.2, 28.3, 28.0, 16.3. IR (neat, c m 1):

2977-2934, 1727, 1717, 1367.

Allyl 3-methyl-4-oxopentanoate 349
A 25-mL oven-dried, round-bottomed flask equipped with a stir bar and a septum
with a flow of nitrogen through a needle was charged with

8

mL of methylene

chloride and diethyl zinc (1.0 M in hexanes, 1.5 mL, 1.5 mmol). The solution was
cooled to 0 °C and compound 348 (73 mg, 0.5 mmol, in 1 mL of methylene chloride)
was added to the solution. After stirring for 10 minutes, 1,1-diiodoethane (0.15 mL,
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1.5 mmol) was added dropwise by syringe. The mixture was stirred for 0.5 hour at
room temperature. Diethyl zinc (1.0 M in hexanes, 1.5 mL, 1.5 mmol) was added to
the solution at room temperature and after 10 minutes, 1,1-diiodoethane (0.15 mL, 1.5
mmol) was added dropwise by syringe. The mixture was stirred for 0.5 horn- at room
temperature and quenched by cautious addition of saturated aqueous ammonium
chloride (5 mL). The mixture was extracted with diethyl ether ( 3 x 8 mL). The
combined organic extracts were washed with brine (5 mL) and dried over anhydrous
sodium sulfate. The resulting liquid was filtered and concentrated under reduced
pressure. The product was purified by flash chromatography on silica (hexanes:ethyl
acetate = 7:1; R /= 0.37) to offer 63 mg (74%) of 349 as a colorless liquid. 'H NMR
(400 MHz, CDC13) 8 5.89 (m, 1H), 5.30 (dd, 1H, J = 1.5, 17.2 Hz), 5.22 (dd, 1H, J =
1.3, 10.4 Hz), 4.57-4.54 (m, 2H), 3.01 (m, 1H), 2.79 (dd, 1H, J = 8.7, 16.8 Hz), 2.32
(dd, 1H, J = 5.4, 16.8 Hz), 2.21 (s> 3H), 1.15 (d, 3H, J = 7.2 Hz);
CDCI3)

8

13CNM R(100

MHz,

210.6, 171.9, 132.0, 118.3, 65.2, 42.7, 36.8, 28.4, 16.5. IR (neat, cm*1):

3021-2936,1733, 1716, 1460.

Methyl 4-oxo-3-phenylpentanoate 357A
A 25-mL oven-dried, round-bottomed flask equipped with a stir bar and a septum
with a flow of nitrogen through a needle was charged with

8

mL of methylene

chloride and diethyl zinc (1.0 M in hexane, 2.5 mL, 2.5 mmol). The solution was
cooled to 0 °C and compound 347A (58 mg, 0.5 mmol, in 1 mL of methylene chloride)
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was added to the solution. After stirring for 10 minutes, 1,1-diiodotoluene (0.86 g, 2.5
mmol, in 2 mL of methylene chloride) was added dropwise by syringe. The mixture
was stirred for

1

hour at room temperature and quenched by cautious addition of

saturated aqueous ammonium chloride (5 mL). The mixture was extracted with
diethyl ether ( 3 x 8 mL). The combined organic extracts were washed with brine (5
mL) and dried over anhydrous sodium sulfate. The resulting liquid was filtered and
concentrated under reduced pressure. The product was purified by flash
chromatography on silica (hexanes:ethyl acetate = 7:1; R/= 0.40) to offer 76 mg
(74%) of 357A as a colorless liquid. 'H NMR (400 MHz, CDC13) 5 7.36-7.20 (m, 5H),
4.19 (dd, 1H ,7= 5.0, 9.8 Hz), 3.65 (s, 3H), 3.22 (dd, 1H, J = 9.9, 17.0 Hz), 2.53 (dd,
1H, J = 5.0, 17.0 Hz), 2.12 (s, 3H); 13C NMR (100 MHz, CDCI3)

8

206.8, 172.5,

137.3, 129.2, 128.2, 127.7, 54.8, 51.8, 36.7, 28.8. IR (neat, cm'1): 3028, 2953-2922,
1754, 1736, 1716, 1453, 1437.

tert-Butyl 4-oxo-3-phenylpentanoate 357B
A 25-mL oven-dried, round-bottomed flask equipped with a stir bar and a septum
with a flow of nitrogen through a needle was charged with

8

mL of methylene

chloride and diethyl zinc (1.0 M in hexanes, 2.0 mL, 2.0 mmol). The solution was
cooled to 0 °C and compound 347B (63 mg, 0.4 mmol, in 1 mL of methylene chloride)
were added to the solution. After stirring for 10 minutes, 1,1-diiodotoluene (0.69 g,
2.0 mmol, in 2 mL of methylene chloride) was added dropwise by syringe. The
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mixture was stirred for 1 hour at room temperature and quenched by cautious addition
of saturated aqueous ammonium chloride (5 mL). The mixture was extracted with
diethyl ether ( 3 x 8 mL). The combined organic extracts were washed with brine (5
mL), and dried over anhydrous sodium sulfate. The resulting liquid was filtered and
concentrated under reduced pressure. The product was purified by flash
chromatography on silica (hexanesrethyl acetate = 7:1; R/= 0.64) to offer 44 mg (44%)
of 357B as a colorless liquid. ’H NMR (500 MHz, CDC13) 5 7.34-7.20 (m, 5H), 4.12
(dd, 1H, J = 5.3, 9.6 Hz), 3.11 (dd, 1H, J = 9.8, 16.7 Hz), 2.46 (dd, 1H, J = 5.3, 16.7
Hz), 2.11 (s, 3H), 1.39 (s, 9H); 13C NMR (100 MHz, CDCI3)

8

206.9, 171.3, 137.5,

129.0, 128.3, 127.6, 80.7, 55.0, 38.2, 28.9, 28.0. IR (neat, cm'1): 2978-2930, 1719,
1367, 1355.

(S)-l-(4-Benzyl-2-oxooxazolidin-3-yl)-3-methylpentane-l,4-dione 366A and 366B
A 10-mL oven-dried, round-bottomed flask equipped with a stir bar and a septum
with a flow of nitrogen through a needle was charged with 3 mL of methylene
chloride and diethyl zinc (1.0 M in hexanes, 1.25 mL, 1.25 mmol). The solution was
cooled to 0 °C and compound 365 (65 mg, 0.25 mmol, in 1 mL of methylene chloride)
was added to the solution. After stirring for 10 minutes, 1,1-diiodoethane (0.13 mL,
1.25 mmol) was added dropwise by syringe. The mixture was stirred for 1 hour at
room temperature and quenched by cautious addition o f saturated aqueous ammonium
chloride (2 mL). The mixture was extracted with diethyl ether ( 3 x 5 mL). The
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combined organic extracts were washed with brine (5 mL) and dried over anhydrous
sodium sulfate. The resulting liquid was filtered and concentrated under reduced
pressure. The product was purified by flash chromatography on silica (hexanes:ethyl
acetate = 3:1; R /= 0.20) to offer 36 mg (50%) of mixture of 366A (24%) and 366B
(26%) as a colorless liquid. 366A: 'H NMR (500 MHz, CDC13) 5 7.35-7.20 (m, 5H),
4.64 (m, 1H), 4.22-6.16 (m, 2H), 3.50 (dd, 1H, J = 9.8, 18.3 Hz), 3.20 (dd, 1H, J = 3.3,
13.5 Hz), 3.12 (m, 1H), 2.84 (dd, 1H, J = 3.9, 18.2 Hz), 2.80 (dd, 1H, J = 8.5, 12.9
Hz), 2.28 (s, 3H), 1.22 (d, 3H, J = 7.4 Hz); 13C (100 MHz, CDC13) 8 211.1, 172.2,
153.7, 135.3, 129.7, 129.2, 127.5, 66.4, 55.1, 42.3, 39.0, 37.9, 28.7, 16.8. 366B: ’H
NMR (500 MHz, CDC13) 5 7.34-7.18 (m, 5H), 4.62 (m, 1H), 4.22 (dd, 1H, J = 9.1,
9.1 Hz), 4.15 (dd, 1H, .7=2.6, 9.1 Hz), 3.43 (dd, 1H, 7= 10.3, 18.4 Hz), 3.27 (dd, 1H,
J = 3.4, 13.4 Hz), 3.15 (m, 1H), 2.91 (dd, 1H, 7 = 3.6, 18.4 Hz), 2.74 (dd, 1H, 7 = 9.8,
13.4 Hz), 2.28 (s, 3H), 1.22 (d, 3H, 7 = 7.3 Hz); 13C (100 MHz, CDC13) 8 211.4, 172.1,
153.7,135.4, 129.6,129.2, 127.6, 66.5, 55.4, 42.1, 39.0, 38.1, 29.9,16.8.
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